#1.3
1022	10	19	36
id	affx_cel	cal_fold_change	cal_range	cell_aliases	cell_comment	cell_gender	cell_histology	cell_id	cell_lineage	cell_source	cell_source_id	cell_type	is_from_metastasis	metastatic_site	original_cid	platform	qc_f_logp	qc_iqr	qc_slope	LJP006_PC3_24H_X3_B19:A03	LJP006_PC3_24H_X3_B19:A04	LJP006_PC3_24H_X3_B19:A05	LJP006_PC3_24H_X3_B19:A06	LJP006_PC3_24H_X3_B19:A07	LJP006_PC3_24H_X3_B19:A08	LJP006_PC3_24H_X3_B19:A09	LJP006_PC3_24H_X3_B19:A10	LJP006_PC3_24H_X3_B19:A11	LJP006_PC3_24H_X3_B19:A12
qc_slope	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	57	58	57	59	60	58	59	59	57	60
qc_f_logp	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	8.4	8	8.4	8.2	8.1	8.5	8.1	8.3	9.1	7.7
qc_iqr	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	7.22	7.91	7.18	8.49	8.88	7.16	8.89	8.11	7.92	7.94
bead_batch	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	b19	b19	b19	b19	b19	b19	b19	b19	b19	b19
bead_revision	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	r2	r2	r2	r2	r2	r2	r2	r2	r2	r2
bead_set	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	dp52,dp53	dp52,dp53	dp52,dp53	dp52,dp53	dp52,dp53	dp52,dp53	dp52,dp53	dp52,dp53	dp52,dp53	dp52,dp53
cell_id	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	PC3	PC3	PC3	PC3	PC3	PC3	PC3	PC3	PC3	PC3
det_mode	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	duo	duo	duo	duo	duo	duo	duo	duo	duo	duo
det_plate	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	LJP006_PC3_24H_X3_B19	LJP006_PC3_24H_X3_B19	LJP006_PC3_24H_X3_B19	LJP006_PC3_24H_X3_B19	LJP006_PC3_24H_X3_B19	LJP006_PC3_24H_X3_B19	LJP006_PC3_24H_X3_B19	LJP006_PC3_24H_X3_B19	LJP006_PC3_24H_X3_B19	LJP006_PC3_24H_X3_B19
det_well	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	A03	A04	A05	A06	A07	A08	A09	A10	A11	A12
mfc_plate_dim	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	-666	-666	-666	-666	-666	-666	-666	-666	-666	-666
mfc_plate_id	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	-666	-666	-666	-666	-666	-666	-666	-666	-666	-666
mfc_plate_name	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	C-5001-01-LM6-001	C-5001-01-LM6-001	C-5001-01-LM6-001	C-5001-01-LM6-001	C-5001-01-LM6-001	C-5001-01-LM6-001	C-5001-01-LM6-001	C-5001-01-LM6-001	C-5001-01-LM6-001	C-5001-01-LM6-001
mfc_plate_quad	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	-666	-666	-666	-666	-666	-666	-666	-666	-666	-666
mfc_plate_well	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	A03	A04	A05	A06	A07	A08	A09	A10	A11	A12
pert_dose	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	-666	-666	-666	-666	10	3.33	1.11	0.37	0.12	0.04
pert_dose_unit	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	-666	-666	-666	-666	um	um	um	um	um	um
pert_id	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	DMSO	DMSO	DMSO	DMSO	BRD-K69932463	BRD-K69932463	BRD-K69932463	BRD-K69932463	BRD-K69932463	BRD-K69932463
pert_id_vendor	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	-666	-666	-666	-666	-666	-666	-666	-666	-666	-666
pert_idose	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	-666	-666	-666	-666	10.0 um	3.33 um	1.11 um	0.37 um	0.12 um	0.04 um
pert_iname	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	DMSO	DMSO	DMSO	DMSO	AZD-8055	AZD-8055	AZD-8055	AZD-8055	AZD-8055	AZD-8055
pert_itime	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	24 h	24 h	24 h	24 h	24 h	24 h	24 h	24 h	24 h	24 h
pert_mfc_desc	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	DMSO	DMSO	DMSO	DMSO	AZD8055	AZD8055	AZD8055	AZD8055	AZD8055	AZD8055
pert_mfc_id	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	dmso	dmso	dmso	dmso	BRD-K69932463-001-09-8	BRD-K69932463-001-09-8	BRD-K69932463-001-09-8	BRD-K69932463-001-09-8	BRD-K69932463-001-09-8	BRD-K69932463-001-09-8
pert_time	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	24	24	24	24	24	24	24	24	24	24
pert_time_unit	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	h	h	h	h	h	h	h	h	h	h
pert_type	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	ctl_vehicle	ctl_vehicle	ctl_vehicle	ctl_vehicle	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp
pert_vehicle	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	-666	-666	-666	-666	DMSO	DMSO	DMSO	DMSO	DMSO	DMSO
pool_id	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	epsilon	epsilon	epsilon	epsilon	epsilon	epsilon	epsilon	epsilon	epsilon	epsilon
rna_plate	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	LJP006_PC3_24H_X3	LJP006_PC3_24H_X3	LJP006_PC3_24H_X3	LJP006_PC3_24H_X3	LJP006_PC3_24H_X3	LJP006_PC3_24H_X3	LJP006_PC3_24H_X3	LJP006_PC3_24H_X3	LJP006_PC3_24H_X3	LJP006_PC3_24H_X3
rna_well	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	A03	A04	A05	A06	A07	A08	A09	A10	A11	A12
x_hmsl_id	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	-666	-666	-666	-666	HMSL10007	HMSL10007	HMSL10007	HMSL10007	HMSL10007	HMSL10007
x_pert_type	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	ctl_vehicle	ctl_vehicle	ctl_vehicle	ctl_vehicle	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp	trt_cp
count_mean	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	62	60	62	59	55	54	53	52	51	55
count_cv	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	23	23	23	24	25	24	24	24	24	23
provenance_code	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	KMV+F2D+INO+QNO	KMV+F2D+INO+QNO	KMV+F2D+INO+QNO	KMV+F2D+INO+QNO	KMV+F2D+INO+QNO	KMV+F2D+INO+QNO	KMV+F2D+INO+QNO	KMV+F2D+INO+QNO	KMV+F2D+INO+QNO	KMV+F2D+INO+QNO
PC3	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_B11_257642	44.2	141	PC-3	-666	M	carcinoma	PC3	prostate	ATCC	CRL-1435	cancer cell line	Y	bone	fh_PC3_PROSTATE-Tumor	rnaseq	7.2	23.71	55	0.6013	0.6129	0.6462	0.5827	0.5280	0.5661	0.5726	0.6216	0.6257	0.6287
PC9	-666	45.3	133	-666	-666	-666	-666	PC9	-666	-666	-666	cancer cell line	-666	-666	fh_PC-9-Tumor	rnaseq	15.7	21.21	55	0.5138	0.5202	0.5408	0.4871	0.4405	0.4697	0.4787	0.5173	0.5307	0.5351
NCIH460	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_H05_241218	51.4	169	NCI-H460|H460	-666	M	carcinoma,large cell	NCIH460	lung	ATCC	HTB-177	cancer cell line	Y	pleural_effusion	fh_NCIH460_LUNG-Tumor	rnaseq	15.7	21.1	53	0.5005	0.5000	0.5374	0.4850	0.3890	0.4501	0.4670	0.5171	0.5168	0.5151
HUPT3	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_H10_241228	44.8	124	HUP-T3	-666	M	carcinoma	HUPT3	pancreas	DSMZ	-666	cancer cell line	-666	-666	fh_HUPT3_PANCREAS-Tumor	rnaseq	6.7	26.17	56	0.4793	0.5065	0.5201	0.4693	0.4349	0.4585	0.4662	0.5052	0.5154	0.5136
IOMMLEE	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_C10_767860	46	195	-666	-666	-666	meningioma	IOMMLEE	CNS	-666	-666	cancer cell line	-666	-666	fh_IOMMLEE_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.9	20.29	54	0.4814	0.4916	0.5261	0.4727	0.3894	0.4406	0.4668	0.5103	0.5138	0.5253
PSN1	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_E08_257708	36.9	125	-666	Identical lines: GR-M and PSN1 share high SNP identity and are likely to be really PSN1 (pancreas)	-666	carcinoma,ductal	PSN1	pancreas	ECACC	-666	cancer cell line	-666	-666	fh_PSN1_PANCREAS-Tumor	rnaseq	7.2	25.85	56	0.4876	0.5010	0.5239	0.4767	0.4188	0.4455	0.4611	0.5064	0.5159	0.5171
NUGC3	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_C02_257648	42.9	129	NUGC-3	-666	M	carcinoma	NUGC3	stomach	HSRRB	-666	cancer cell line	-666	-666	fh_NUGC3_STOMACH-Tumor	rnaseq	15.7	19.22	55	0.4764	0.5029	0.5313	0.4763	0.4165	0.4507	0.4496	0.4980	0.5079	0.5231
SW480	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_E08_436474	56.5	216	-666	Metastatic pair: SW620 and SW480 were derived from the same patient	M	adenocarcinoma,colorectal	SW480	large intestine,colon	ATCC	CCL-228	cancer cell line	-666	-666	fh_SW480_LARGE_INTESTINE-Tumor	rnaseq	7.2	20.33	53	0.4713	0.4998	0.5287	0.4757	0.4071	0.4502	0.4517	0.5011	0.4989	0.5212
NCIH1915	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_E04_698784	51.3	220	NCI-H1915	-666	F	carcinoma,large cell	NCIH1915	lung	ATCC	CRL-5904	cancer cell line	Y	brain	fh_NCIH1915_LUNG-Tumor	rnaseq	15.7	17.3	53	0.4752	0.5022	0.5343	0.4721	0.4128	0.4423	0.4590	0.4998	0.5060	0.5276
NCIH2887	-666	30.9	140	-666	-666	-666	-666	NCIH2887	-666	-666	-666	cancer cell line	-666	-666	fh_NCI-H2887-Tumor	rnaseq	6.1	25.96	57	0.4714	0.5035	0.5280	0.4833	0.4073	0.4553	0.4564	0.4961	0.4969	0.4969
SF172	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_B04_767848	38.4	126	-666	-666	-666	glioma	SF172	CNS	-666	-666	cancer cell line	-666	-666	fh_SF172_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	21.1	56	0.4764	0.4960	0.5244	0.4705	0.4103	0.4483	0.4510	0.4945	0.5021	0.5162
DANG	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_H04_241216	32.2	91	DAN-G	-666	-666	carcinoma	DANG	pancreas	DSMZ	-666	cancer cell line	N	-666	fh_DANG_PANCREAS-Tumor	rnaseq	7.2	15.49	55	0.4764	0.4938	0.5128	0.4670	0.4158	0.4544	0.4678	0.5047	0.5080	0.4994
HCC364	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_C07_767802	38.6	129	-666	-666	-666	carcinoma	HCC364	lung	-666	-666	cancer cell line	-666	-666	fh_HCC364_LUNG-Tumor	rnaseq	7.2	16.42	56	0.4648	0.4965	0.5202	0.4551	0.4144	0.4397	0.4538	0.4920	0.5066	0.5059
HSC3	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_G03_419808	37	113	HSC-3	-666	M	carcinoma,squamous cell	HSC3	upper aerodigestive tract,tongue	HSRRB	-666	cancer cell line	-666	-666	fh_HSC3_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	16.91	56	0.4619	0.4918	0.5291	0.4583	0.3957	0.4422	0.4509	0.4893	0.5066	0.5085
HARA	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_A03_383722	31	105	-666	-666	M	carcinoma,squamous cell	HARA	lung	HSRRB	-666	cancer cell line	N	-666	fh_HARA_LUNG-Tumor	rnaseq	15.7	15.01	56	0.4693	0.4832	0.5191	0.4707	0.3890	0.4320	0.4587	0.4919	0.5012	0.5037
HCC461	-666	37.9	133	-666	-666	-666	-666	HCC461	-666	-666	-666	cancer cell line	-666	-666	fh_HCC461-Tumor	rnaseq	6.4	25.66	57	0.4676	0.4896	0.5160	0.4591	0.4024	0.4430	0.4522	0.4955	0.4927	0.5084
CAL120	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_H01_474610	36.8	147	CAL-120	-666	F	carcinoma	CAL120	breast	DSMZ	-666	cancer cell line	-666	-666	fh_CAL120_BREAST-Tumor	rnaseq	6.7	24.71	56	0.4685	0.4822	0.5223	0.4706	0.4300	0.4347	0.4512	0.4889	0.4971	0.5050
OVCAR8	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_G07_569544	32.9	107	OVCAR-8	-666	F	carcinoma	OVCAR8	ovary	NCI/DCTD	-666	cancer cell line	-666	-666	fh_OVCAR8_OVARY-Tumor	rnaseq	15.7	20.17	56	0.4651	0.4955	0.5189	0.4608	0.3965	0.4375	0.4551	0.5035	0.4958	0.5007
NCIH358	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_B06_383736	37.5	121	NCI-H358|H358	-666	M	carcinoma,bronchioalveolar,non-small cell lung cancer	NCIH358	lung,bronchus,alveolus	ATCC	CRL-5807	cancer cell line	-666	-666	fh_NCIH358_LUNG-Tumor	rnaseq	15.7	17.95	56	0.4736	0.4797	0.5204	0.4639	0.4059	0.4368	0.4419	0.4868	0.4981	0.5210
NCIH2347	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_D01_436528	38.3	120	NCI-H2347|H2347	-666	F	adenocarcinoma,NSCLC	NCIH2347	lung	ATCC	CRL-5942	cancer cell line	-666	-666	fh_NCIH2347_LUNG-Tumor	rnaseq	15.7	18.75	56	0.4642	0.4918	0.5107	0.4506	0.4075	0.4526	0.4441	0.4898	0.4991	0.5094
BC3C	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_F07_474594	36.1	117	BC-3C	-666	F	carcinoma,transitional cell	BC3C	urinary tract,bladder	DSMZ	-666	cancer cell line	N	-666	fh_BC3C_URINARY_TRACT-Tumor	rnaseq	15.7	20.79	56	0.4795	0.4774	0.4987	0.4708	0.3932	0.4418	0.4470	0.4952	0.4902	0.5042
ES2	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_G02_296136	44.8	145	ES-2	-666	F	carcinoma,clearcell	ES2	ovary	ATCC	CRL-1978	cancer cell line	-666	-666	fh_ES2_OVARY-Tumor	rnaseq	7.2	21.81	55	0.4769	0.4871	0.5039	0.4579	0.4061	0.4323	0.4441	0.4970	0.4994	0.5065
YD15	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_D10_698782	42.4	121	-666	-666	M	mucoepidermoid carcinoma	YD15	salivary gland	KCLB	-666	cancer cell line	-666	-666	fh_YD15_SALIVARY_GLAND-Tumor	rnaseq	7.2	17.94	56	0.4733	0.4814	0.5135	0.4596	0.3977	0.4317	0.4472	0.4878	0.5020	0.5035
PANC0403	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_A01_295990	26.5	83	PANC 04.03	-666	M	carcinoma	PANC0403	pancreas	ATCC	CRL-2555	cancer cell line	-666	-666	fh_PANC0403_PANCREAS-Tumor	rnaseq	7.2	18.02	57	0.4684	0.4825	0.5122	0.4514	0.4145	0.4437	0.4385	0.4858	0.4943	0.5009
NCIH3122	-666	41.6	131	-666	-666	-666	-666	NCIH3122	-666	-666	-666	cancer cell line	-666	-666	fh_NCIH3122-Tumor	rnaseq	15.7	20.13	55	0.4707	0.4753	0.5221	0.4623	0.4003	0.4414	0.4353	0.4834	0.4896	0.5089
SNU46	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_C01_587674	36.1	138	NCI-SNU-46	-666	M	carcinoma,squamous cell	SNU46	upper aerodigestive tract	KCLB	-666	cancer cell line	-666	-666	fh_SNU46_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	4.8	29.52	58	0.4661	0.4863	0.5094	0.4628	0.4147	0.4269	0.4412	0.4922	0.4897	0.5020
CALU6	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_E04_241144	40.3	136	CALU-6	-666	F	carcinoma,undifferentiated,probably lung anaplastic	CALU6	lung	ATCC	HTB-56	cancer cell line	-666	-666	fh_CALU6_LUNG-Tumor	rnaseq	6.7	20.89	56	0.4621	0.4938	0.5120	0.4647	0.4208	0.4336	0.4506	0.4879	0.4817	0.4936
SW1990	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_D02_436522	61.5	222	SW 1990	-666	M	carcinoma,ductal	SW1990	pancreas	ATCC	CRL-2172	cancer cell line	Y	spleen	fh_SW1990_PANCREAS-Tumor	rnaseq	7.2	18.91	53	0.4684	0.4680	0.5131	0.4555	0.4025	0.4350	0.4537	0.4850	0.4908	0.5090
T3M10	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_A02_454760	30.9	105	T3M-10	-666	M	carcinoma,large cell	T3M10	lung	RIKEN	-666	cancer cell line	N	-666	fh_T3M10_LUNG-Tumor	rnaseq	6.6	25.53	57	0.4849	0.4782	0.4877	0.4419	0.4103	0.4498	0.4441	0.4914	0.4942	0.4939
DETROIT562	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_E06_302136	40.7	120	DETROIT 562	-666	F	carcinoma	DETROIT562	upper aerodigestive tract,pharynx	ATCC	CCL-138	cancer cell line	Y	pleural_effusion	fh_DETROIT562_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	25.65	56	0.4604	0.4802	0.5165	0.4589	0.3965	0.4392	0.4469	0.4838	0.4901	0.5021
DU145	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_G07_241006	46.8	142	DU 145	-666	M	carcinoma	DU145	prostate	ATCC	HTB-81	cancer cell line	Y	brain	fh_DU145_PROSTATE-Tumor	rnaseq	6.6	20.89	55	0.4565	0.4903	0.5173	0.4579	0.3894	0.4256	0.4436	0.4862	0.4975	0.5057
HT115	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_F05_698832	37.2	132	HT115	-666	-666	carcinoma	HT115	large intestine,colon	ECACC	-666	cancer cell line	N	-666	fh_HT115_LARGE_INTESTINE-Tumor	rnaseq	15.7	17.08	55	0.4687	0.4766	0.5159	0.4587	0.4004	0.4342	0.4376	0.4775	0.4951	0.4981
HCT116	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_G05_241002	38.1	136	HCT 116	-666	M	carcinoma,colorectal	HCT116	large intestine,colon	ATCC	CCL-247	cancer cell line	-666	-666	fh_HCT116_LARGE_INTESTINE-Tumor	rnaseq	6.4	20.17	56	0.4550	0.4785	0.5142	0.4590	0.3876	0.4213	0.4441	0.4702	0.4906	0.4986
PK1	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_D06_454644	37.9	129	PK-1	PK-1 is derived from the same patient as KLM-1 cells	-666	carcinoma	PK1	pancreas	RIKEN	-666	cancer cell line	N	-666	fh_PK1_PANCREAS-Tumor	rnaseq	15.7	28.62	56	0.4673	0.4758	0.5077	0.4577	0.3968	0.4348	0.4388	0.4872	0.4990	0.4938
HEYA8	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_G01_240994	61	210	HEY-A8	-666	F	carcinoma	HEYA8	ovary	-666	-666	cancer cell line	N	-666	fh_HEYA8_OVARY-Tumor	rnaseq	6.4	21.94	54	0.4591	0.4823	0.5130	0.4561	0.3985	0.4147	0.4376	0.4827	0.4928	0.5058
NCIH1792	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_D04_383692	30.4	123	NCI-H1792|H1792	-666	M	carcinoma	NCIH1792	lung	ATCC	CRL-5895	cancer cell line	Y	pleural_effusion	fh_NCIH1792_LUNG-Tumor	rnaseq	6.9	29.84	57	0.4789	0.4782	0.5047	0.4598	0.3927	0.4277	0.4336	0.4933	0.4886	0.4910
PC14	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_G01_241186	30.6	98	PC-14	-666	-666	carcinoma,non-small cell	PC14	lung	RIKEN	-666	cancer cell line	-666	-666	fh_PC14_LUNG-Tumor	rnaseq	15.7	21.65	57	0.4779	0.4767	0.4960	0.4552	0.4190	0.4330	0.4387	0.4839	0.4869	0.4890
TT2609C02	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_G09_474750	33.8	129	TT2609-C02	-666	M	carcinoma,follicular	TT2609C02	thyroid	DSMZ	-666	cancer cell line	N	-666	fh_TT2609C02_THYROID-Tumor	rnaseq	7.2	19.87	56	0.4617	0.4789	0.5130	0.4465	0.3884	0.4272	0.4473	0.4830	0.4917	0.4957
HELA	-666	54	211	-666	-666	-666	adenocarcinoma	HELA	cervix	ATCC	CCL-2	cancer cell line	-666	-666	fh_HeLa-Tumor	rnaseq	6.2	22.23	54	0.4507	0.4774	0.5086	0.4500	0.3864	0.4245	0.4404	0.4876	0.4862	0.5000
KM12	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_D03_257674	64.2	264	-666	-666	-666	carcinoma	KM12	large intestine	-666	-666	cancer cell line	-666	-666	fh_KM12_LARGE_INTESTINE-Tumor	rnaseq	5.9	20.06	53	0.4490	0.4696	0.5276	0.4701	0.4050	0.4256	0.4249	0.4666	0.4873	0.5067
OC314	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_H10_454746	28.1	119	OC-314	Identical lines: OC314, OC315 and OC316 share high SNP identity	F	serous carcinoma	OC314	ovary	ICLC	-666	cancer cell line	-666	-666	fh_OC314_OVARY-Tumor	rnaseq	6.9	24.62	57	0.4482	0.4825	0.5122	0.4489	0.4007	0.4093	0.4387	0.4764	0.4891	0.4986
RERFLCAI	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_C12_241112	35.2	119	RERF-LC-AI	-666	M	carcinoma,squamous cell	RERFLCAI	lung	RIKEN	-666	cancer cell line	N	-666	fh_RERFLCAI_LUNG-Tumor	rnaseq	6.6	17.25	57	0.4532	0.4740	0.5106	0.4591	0.3978	0.4139	0.4433	0.4805	0.4856	0.5020
RKO	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_G02_454712	55.2	257	-666	-666	-666	carcinoma	RKO	large intestine	ATCC	-666	cancer cell line	-666	-666	fh_RKO_LARGE_INTESTINE-Tumor	rnaseq	5.4	22.11	54	0.4557	0.4757	0.5139	0.4591	0.3762	0.4238	0.4399	0.4791	0.4891	0.5067
J82	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_D12_241136	32.3	105	-666	-666	M	carcinoma,transitional cell	J82	urinary tract,bladder	ATCC	HTB-1	cancer cell line	-666	-666	fh_J82_URINARY_TRACT-Tumor	rnaseq	15.7	20.1	57	0.4590	0.4705	0.5019	0.4540	0.3960	0.4401	0.4477	0.4876	0.4778	0.4941
HEC50B	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_G01_419812	49.5	151	HEC-50B	-666	F	carcinoma	HEC50B	endometrium	HSRRB	-666	cancer cell line	N	-666	fh_HEC50B_ENDOMETRIUM-Tumor	rnaseq	15.7	19.85	54	0.4590	0.4820	0.5027	0.4499	0.3930	0.4051	0.4444	0.4747	0.4908	0.4859
T24	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_E03_383672	34	116	-666	Identical lines: T24 and ACCS share high SNP identity	F	carcinoma,transitional cell	T24	urinary tract,bladder	ATCC	HTB-4	cancer cell line	-666	-666	fh_T24_URINARY_TRACT-Tumor	rnaseq	15.7	21.3	57	0.4585	0.4719	0.5018	0.4532	0.3913	0.4209	0.4420	0.4915	0.4826	0.4933
MDAMB231	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_A01_241042	36.1	121	MDA-MB-231	-666	F	carcinoma	MDAMB231	breast	ATCC	HTB-26	cancer cell line	Y	pleural_effusion	fh_MDAMB231_BREAST-Tumor	rnaseq	6.1	22.94	57	0.4551	0.4731	0.5001	0.4424	0.4015	0.4316	0.4468	0.4877	0.4808	0.4906
639V	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_G06_474746	34.3	166	639-V	-666	M	carcinoma,transitional cell	639V	urinary tract	DSMZ	-666	cancer cell line	-666	-666	fh_639V_URINARY_TRACT-Tumor	rnaseq	5.5	26.45	57	0.4601	0.4764	0.4980	0.4492	0.3840	0.4176	0.4420	0.4889	0.4774	0.4883
PATU8902	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_G05_241194	36	113	PA-TU-8902	-666	F	carcinoma,ductal	PATU8902	pancreas	DSMZ	-666	cancer cell line	N	-666	fh_PATU8902_PANCREAS-Tumor	rnaseq	15.7	16.54	55	0.4561	0.4650	0.4950	0.4507	0.3968	0.4272	0.4358	0.4772	0.4745	0.4960
MIAPACA2	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_B01_240874	44.9	159	MIA PACA-2	-666	M	carcinoma,ductal	MIAPACA2	pancreas	ATCC	CRL-1420	cancer cell line	-666	-666	fh_MIAPACA2_PANCREAS-Tumor	rnaseq	15.7	21.98	54	0.4529	0.4649	0.4952	0.4600	0.3955	0.4177	0.4420	0.4870	0.4854	0.5003
PATU8988T	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_E11_257714	32.6	120	PA-TU-8988T	Identical lines: PA-TU-8988T and PA-TU-8988S are from the same patient	F	carcinoma,ductal	PATU8988T	pancreas	DSMZ	-666	cancer cell line	N	-666	fh_PATU8988T_PANCREAS-Tumor	rnaseq	6.3	18.8	57	0.4457	0.4754	0.5001	0.4567	0.3806	0.4094	0.4336	0.4776	0.4748	0.4910
CL11	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_G07_474626	35.5	118	CL-11	-666	-666	carcinoma	CL11	large intestine,colon	DSMZ	-666	cancer cell line	N	-666	fh_CL11_LARGE_INTESTINE-Tumor	rnaseq	7.2	25.72	56	0.4606	0.4715	0.4961	0.4478	0.4178	0.4376	0.4280	0.4732	0.4811	0.4806
LS180	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_G11_296154	34.7	118	LS 180	-666	F	adenocarcinoma,colorectal	LS180	large intestine,colon	ATCC	CL-187	cancer cell line	-666	-666	fh_LS180_LARGE_INTESTINE-Tumor	rnaseq	15.7	22.81	56	0.4563	0.4690	0.4974	0.4456	0.3955	0.4221	0.4349	0.4634	0.4796	0.4875
A1207	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_C05_767940	42.7	137	-666	-666	-666	glioma	A1207	CNS	-666	-666	cancer cell line	-666	-666	fh_A1207_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	20.38	55	0.4597	0.4724	0.4966	0.4475	0.3827	0.4162	0.4370	0.4721	0.4761	0.4801
8505C	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_D05_474716	39.8	125	-666	-666	F	carcinoma,anaplastic	8505C	thyroid	HSRRB	-666	cancer cell line	-666	-666	fh_8505C_THYROID-Tumor	rnaseq	6.2	24.75	56	0.4480	0.4737	0.4964	0.4475	0.3940	0.4198	0.4435	0.4806	0.4729	0.4833
OVCAR4	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_A11_241062	66.1	186	OVCAR-4	-666	F	carcinoma	OVCAR4	ovary	NCI/DCTD	-666	cancer cell line	-666	-666	fh_OVCAR4_OVARY-Tumor	rnaseq	6.9	23.94	53	0.4527	0.4726	0.4986	0.4334	0.4031	0.4254	0.4263	0.4690	0.4794	0.4859
MPP89	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_D03_454638	45.3	156	MPP-89	-666	M	mesothelioma	MPP89	pleura	ICLC	-666	cancer cell line	-666	-666	fh_MPP89_PLEURA-Tumor	rnaseq	6.3	21.24	55	0.4524	0.4727	0.5028	0.4489	0.3926	0.4189	0.4263	0.4737	0.4764	0.4869
A2058	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_C11_779802	45.2	141	-666	-666	M	melanoma	A2058	skin	ATCC	CRL-11147	cancer cell line	Y	lymph_node	fh_A2058_SKIN-Tumor	rnaseq	6.5	23.95	55	0.4656	0.4796	0.4961	0.4417	0.3855	0.4214	0.4308	0.4717	0.4666	0.4696
NCIH2087	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_D09_436574	34.4	117	NCI-H2087|H2087	-666	M	adenocarcinoma,NSCLC	NCIH2087	lung	ATCC	CRL-5922	cancer cell line	Y	lymph_node	fh_NCIH2087_LUNG-Tumor	rnaseq	6.9	23.27	57	0.4503	0.4729	0.4977	0.4433	0.3957	0.4221	0.4264	0.4688	0.4776	0.4910
TE10	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_A05_698772	41.4	108	TE-10	-666	-666	carcinoma,squamous cell	TE10	oesophagus	RIKEN	-666	cancer cell line	-666	-666	fh_TE10_OESOPHAGUS-Tumor	rnaseq	15.7	20.34	55	0.4524	0.4629	0.4989	0.4523	0.3808	0.4221	0.4248	0.4737	0.4771	0.4868
TE4	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_D06_698874	36.7	127	TE-4	-666	-666	carcinoma,squamous cell	TE4	oesophagus	RIKEN	-666	cancer cell line	N	-666	fh_TE4_OESOPHAGUS-Tumor	rnaseq	15.7	19.72	56	0.4630	0.4734	0.4965	0.4441	0.4027	0.4202	0.4252	0.4656	0.4738	0.4850
NCIH2444	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_D12_257692	36.3	102	NCI-H2444|H2444	-666	M	carcinoma,non-small cell	NCIH2444	lung	ATCC	CRL-5945	cancer cell line	-666	-666	fh_NCIH2444_LUNG-Tumor	rnaseq	7.2	21.89	56	0.4512	0.4733	0.5001	0.4377	0.4132	0.4304	0.4295	0.4718	0.4704	0.4772
5637	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_F08_436450	40	119	5637	-666	M	carcinoma	5637	urinary tract,bladder	ATCC	HTB-9	cancer cell line	-666	-666	fh_5637_URINARY_TRACT-Tumor	rnaseq	15.7	16.31	55	0.4554	0.4633	0.4936	0.4359	0.3796	0.4423	0.4308	0.4783	0.4821	0.4832
CAL62	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_E01_474604	37.1	122	CAL-62	-666	F	carcinoma,anaplastic	CAL62	thyroid	DSMZ	-666	cancer cell line	-666	-666	fh_CAL62_THYROID-Tumor	rnaseq	7.2	22.58	56	0.4545	0.4722	0.4907	0.4468	0.3940	0.4142	0.4488	0.4795	0.4758	0.4831
LU99	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_B12_419712	42	148	LU99A	-666	M	carcinoma,large cell	LU99	lung	HSRRB	-666	cancer cell line	N	-666	fh_LU99_LUNG-Tumor	rnaseq	5.8	17.85	56	0.4553	0.4752	0.4907	0.4446	0.3663	0.4054	0.4296	0.4788	0.4813	0.4817
OE21	-666	36.8	98	OE21	-666	M	carcinoma,squamous cell	OE21	oesophagus	ECACC	-666	cancer cell line	N	-666	fh_OE21_OESOPHAGUS-Tumor	rnaseq	15.7	18.41	57	0.4560	0.4588	0.4927	0.4489	0.3823	0.4211	0.4275	0.4744	0.4837	0.4827
ACCMESO1	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_C01_698828	85.7	281	ACC-MESO-1	-666	-666	mesothelioma	ACCMESO1	pleura	RIKEN	-666	cancer cell line	Y	pleural_effusion	fh_ACCMESO1_PLEURA-Tumor	rnaseq	15.7	17.75	50	0.4394	0.4625	0.5135	0.4478	0.3932	0.4253	0.4216	0.4633	0.4923	0.5037
HCC2108	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_A09_569560	25.7	88	HCC-2108	-666	M	adenocarcinoma	HCC2108	lung	KCLB	-666	cancer cell line	N	-666	fh_HCC2108_LUNG-Tumor	rnaseq	15.7	22.95	57	0.4508	0.4709	0.4854	0.4347	0.4006	0.4086	0.4311	0.4673	0.4800	0.4922
KNS62	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_B12_383632	28.3	87	KNS-62	-666	M	carcinoma,squamous cell	KNS62	lung	HSRRB	-666	cancer cell line	-666	-666	fh_KNS62_LUNG-Tumor	rnaseq	6.6	25.53	59	0.4640	0.4606	0.4948	0.4404	0.3944	0.4200	0.4306	0.4671	0.4805	0.4666
CORL23	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_A01_383726	37.2	123	COR-L23	-666	M	carcinoma,large cell	CORL23	lung	ECACC	-666	cancer cell line	-666	-666	fh_CORL23_LUNG-Tumor	rnaseq	7.2	23.15	56	0.4516	0.4818	0.4894	0.4476	0.4063	0.4165	0.4258	0.4757	0.4721	0.4778
SNU1033	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_G01_698894	37.7	106	SNU-1033|NCI-SNU-1033	-666	F	carcinoma	SNU1033	large intestine,colon	KCLB	-666	cancer cell line	N	-666	fh_SNU1033_LARGE_INTESTINE-Tumor	rnaseq	15.7	22.12	56	0.4526	0.4684	0.4871	0.4353	0.4008	0.4238	0.4168	0.4643	0.4771	0.4933
SH10TC	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_B01_419872	35.6	120	-666	-666	-666	carcinoma	SH10TC	stomach	RIKEN	-666	cancer cell line	-666	-666	fh_SH10TC_STOMACH-Tumor	rnaseq	15.7	22.13	56	0.4514	0.4705	0.4935	0.4381	0.3848	0.4085	0.4339	0.4717	0.4806	0.4799
OV7	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_F06_569466	37.9	105	-666	-666	F	carcinoma	OV7	ovary	ECACC	-666	cancer cell line	-666	-666	fh_OV7_OVARY-Tumor	rnaseq	15.7	19.14	56	0.4548	0.4610	0.4939	0.4410	0.3922	0.4170	0.4276	0.4751	0.4760	0.4914
HOP62	-666	44.3	146	HOP-62	-666	-666	carcinoma	HOP62	lung	DTP	-666	cancer cell line	-666	-666	fh_HOP62_LUNG-Tumor	rnaseq	7.2	19.78	55	0.4403	0.4742	0.4955	0.4468	0.3901	0.4080	0.4348	0.4666	0.4803	0.4842
SNU61	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_E03_698884	41.9	119	SNU-61|NCI-SNU-61	-666	M	carcinoma	SNU61	large intestine,colon	KCLB	-666	cancer cell line	N	-666	fh_SNU61_LARGE_INTESTINE-Tumor	rnaseq	15.7	19.32	55	0.4505	0.4688	0.4952	0.4504	0.3867	0.4150	0.4238	0.4616	0.4817	0.4914
SW1463	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_B05_241074	57.1	204	-666	-666	F	adenocarcinoma,colorectal	SW1463	large intestine,rectum	ATCC	CCL-234	cancer cell line	-666	-666	fh_SW1463_LARGE_INTESTINE-Tumor	rnaseq	6.1	27.18	54	0.4471	0.4647	0.5027	0.4485	0.3878	0.4191	0.4118	0.4585	0.4818	0.4953
MCAS	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_B02_240876	41.6	111	-666	-666	F	carcinoma	MCAS	ovary	HSRRB	-666	cancer cell line	N	-666	fh_MCAS_OVARY-Tumor	rnaseq	7.2	19.09	56	0.4504	0.4704	0.4874	0.4424	0.3918	0.4242	0.4359	0.4766	0.4756	0.4842
MDAMB436	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_C09_383596	44.1	149	MDA-MB-436	-666	F	carcinoma	MDAMB436	breast	ATCC	HTB-130	cancer cell line	Y	pleural_effusion	fh_MDAMB436_BREAST-Tumor	rnaseq	5.9	24.7	55	0.4479	0.4679	0.4850	0.4374	0.3788	0.4234	0.4298	0.4750	0.4764	0.4846
TE11	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_C09_296054	40.9	123	TE-11	-666	-666	carcinoma,squamous cell	TE11	oesophagus	RIKEN	-666	cancer cell line	-666	-666	fh_TE11_OESOPHAGUS-Tumor	rnaseq	15.7	18.85	56	0.4588	0.4688	0.4859	0.4417	0.3747	0.4160	0.4262	0.4690	0.4795	0.4847
HUPT4	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_E04_257700	41.5	119	HUP-T4	-666	M	carcinoma	HUPT4	pancreas	DSMZ	-666	cancer cell line	-666	-666	fh_HUPT4_PANCREAS-Tumor	rnaseq	15.7	17.44	55	0.4503	0.4698	0.4926	0.4407	0.4139	0.4316	0.4224	0.4615	0.4788	0.4837
HCC827	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_B05_523590	27.3	88	-666	-666	F	carcinoma	HCC827	lung	ATCC	CRL-2868	cancer cell line	-666	-666	fh_HCC827_LUNG-Tumor	rnaseq	7.2	23.98	59	0.4461	0.4808	0.5002	0.4390	0.3912	0.4162	0.4268	0.4679	0.4842	0.4877
NCIH647	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_A10_296008	45	146	NCI-H647|H647	-666	M	carcinoma,mixed adenosquamous	NCIH647	lung	ATCC	CRL-5834	cancer cell line	Y	pleural_effusion	fh_NCIH647_LUNG-Tumor	rnaseq	6.4	23.38	56	0.4594	0.4640	0.4916	0.4344	0.3848	0.4157	0.4380	0.4811	0.4761	0.4863
MSTO211H	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_F02_436470	34.3	124	MSTO-211H	-666	M	mesothelioma,biphasic	MSTO211H	lung,pleura	ATCC	CRL-2081	cancer cell line	Y	pleural_effusion	fh_MSTO211H_PLEURA-Tumor	rnaseq	6.3	23.52	57	0.4538	0.4681	0.4859	0.4394	0.3703	0.4023	0.4292	0.4698	0.4781	0.4829
NCIH2882	-666	42.8	143	-666	-666	-666	-666	NCIH2882	-666	-666	-666	cancer cell line	-666	-666	fh_NCI-H2882-Tumor	rnaseq	7.2	20.22	55	0.4515	0.4558	0.4958	0.4393	0.3879	0.4162	0.4443	0.4673	0.4715	0.4861
NCIH2009	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_A04_474636	33.2	103	NCI-H2009|H2009	-666	F	carcinoma	NCIH2009	lung	ATCC	CRL-5911	cancer cell line	Y	lymph_node	fh_NCIH2009_LUNG-Tumor	rnaseq	15.7	19.54	56	0.4439	0.4677	0.5000	0.4414	0.3928	0.4160	0.4303	0.4661	0.4807	0.4807
HCC827GR5	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_D05_767812	31.2	95	-666	-666	-666	carcinoma	HCC827GR5	lung	-666	-666	cancer cell line	-666	-666	fh_HCC827GR5_LUNG-Tumor	rnaseq	7.2	22.11	57	0.4484	0.4695	0.4881	0.4349	0.4186	0.4178	0.4224	0.4631	0.4845	0.4844
HS766T	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_B12_240896	31.8	123	HS 766T	-666	M	carcinoma,ductal	HS766T	pancreas	ATCC	HTB-134	cancer cell line	Y	lymph_node	fh_HS766T_PANCREAS-Tumor	rnaseq	6.9	23.65	57	0.4465	0.4655	0.4918	0.4499	0.4082	0.4199	0.4249	0.4758	0.4679	0.4822
SW620	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_G04_241000	28.4	123	-666	Metastatic pair: SW620 and SW480 were derived from the same patient	M	adenocarcinoma,colorectal	SW620	large intestine,colon	ATCC	CCL-227	cancer cell line	Y	lymph_node	fh_SW620_LARGE_INTESTINE-Tumor	rnaseq	6	19.41	58	0.4472	0.4621	0.4935	0.4535	0.3760	0.4149	0.4205	0.4710	0.4758	0.4983
MDAMB435S	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_D05_569444	33.3	158	MDA-MB-435S	-666	F	melanoma	MDAMB435S	breast,skin	ATCC	HTB-129	cancer cell line	Y	pleural_effusion	fh_MDAMB435S_SKIN-Tumor	rnaseq	5.1	25.62	57	0.4651	0.4609	0.4851	0.4368	0.4073	0.4216	0.4197	0.4662	0.4750	0.4855
SNU840	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_E04_587670	41.3	119	SNU-840|NCI-SNU-840	-666	F	Brenner tumour	SNU840	ovary	KCLB	-666	cancer cell line	N	-666	fh_SNU840_OVARY-Tumor	rnaseq	5.4	32.29	58	0.4479	0.4588	0.4883	0.4332	0.3925	0.4166	0.4270	0.4691	0.4774	0.4666
SLR25	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_B10_767824	30.6	100	-666	-666	-666	carcinoma	SLR25	kidney	-666	-666	cancer cell line	-666	-666	fh_SLR25_KIDNEY-Tumor	rnaseq	6.9	25.85	57	0.4466	0.4739	0.4921	0.4461	0.3777	0.4072	0.4394	0.4648	0.4762	0.4716
KYSE410	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_G02_241188	33.5	123	KYSE-410	-666	M	carcinoma,squamous cell	KYSE410	oesophagus	DSMZ	-666	cancer cell line	-666	-666	fh_KYSE410_OESOPHAGUS-Tumor	rnaseq	6.5	28.22	57	0.4454	0.4723	0.5087	0.4486	0.3805	0.4128	0.4223	0.4637	0.4843	0.4843
MFE319	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_E11_241158	28.9	115	MFE-319	-666	F	carcinoma	MFE319	endometrium	DSMZ	-666	cancer cell line	N	-666	fh_MFE319_ENDOMETRIUM-Tumor	rnaseq	15.7	22.27	57	0.4530	0.4732	0.4913	0.4355	0.4006	0.4136	0.4316	0.4629	0.4713	0.4743
PK45H	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_G10_587714	41.2	128	PK-45H	-666	-666	carcinoma	PK45H	pancreas	RIKEN	-666	cancer cell line	N	-666	fh_PK45H_PANCREAS-Tumor	rnaseq	6.2	23.91	56	0.4419	0.4628	0.4906	0.4334	0.4076	0.4154	0.4262	0.4708	0.4691	0.4818
A549	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_H01_241018	50	136	-666	-666	M	carcinoma,non-small cell	A549	lung	ATCC	CCL-185	cancer cell line	-666	-666	fh_A549_LUNG-Tumor	rnaseq	7.2	26.79	55	0.4481	0.4701	0.5020	0.4443	0.3875	0.4076	0.4221	0.4563	0.4801	0.4806
SCABER	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_F03_296114	33.1	84	-666	-666	M	carcinoma,transitional cell	SCABER	urinary tract,bladder	ATCC	HTB-3	cancer cell line	-666	-666	fh_SCABER_URINARY_TRACT-Tumor	rnaseq	15.7	21.24	57	0.4474	0.4601	0.4964	0.4415	0.3893	0.4245	0.4192	0.4685	0.4636	0.4810
EFE184	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_H11_241230	37	100	EFE-184	-666	F	carcinoma	EFE184	endometrium	DSMZ	-666	cancer cell line	Y	ascites	fh_EFE184_ENDOMETRIUM-Tumor	rnaseq	15.7	19.97	56	0.4453	0.4790	0.4899	0.4394	0.4184	0.4095	0.4247	0.4755	0.4680	0.4766
NCIH1437	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_B11_383748	36	119	NCI-H1437|H1437	-666	M	adenocarcinoma,NSCLC	NCIH1437	lung	ATCC	CRL-5872	cancer cell line	Y	pleural_effusion	fh_NCIH1437_LUNG-Tumor	rnaseq	15.7	16.44	55	0.4619	0.4532	0.4840	0.4380	0.3921	0.4132	0.4235	0.4679	0.4732	0.4870
PANC0327	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_F08_296124	39.1	106	PANC 03.27	-666	F	carcinoma,ductal	PANC0327	pancreas	ATCC	CRL-2549	cancer cell line	-666	-666	fh_PANC0327_PANCREAS-Tumor	rnaseq	6.9	25.78	57	0.4362	0.4663	0.4843	0.4275	0.3744	0.4264	0.4270	0.4689	0.4723	0.4813
HCC1395	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_E12_383706	31.8	96	-666	-666	F	carcinoma,ductal,primary	HCC1395	breast	ATCC	CRL-2324	cancer cell line	-666	-666	fh_HCC1395_BREAST-Tumor	rnaseq	15.7	14.82	55	0.4465	0.4554	0.4916	0.4402	0.3945	0.4139	0.4483	0.4656	0.4726	0.4775
NCIH1373	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_D12_454650	26.9	83	NCI-H1373|H1373	-666	M	carcinoma	NCIH1373	lung	ATCC	CRL-5866	cancer cell line	-666	-666	fh_NCIH1373_LUNG-Tumor	rnaseq	6.7	21.01	58	0.4467	0.4628	0.4810	0.4312	0.3913	0.4174	0.4270	0.4698	0.4600	0.4744
HT29	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_B02_257624	31	103	HT-29	-666	F	adenocarcinoma,colorectal	HT29	large intestine,colon	ATCC	HTB-38	cancer cell line	-666	-666	fh_HT29_LARGE_INTESTINE-Tumor	rnaseq	15.7	17.59	56	0.4500	0.4625	0.4890	0.4421	0.3934	0.4176	0.4228	0.4659	0.4694	0.4805
HCC515	-666	44	175	-666	-666	-666	carcinoma	HCC515	lung	-666	-666	cancer cell line	-666	-666	fh_HCC515-Tumor	rnaseq	6.1	18.78	55	0.4523	0.4622	0.4904	0.4374	0.4005	0.3987	0.4242	0.4624	0.4725	0.4788
NCIH2170	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_D09_257686	28	93	NCI-H2170|H2170	-666	M	carcinoma,squamous cell	NCIH2170	lung	ATCC	CRL-5928	cancer cell line	-666	-666	fh_NCIH2170_LUNG-Tumor	rnaseq	15.7	15.48	56	0.4583	0.4586	0.4921	0.4424	0.3792	0.4088	0.4198	0.4644	0.4722	0.4898
NCIH1693	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_F11_454698	63.8	260	NCI-H1693|H1693	-666	F	adenocarcinoma,NSCLC	NCIH1693	lung	ATCC	CRL-5887	cancer cell line	Y	lymph_node	fh_NCIH1693_LUNG-Tumor	rnaseq	5.4	27.27	53	0.4328	0.4576	0.5103	0.4483	0.3796	0.4206	0.3982	0.4646	0.4716	0.5003
BT12	-666	53.8	172	-666	-666	-666	atypical-teratoid, rhabdoid tumor	BT12	CNS	-666	-666	cancer cell line	-666	-666	fh_BT-12-Tumor	rnaseq	15.7	16.94	53	0.4445	0.4586	0.4888	0.4427	0.3757	0.4181	0.4372	0.4753	0.4614	0.4677
FTC238	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_C09_569492	26.7	106	FTC-238	Metastatic pair: FTC-133 and FTC-238 are from the same patient. FTC-133 was derived from the primary tumor.	M	carcinoma,follicular	FTC238	thyroid	ECACC	-666	cancer cell line	N	-666	fh_FTC238_THYROID-Tumor	rnaseq	15.7	16.58	57	0.4486	0.4583	0.4898	0.4308	0.3775	0.4040	0.4231	0.4669	0.4756	0.4783
HEC251	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_H12_383740	27.5	111	HEC-251	-666	F	carcinoma	HEC251	endometrium	HSRRB	-666	cancer cell line	N	-666	fh_HEC251_ENDOMETRIUM-Tumor	rnaseq	7.2	24.25	58	0.4404	0.4843	0.4953	0.4431	0.3886	0.4101	0.4156	0.4604	0.4711	0.4858
SKHEP1	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_G06_569542	46.7	134	SK-HEP-1	-666	M	carcinoma	SKHEP1	liver	ATCC	HTB-52	cancer cell line	Y	ascites	fh_SKHEP1_LIVER-Tumor	rnaseq	15.7	20.78	55	0.4507	0.4666	0.4863	0.4327	0.3845	0.4102	0.4294	0.4708	0.4707	0.4728
CAL12T	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_F04_419796	51	152	CAL-12T	-666	M	carcinoma,non-small cell	CAL12T	lung	DSMZ	-666	cancer cell line	-666	-666	fh_CAL12T_LUNG-Tumor	rnaseq	7.2	27.22	55	0.4384	0.4625	0.4836	0.4373	0.3901	0.4094	0.4100	0.4642	0.4744	0.4773
NCIH1944	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_B11_474698	74.1	243	NCI-H1944|H1944	-666	F	carcinoma,non-small cell	NCIH1944	lung	ATCC	CRL-5907	cancer cell line	Y	soft_tissue	fh_NCIH1944_LUNG-Tumor	rnaseq	7.2	22.46	52	0.4457	0.4503	0.4933	0.4413	0.3626	0.4018	0.4220	0.4642	0.4698	0.4852
HEC151	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_F01_436468	41.5	145	HEC-151	-666	F	carcinoma	HEC151	endometrium	HSRRB	-666	cancer cell line	N	-666	fh_HEC151_ENDOMETRIUM-Tumor	rnaseq	15.7	20.54	55	0.4446	0.4688	0.4870	0.4318	0.3607	0.4047	0.4256	0.4634	0.4714	0.4680
NCIH2073	-666	30.8	92	NCI-H2073	-666	F	adenocarcinoma,NSCLC	NCIH2073	lung	ATCC	CRL-5918	cancer cell line	-666	-666	fh_NCIH2073_LUNG-Tumor	rnaseq	6.3	20.14	58	0.4402	0.4594	0.4882	0.4296	0.3970	0.4148	0.4270	0.4706	0.4674	0.4641
PECAPJ34CLONEC12	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_F02_569502	51.3	132	PE/CA-PJ34 (CLONE C12)	-666	M	carcinoma,squamous cell	PECAPJ34CLONEC12	upper aerodigestive tract,mouth	ECACC	-666	cancer cell line	N	-666	fh_PECAPJ34CLONEC12_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	18.97	53	0.4426	0.4562	0.4778	0.4442	0.3870	0.4130	0.4185	0.4661	0.4721	0.4801
FADU	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_C06_383656	36.8	113	-666	-666	M	carcinoma,squamous cell	FADU	upper aerodigestive tract,pharynx	ATCC	HTB-43	cancer cell line	-666	-666	fh_FADU_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	7.2	20.94	56	0.4445	0.4587	0.4900	0.4460	0.3759	0.4051	0.4272	0.4592	0.4722	0.4773
HLF	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_A12_241064	26.1	94	-666	Identical lines: HLE and HLF share high SNP identity	M	carcinoma,hepatocellular	HLF	liver	HSRRB	-666	cancer cell line	N	-666	fh_HLF_LIVER-Tumor	rnaseq	15.7	19.37	57	0.4456	0.4595	0.4969	0.4455	0.3787	0.4084	0.4163	0.4578	0.4787	0.4855
PANC0504	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_E07_454668	37.4	110	PANC 05.04	-666	F	carcinoma	PANC0504	pancreas	ATCC	CRL-2557	cancer cell line	-666	-666	fh_PANC0504_PANCREAS-Tumor	rnaseq	7.2	24.6	56	0.4463	0.4545	0.4827	0.4257	0.3999	0.4206	0.4239	0.4668	0.4682	0.4730
SKLMS1	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_G08_454744	25.3	104	SK-LMS-1	-666	F	sarcoma	SKLMS1	sofT tissue,uterus,endometrium	ATCC	HTB-88	cancer cell line	-666	-666	fh_SKLMS1_SOFT_TISSUE-Tumor	rnaseq	7.2	27.04	58	0.4441	0.4608	0.4844	0.4311	0.4107	0.4070	0.4280	0.4748	0.4672	0.4848
LU65	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_E10_436478	36.5	133	LU-65	-666	M	carcinoma,non-small cell	LU65	lung	HSRRB	-666	cancer cell line	-666	-666	fh_LU65_LUNG-Tumor	rnaseq	15.7	16.52	56	0.4469	0.4606	0.4817	0.4331	0.3827	0.4089	0.4223	0.4647	0.4704	0.4646
AM38	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_F12_419810	29.2	110	AM-38	-666	M	glioma,astrocytoma,grade IV	AM38	CNS	HSRRB	-666	cancer cell line	-666	-666	fh_AM38_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	21.74	56	0.4499	0.4537	0.4810	0.4339	0.3533	0.4085	0.4226	0.4686	0.4710	0.4810
CAKI1	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_E01_436550	63.5	166	CAKI-1	-666	M	clear cell renal cell carcinoma	CAKI1	kidney	ATCC	HTB-46	cancer cell line	Y	skin	fh_CAKI1_KIDNEY-Tumor	rnaseq	15.7	21.03	53	0.4475	0.4635	0.4806	0.4275	0.4012	0.4006	0.4231	0.4600	0.4717	0.4693
NCIH838	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_F11_698878	71.6	254	NCI-H838	-666	M	carcinoma,non-small cell	NCIH838	lung	ATCC	CRL-5844	cancer cell line	Y	lymph_node	fh_NCIH838_LUNG-Tumor	rnaseq	7.2	19.6	52	0.4323	0.4666	0.5087	0.4395	0.3733	0.3988	0.4153	0.4570	0.4774	0.5007
NCIH2122	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_G02_240996	39.2	132	NCI-H2122|H2122	-666	F	adenocarcinoma,NSCLC	NCIH2122	lung	ATCC	CRL-5985	cancer cell line	Y	pleural_effusion	fh_NCIH2122_LUNG-Tumor	rnaseq	15.7	21.22	55	0.4598	0.4573	0.4808	0.4331	0.4005	0.4164	0.4200	0.4683	0.4708	0.4638
SNU324	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_E05_698926	37.4	100	SNU-324|NCI-SNU-324	-666	M	carcinoma	SNU324	pancreas	KCLB	-666	cancer cell line	N	-666	fh_SNU324_PANCREAS-Tumor	rnaseq	15.7	13.45	55	0.4529	0.4603	0.4722	0.4231	0.3918	0.4140	0.4238	0.4616	0.4612	0.4724
A375	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_B01_257622	32.5	128	A-375	-666	F	melanoma	A375	skin	ATCC	CRL-1619	cancer cell line	-666	-666	fh_A375_SKIN-Tumor	rnaseq	6.7	16.42	56	0.4457	0.4645	0.4852	0.4412	0.3790	0.4078	0.4305	0.4627	0.4612	0.4669
SQ1	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_D10_257688	31.5	88	SQ-1	-666	-666	carcinoma,squamous cell	SQ1	lung	RIKEN	-666	cancer cell line	N	-666	fh_SQ1_LUNG-Tumor	rnaseq	15.7	20.6	57	0.4389	0.4636	0.4862	0.4340	0.3895	0.4096	0.4190	0.4555	0.4698	0.4724
KU1919	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_D06_474634	35.3	107	KU-19-19	-666	M	carcinoma,transitional cell	KU1919	urinary tract,bladder	DSMZ	-666	cancer cell line	-666	-666	fh_KU1919_URINARY_TRACT-Tumor	rnaseq	7.2	25.03	57	0.4429	0.4606	0.4859	0.4307	0.3868	0.4020	0.4306	0.4677	0.4694	0.4604
SNU478	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_C06_587664	42.2	123	NCI-SNU-478	-666	-666	carcinoma	SNU478	biliary tract	KCLB	-666	cancer cell line	-666	-666	fh_SNU478_BILIARY_TRACT-Tumor	rnaseq	15.7	21.82	55	0.4445	0.4609	0.4860	0.4298	0.3733	0.4153	0.4142	0.4639	0.4688	0.4735
COV362	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_B06_569438	46.1	142	-666	-666	F	carcinoma	COV362	ovary	ECACC	-666	cancer cell line	N	-666	fh_COV362_OVARY-Tumor	rnaseq	6.7	25.84	56	0.4573	0.4576	0.4857	0.4342	0.3937	0.4134	0.4192	0.4723	0.4662	0.4744
OE33	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_C02_241092	29.8	90	-666	-666	F	metaplasia	OE33	oesophagus	ECACC	-666	cancer cell line	-666	-666	fh_OE33_OESOPHAGUS-Tumor	rnaseq	15.7	19.03	57	0.4470	0.4584	0.4819	0.4300	0.3992	0.4123	0.4137	0.4627	0.4742	0.4676
YD38	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_B06_587700	56.3	148	-666	-666	M	carcinoma,squamous cell	YD38	upper aerodigestive tract	KCLB	-666	cancer cell line	-666	-666	fh_YD38_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	6.3	21.51	54	0.4363	0.4533	0.4896	0.4341	0.3886	0.4093	0.4042	0.4615	0.4700	0.4741
MKN7	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_A08_523516	34	93	-666	-666	M	adenocarcinoma,tubular	MKN7	stomach	RIKEN	-666	cancer cell line	-666	-666	fh_MKN7_STOMACH-Tumor	rnaseq	15.7	19.95	57	0.4324	0.4646	0.4909	0.4371	0.3885	0.4160	0.4103	0.4605	0.4581	0.4683
CAL851	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_A11_257618	51.5	122	CAL-85-1	-666	F	carcinoma	CAL851	breast	DSMZ	-666	cancer cell line	-666	-666	fh_CAL851_BREAST-Tumor	rnaseq	15.7	19.4	54	0.4435	0.4554	0.4845	0.4273	0.3946	0.4195	0.4134	0.4589	0.4781	0.4766
HCC1359	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_A12_569494	32.6	107	HCC-1359	-666	F	carcinoma,large cell	HCC1359	lung	KCLB	-666	cancer cell line	N	-666	fh_HCC1359_LUNG-Tumor	rnaseq	7.2	20.15	57	0.4422	0.4553	0.4829	0.4354	0.3785	0.3924	0.4194	0.4671	0.4731	0.4865
UMUC3	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_A07_436590	44.9	199	UM-UC-3	-666	M	carcinoma,transitional cell	UMUC3	urinary tract,bladder	ATCC	CRL-1749	cancer cell line	-666	-666	fh_UMUC3_URINARY_TRACT-Tumor	rnaseq	5.2	28.49	55	0.4347	0.4573	0.4906	0.4331	0.3729	0.3905	0.4246	0.4625	0.4742	0.4872
HCT15	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_B01_241066	34	122	HCT-15	Identical lines: HRT18, HCT15 and DLD1 share high SNP identity	M	adenocarcinoma,colorectal	HCT15	large intestine,colon	ATCC	CCL-225	cancer cell line	-666	-666	fh_HCT15_LARGE_INTESTINE-Tumor	rnaseq	15.7	15.41	55	0.4352	0.4618	0.4979	0.4441	0.3667	0.4042	0.4158	0.4547	0.4746	0.4897
SLR20	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_D06_767962	26.9	119	-666	-666	-666	carcinoma	SLR20	kidney	-666	-666	cancer cell line	-666	-666	fh_SLR20_KIDNEY-Tumor	rnaseq	6.2	24.34	58	0.4359	0.4635	0.4832	0.4264	0.3944	0.3889	0.4243	0.4696	0.4695	0.4703
T84	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_D06_257680	25	94	-666	-666	M	carcinoma,colorectal	T84	large intestine,colon	ATCC	CCL-248	cancer cell line	Y	lung	fh_T84_LARGE_INTESTINE-Tumor	rnaseq	15.7	23.21	58	0.4392	0.4575	0.4856	0.4413	0.3816	0.4117	0.4159	0.4520	0.4766	0.4774
TYKNU	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_A02_295992	45.2	133	TYK-NU	-666	F	carcinoma,undifferentiated	TYKNU	ovary	HSRRB	-666	cancer cell line	-666	-666	fh_TYKNU_OVARY-Tumor	rnaseq	7.2	19.48	55	0.4306	0.4611	0.4829	0.4336	0.3697	0.3919	0.4201	0.4621	0.4588	0.4820
CALU3	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_A02_474612	41.9	105	CALU-3	-666	M	carcinoma	CALU3	lung	ATCC	HTB-55	cancer cell line	Y	pleural_effusion	fh_CALU3_LUNG-Tumor	rnaseq	15.7	15.26	55	0.4511	0.4600	0.4878	0.4380	0.3833	0.4105	0.3942	0.4507	0.4585	0.4674
UBLC1	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_D11_698872	39.4	107	U-BLC1	-666	F	carcinoma,transitional cell	UBLC1	urinary tract,bladder	ECACC	-666	cancer cell line	N	-666	fh_UBLC1_URINARY_TRACT-Tumor	rnaseq	15.7	20.35	56	0.4402	0.4587	0.4923	0.4334	0.4063	0.4147	0.4113	0.4522	0.4650	0.4712
NCIH1975	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_H03_241022	21.4	92	NCI-H1975|H1975	-666	F	carcinoma,non-small cell	NCIH1975	lung	ATCC	CRL-5908	cancer cell line	-666	-666	fh_NCIH1975_LUNG-Tumor	rnaseq	15.7	18.26	58	0.4376	0.4602	0.4822	0.4283	0.3888	0.4035	0.4270	0.4526	0.4726	0.4736
NCIH1355	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_H09_383782	34.4	134	NCI-H1355|H1355	-666	M	carcinoma	NCIH1355	lung	ATCC	CRL-5865	cancer cell line	Y	pleural_effusion	fh_NCIH1355_LUNG-Tumor	rnaseq	5.8	26.42	56	0.4517	0.4534	0.4867	0.4464	0.3855	0.4055	0.4178	0.4564	0.4714	0.4664
HCC15	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_E01_241138	48.1	175	HCC-15	-666	M	carcinoma,squamous cell	HCC15	lung	DSMZ	-666	cancer cell line	N	-666	fh_HCC15_LUNG-Tumor	rnaseq	5.7	24.93	55	0.4384	0.4538	0.4873	0.4304	0.3755	0.4008	0.4196	0.4659	0.4688	0.4752
LOVO	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_E09_296102	32.2	141	-666	-666	M	adenocarcinoma,colorectal	LOVO	large intestine,colon	ATCC	CCL-229	cancer cell line	Y	lymph_node,left_supraclavicular	fh_LOVO_LARGE_INTESTINE-Tumor	rnaseq	6.7	22.91	56	0.4363	0.4553	0.4924	0.4387	0.3708	0.4078	0.4104	0.4484	0.4727	0.4733
TE14	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_F06_698812	29.7	119	TE-14	-666	-666	carcinoma,squamous cell	TE14	oesophagus	RIKEN	-666	cancer cell line	N	-666	fh_TE14_OESOPHAGUS-Tumor	rnaseq	15.7	18.42	57	0.4502	0.4577	0.4829	0.4410	0.3785	0.3985	0.4120	0.4570	0.4655	0.4721
SW900	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_E08_241152	33.3	110	SW 900	-666	M	carcinoma,squamous cell	SW900	lung	ATCC	HTB-59	cancer cell line	-666	-666	fh_SW900_LUNG-Tumor	rnaseq	15.7	25.37	56	0.4389	0.4533	0.4791	0.4168	0.3859	0.4081	0.4244	0.4638	0.4548	0.4724
CACO2	-666	28.4	103	CACO-2	-666	-666	adenocarcinoma,colorectal	CACO2	large intestine,colon	ATCC	HTB-37	cancer cell line	-666	-666	fh_Caco-2-Tumor	rnaseq	15.7	19.66	57	0.4340	0.4634	0.4855	0.4437	0.3787	0.4046	0.4112	0.4498	0.4654	0.4803
NCIH2052	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_F12_383630	35.4	124	NCI-H2052|H2052	-666	M	mesothelioma	NCIH2052	pleura	ATCC	CRL-5915	cancer cell line	Y	pleural_effusion	fh_NCIH2052_PLEURA-Tumor	rnaseq	6.2	30.26	57	0.4328	0.4573	0.4794	0.4302	0.3898	0.4006	0.4183	0.4556	0.4661	0.4723
SNU8	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_E05_587672	32.6	91	SNU-8|NCI-SNU-8	-666	F	adenocarcinoma	SNU8	ovary	KCLB	-666	cancer cell line	N	-666	fh_SNU8_OVARY-Tumor	rnaseq	6.5	19.36	57	0.4338	0.4585	0.4861	0.4232	0.3902	0.4082	0.4027	0.4554	0.4604	0.4723
IGR39	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_E07_587632	44.5	143	IGR-39	Metastatic pair: IGR-37 and IGR-39 are from the same patient. IGR-37 is a metastasis	M	melanoma	IGR39	skin	DSMZ	-666	cancer cell line	N	-666	fh_IGR39_SKIN-Tumor	rnaseq	15.7	26.25	55	0.4400	0.4437	0.4739	0.4304	0.3920	0.4070	0.4158	0.4583	0.4652	0.4630
NCIH2023	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_A10_454768	29	115	NCI-H2023|H2023	-666	M	adenocarcinoma,NSCLC	NCIH2023	lung	ATCC	CRL-5912	cancer cell line	Y	lymph_node	fh_NCIH2023_LUNG-Tumor	rnaseq	6.9	21.39	57	0.4444	0.4578	0.4821	0.4327	0.3765	0.3901	0.4158	0.4561	0.4672	0.4705
GCT	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_D05_383696	38.7	141	-666	-666	M	Histiocytoma,fibrous	GCT	sofT tissue	ATCC	TIB-223	cancer cell line	Y	lung	fh_GCT_SOFT_TISSUE-Tumor	rnaseq	6.6	23.61	56	0.4421	0.4666	0.4761	0.4282	0.3755	0.4041	0.4093	0.4659	0.4657	0.4713
LS411N	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_C04_296044	42.3	165	-666	-666	M	carcinoma,colorectal	LS411N	large intestine,cecum	ATCC	CRL-2159	cancer cell line	-666	-666	fh_LS411N_LARGE_INTESTINE-Tumor	rnaseq	6.4	25.88	55	0.4334	0.4569	0.4899	0.4381	0.3822	0.3996	0.4138	0.4526	0.4664	0.4787
OVTOKO	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_A09_241058	46.5	127	-666	-666	F	carcinoma,clearcell	OVTOKO	ovary	HSRRB	-666	cancer cell line	N	-666	fh_OVTOKO_OVARY-Tumor	rnaseq	15.7	18.57	55	0.4423	0.4643	0.4875	0.4269	0.3628	0.3995	0.4176	0.4563	0.4626	0.4703
HEKTE	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_C01_767952	40.2	137	-666	-666	-666	immortalized_epithelial	HEKTE	kidney	-666	-666	immortalized epithelial	-666	-666	fh_HEKTE_KIDNEY-Tumor	rnaseq	7.2	20.57	56	0.4410	0.4725	0.4891	0.4300	0.3850	0.4003	0.4109	0.4571	0.4581	0.4696
SUIT2	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_G02_569480	37.9	130	SUIT-2	-666	M	carcinoma,ductal	SUIT2	pancreas	HSRRB	-666	cancer cell line	N	-666	fh_SUIT2_PANCREAS-Tumor	rnaseq	6.5	25.96	57	0.4311	0.4516	0.4909	0.4306	0.3602	0.4046	0.4177	0.4527	0.4817	0.4743
CALU1	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_D07_257682	19.9	80	CALU-1	-666	M	carcinoma,epidermoid	CALU1	lung	ATCC	HTB-54	cancer cell line	Y	pleura	fh_CALU1_LUNG-Tumor	rnaseq	7.2	22.41	59	0.4329	0.4545	0.4886	0.4288	0.3913	0.4048	0.4211	0.4543	0.4633	0.4715
SW1783	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_G08_436492	28.2	107	SW 1783	-666	M	glioma,astrocytoma,grade III	SW1783	CNS	ATCC	HTB-13	cancer cell line	-666	-666	fh_SW1783_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	21.67	57	0.4357	0.4563	0.4827	0.4239	0.3869	0.4074	0.4198	0.4528	0.4576	0.4589
T3M4	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_G06_587736	28.7	95	T3M-4	-666	M	carcinoma,ductal	T3M4	pancreas	RIKEN	-666	cancer cell line	Y	lymph_node	fh_T3M4_PANCREAS-Tumor	rnaseq	15.7	20.48	57	0.4384	0.4490	0.4750	0.4383	0.3764	0.4057	0.4150	0.4557	0.4671	0.4576
SNU5	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_H10_383770	54.5	147	SNU-5|NCI-SNU-5	-666	F	adenocarcinoma,undifferentiated,gastric	SNU5	stomach	ATCC	CRL-5973	cancer cell line	Y	ascites	fh_SNU5_STOMACH-Tumor	rnaseq	15.7	23.23	54	0.4317	0.4513	0.4862	0.4403	0.3704	0.4078	0.4110	0.4501	0.4686	0.4721
FTC133	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_C11_569508	30.4	105	FTC-133	Metastatic pair: FTC-133 and FTC-238 are from the same patient. FTC-133 was derived from the primary tumor.	M	carcinoma,follicular	FTC133	thyroid	ECACC	-666	cancer cell line	-666	-666	fh_FTC133_THYROID-Tumor	rnaseq	15.7	20.47	56	0.4437	0.4444	0.4713	0.4170	0.3816	0.4096	0.4293	0.4589	0.4631	0.4638
NCIH322	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_H05_436448	37.4	105	NCI-H322|H322|NCI-H322M	Identical lines: NCI-H322 and NCI-H3255 share high SNP identity	M	carcinoma	NCIH322	lung	ECACC	-666	cancer cell line	N	-666	fh_NCIH322_LUNG-Tumor	rnaseq	7.2	19.85	57	0.4459	0.4504	0.4802	0.4335	0.3751	0.3974	0.4077	0.4563	0.4624	0.4864
IPC298	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_B08_240888	32	100	IPC-298	-666	F	melanoma	IPC298	skin	DSMZ	-666	cancer cell line	-666	-666	fh_IPC298_SKIN-Tumor	rnaseq	15.7	14.21	55	0.4375	0.4547	0.4779	0.4249	0.3821	0.4128	0.4051	0.4549	0.4582	0.4567
NCIH23	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_D08_454648	26	77	NCI-H23|H23	-666	M	carcinoma,non-small cell	NCIH23	lung	ATCC	CRL-5800	cancer cell line	-666	-666	fh_NCIH23_LUNG-Tumor	rnaseq	5.9	11.94	57	0.4191	0.4573	0.4837	0.4254	0.3681	0.3859	0.4142	0.4553	0.4676	0.4726
PANC0203	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_C10_698866	28.8	92	PANC 02.03	-666	F	carcinoma	PANC0203	pancreas	ATCC	CRL-2553	cancer cell line	-666	-666	fh_PANC0203_PANCREAS-Tumor	rnaseq	7.2	29.96	58	0.4351	0.4521	0.4745	0.4328	0.3971	0.4033	0.4054	0.4585	0.4643	0.4668
SNU685	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_C02_779646	37.3	109	SNU-685|NCI-SNU-685	-666	F	carcinosarcoma,mesodermal mixed	SNU685	endometrium	KCLB	-666	cancer cell line	N	-666	fh_SNU685_ENDOMETRIUM-Tumor	rnaseq	15.7	23.63	57	0.4455	0.4550	0.4842	0.4281	0.3914	0.3960	0.4144	0.4466	0.4628	0.4587
HCC1937	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_E05_383680	30.1	109	-666	-666	F	carcinoma,ductal,primary	HCC1937	breast	ATCC	CRL-2336	cancer cell line	-666	-666	fh_HCC1937_BREAST-Tumor	rnaseq	5.7	23.34	58	0.4363	0.4513	0.4723	0.4332	0.3779	0.4147	0.4119	0.4533	0.4651	0.4706
HCC2814	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_A12_767798	28.3	97	-666	-666	-666	squamous_cell_carcinoma	HCC2814	lung	-666	-666	cancer cell line	-666	-666	fh_HCC2814_LUNG-Tumor	rnaseq	15.7	17.45	56	0.4430	0.4477	0.4763	0.4381	0.3732	0.4032	0.4169	0.4508	0.4643	0.4565
KP2	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_H07_241030	53.3	166	KP-2	-666	F	carcinoma	KP2	pancreas	HSRRB	-666	cancer cell line	N	-666	fh_KP2_PANCREAS-Tumor	rnaseq	15.7	17.67	53	0.4367	0.4410	0.4855	0.4278	0.3982	0.4139	0.4085	0.4516	0.4670	0.4635
SNU1040	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_A01_587656	41.8	138	SNU-1040|NCI-SNU-1040	-666	M	carcinoma	SNU1040	large intestine,colon	KCLB	-666	cancer cell line	N	-666	fh_SNU1040_LARGE_INTESTINE-Tumor	rnaseq	6.4	23.72	56	0.4351	0.4537	0.4753	0.4251	0.3825	0.3972	0.4201	0.4481	0.4690	0.4768
CL34	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_G11_474742	27.8	116	CL-34	-666	F	carcinoma	CL34	large intestine	DSMZ	-666	cancer cell line	N	-666	fh_CL34_LARGE_INTESTINE-Tumor	rnaseq	15.7	20.34	56	0.4340	0.4505	0.4771	0.4320	0.3881	0.4031	0.4115	0.4436	0.4610	0.4700
NCIH727	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_C12_474736	31.1	99	NCI-H727|H727	-666	F	carcinoma,endocrine	NCIH727	lung,bronchus	ATCC	CRL-5815	cancer cell line	-666	-666	fh_NCIH727_LUNG-Tumor	rnaseq	6.5	26.26	57	0.4342	0.4622	0.4798	0.4246	0.3744	0.3973	0.4107	0.4630	0.4647	0.4698
MDAMB468	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_A02_257600	44.1	154	MDA-MB-468	-666	F	carcinoma	MDAMB468	breast	ATCC	HTB-132	cancer cell line	Y	pleural_effusion	fh_MDAMB468_BREAST-Tumor	rnaseq	5.8	21.19	56	0.4318	0.4507	0.4766	0.4293	0.3823	0.4058	0.4093	0.4489	0.4652	0.4674
NCIH1435	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_A03_474622	35.7	128	NCI-H1435|H1435	-666	F	carcinoma,non-small cell	NCIH1435	lung	ATCC	CRL-5870	cancer cell line	-666	-666	fh_NCIH1435_LUNG-Tumor	rnaseq	6.7	22.97	56	0.4405	0.4461	0.4758	0.4259	0.3726	0.4077	0.4052	0.4545	0.4624	0.4811
PANC1	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_H09_436440	30.8	99	PANC-1	Identical lines: PANC-1, KP-1N and KP-1NL share high SNP identity	-666	carcinoma,epithelioid	PANC1	pancreas,duct	ATCC	CRL-1469	cancer cell line	-666	-666	fh_PANC1_PANCREAS-Tumor	rnaseq	15.7	20.83	57	0.4312	0.4549	0.4782	0.4337	0.3848	0.3942	0.4232	0.4487	0.4515	0.4665
KP4	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_G06_419798	57	202	KP-4	-666	M	carcinoma,ductal	KP4	pancreas	RIKEN	-666	cancer cell line	-666	-666	fh_KP4_PANCREAS-Tumor	rnaseq	5.7	24.24	54	0.4421	0.4535	0.4788	0.4351	0.3794	0.3875	0.4185	0.4475	0.4602	0.4650
OVSAHO	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_E04_240952	28.5	101	-666	-666	F	carcinoma	OVSAHO	ovary	HSRRB	-666	cancer cell line	N	-666	fh_OVSAHO_OVARY-Tumor	rnaseq	6.9	20.56	56	0.4351	0.4491	0.4707	0.4227	0.3895	0.4014	0.4188	0.4578	0.4489	0.4862
HOS	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_A08_436610	37.3	121	-666	Identical lines: HTK-, HOS and 143B share high SNP identity and are very likely to be osteosarcoma	F	osteosarcoma	HOS	bone	ATCC	CRL-1543	cancer cell line	-666	-666	fh_HOS_BONE-Tumor	rnaseq	15.7	17.32	55	0.4195	0.4512	0.4821	0.4291	0.3514	0.3891	0.4193	0.4495	0.4631	0.4744
NCIH1650	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_B09_383752	40.3	120	NCI-H1650|H1650	-666	M	adenocarcinoma,bronchoalveolar	NCIH1650	lung	ATCC	CRL-5883	cancer cell line	Y	pleural_effusion	fh_NCIH1650_LUNG-Tumor	rnaseq	15.7	19.91	55	0.4298	0.4375	0.4819	0.4293	0.3810	0.3981	0.4109	0.4519	0.4630	0.4721
SKUT1	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_G02_436512	43.1	134	SK-UT-1	-666	F	leiomyosarcoma	SKUT1	sofT tissue,deferens	ATCC	HTB-114	cancer cell line	-666	-666	fh_SKUT1_SOFT_TISSUE-Tumor	rnaseq	7.2	18.38	55	0.4260	0.4514	0.4760	0.4229	0.3529	0.3858	0.4156	0.4540	0.4644	0.4723
UACC62	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_E09_241154	40.1	139	UACC-62	-666	-666	melanoma	UACC62	skin	NCI/DCTD	-666	cancer cell line	-666	-666	fh_UACC62_SKIN-Tumor	rnaseq	15.7	20.32	54	0.4397	0.4525	0.4759	0.4244	0.3781	0.4001	0.4149	0.4576	0.4527	0.4604
AU565	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_B02_383772	26.3	85	-666	Metastatic pair: SK-BR-3 and AU565 are from the same patient	F	carcinoma	AU565	breast	ATCC	CRL-2351	cancer cell line	Y	pleural_effusion	fh_AU565_BREAST-Tumor	rnaseq	15.7	14.7	57	0.4408	0.4514	0.4683	0.4342	0.3751	0.4019	0.4134	0.4503	0.4548	0.4770
HCC1438	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_A04_569436	34.7	125	HCC-1438	-666	M	carcinoma,large cell	HCC1438	lung	KCLB	-666	cancer cell line	N	-666	fh_HCC1438_LUNG-Tumor	rnaseq	6.3	23.27	56	0.4419	0.4592	0.4766	0.4315	0.3703	0.3987	0.4121	0.4593	0.4471	0.4640
SNU308	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_C03_587614	28.6	96	NCI-SNU-308	-666	-666	carcinoma	SNU308	biliary tract	KCLB	-666	cancer cell line	-666	-666	fh_SNU308_BILIARY_TRACT-Tumor	rnaseq	7.2	22.81	58	0.4398	0.4544	0.4738	0.4325	0.3722	0.3990	0.4015	0.4479	0.4608	0.4714
TCCPAN2	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_B08_257636	55	170	TCC-PAN2	-666	F	carcinoma	TCCPAN2	pancreas	HSRRB	-666	cancer cell line	N	-666	fh_TCCPAN2_PANCREAS-Tumor	rnaseq	7.2	25.4	54	0.4377	0.4485	0.4813	0.4310	0.3938	0.3977	0.4056	0.4494	0.4625	0.4610
TC71	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_B02_436622	61	228	TC-71	-666	M	sarcoma,Ewings,PNET	TC71	bone	DSMZ	-666	cancer cell line	N	-666	fh_TC71_BONE-Tumor	rnaseq	6.7	20.15	53	0.4241	0.4420	0.4766	0.4394	0.3208	0.3784	0.4130	0.4518	0.4584	0.4797
EBC1	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_G12_436484	30	104	EBC-1	-666	M	carcinoma,squamous cell	EBC1	lung	RIKEN	-666	cancer cell line	N	-666	fh_EBC1_LUNG-Tumor	rnaseq	6.3	21.35	58	0.4352	0.4376	0.4750	0.4197	0.3685	0.3980	0.4125	0.4570	0.4593	0.4729
JHOS2	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_G04_454708	40.1	148	JHOS-2	-666	F	carcinoma	JHOS2	ovary	RIKEN	-666	cancer cell line	N	-666	fh_JHOS2_OVARY-Tumor	rnaseq	7.2	30.95	56	0.4204	0.4465	0.4932	0.4256	0.3973	0.3995	0.4031	0.4417	0.4633	0.4854
LOUNH91	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_D09_240938	28.3	101	LOU-NH91	-666	F	carcinoma,squamous cell	LOUNH91	lung	DSMZ	-666	cancer cell line	N	-666	fh_LOUNH91_LUNG-Tumor	rnaseq	15.7	26.12	57	0.4302	0.4523	0.4767	0.4211	0.3908	0.3938	0.4142	0.4585	0.4574	0.4552
JHH6	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_E01_569420	34.3	95	JHH-6	-666	F	hepatocellular carcinoma	JHH6	liver	HSRRB	-666	cancer cell line	N	-666	fh_JHH6_LIVER-Tumor	rnaseq	15.7	17.37	56	0.4393	0.4429	0.4638	0.4249	0.3793	0.4042	0.4137	0.4519	0.4513	0.4661
HCC4006	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_A11_474652	33.2	103	-666	-666	M	carcinoma	HCC4006	lung	ATCC	CRL-2871	cancer cell line	-666	-666	fh_HCC4006_LUNG-Tumor	rnaseq	7.2	22.45	57	0.4329	0.4499	0.4757	0.4172	0.3982	0.4057	0.4188	0.4439	0.4584	0.4648
HCC95	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_A01_569468	41.8	125	HCC-95	-666	M	carcinoma,squamous cell	HCC95	lung	KCLB	-666	cancer cell line	N	-666	fh_HCC95_LUNG-Tumor	rnaseq	6.5	21.79	56	0.4419	0.4359	0.4686	0.4285	0.3577	0.3984	0.4173	0.4511	0.4607	0.4555
NCIH1299	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_E09_257710	44.8	157	NCI-H1299|H1299	-666	M	carcinoma,non-small cell	NCIH1299	lung	ATCC	CRL-5803	cancer cell line	Y	lymph_node	fh_NCIH1299_LUNG-Tumor	rnaseq	5.9	24.32	56	0.4317	0.4511	0.4775	0.4242	0.3657	0.3809	0.4055	0.4591	0.4589	0.4762
RT112	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_C01_257646	49.9	174	RT-112	RT112/84 is a clonal derivative of RT112	F	carcinoma,transitional cell	RT112	urinary tract,bladder	DSMZ	-666	cancer cell line	-666	-666	fh_RT112_URINARY_TRACT-Tumor	rnaseq	15.7	24.47	54	0.4407	0.4400	0.4709	0.4221	0.3893	0.4152	0.4156	0.4459	0.4598	0.4645
JIMT1	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_H09_474734	31.4	96	JIMT-1	-666	F	carcinoma,ductal	JIMT1	breast	DSMZ	-666	cancer cell line	Y	pleura	fh_JIMT1_BREAST-Tumor	rnaseq	6.2	19.25	58	0.4332	0.4440	0.4671	0.4331	0.3764	0.4037	0.4074	0.4503	0.4661	0.4652
OAW42	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_F08_569484	34.5	122	OAW-42	-666	F	carcinoma	OAW42	ovary	ECACC	-666	cancer cell line	-666	-666	fh_OAW42_OVARY-Tumor	rnaseq	15.7	23.03	56	0.4398	0.4508	0.4748	0.4236	0.3666	0.3961	0.4189	0.4472	0.4577	0.4716
8305C	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_B12_523504	32.3	97	8305C	-666	F	carcinoma,anaplastic	8305C	thyroid	DSMZ	-666	cancer cell line	N	-666	fh_8305C_THYROID-Tumor	rnaseq	7.2	21.11	57	0.4345	0.4624	0.4648	0.4103	0.3883	0.3990	0.4111	0.4563	0.4540	0.4581
NCIH226	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_G06_436504	43.4	118	NCI-H226|H226	-666	M	carcinoma,squamous cell mesothelioma	NCIH226	lung,pleura	ATCC	CRL-5826	cancer cell line	Y	pleural_effusion	fh_NCIH226_LUNG-Tumor	rnaseq	6.3	17.43	56	0.4246	0.4523	0.4685	0.4206	0.3780	0.3907	0.4215	0.4505	0.4600	0.4653
PANC0813	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_D04_454640	44.3	117	PANC 08.13	-666	M	carcinoma,ductal	PANC0813	pancreas	ATCC	CRL-2551	cancer cell line	-666	-666	fh_PANC0813_PANCREAS-Tumor	rnaseq	15.7	23.31	55	0.4311	0.4540	0.4728	0.4220	0.3781	0.4022	0.4077	0.4538	0.4580	0.4670
SW837	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_D12_569532	42.8	137	-666	-666	M	carcinoma	SW837	large intestine,rectum	ATCC	CCL-235	cancer cell line	-666	-666	fh_SW837_LARGE_INTESTINE-Tumor	rnaseq	6.6	22.13	56	0.4250	0.4478	0.4822	0.4386	0.3714	0.4016	0.3967	0.4362	0.4591	0.4696
SW1271	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_D03_383620	33.4	120	SW 1271	-666	M	carcinoma,small cell	SW1271	lung	ATCC	CRL-2177	cancer cell line	-666	-666	fh_SW1271_LUNG-Tumor	rnaseq	6.7	22.41	57	0.4252	0.4491	0.4712	0.4238	0.3852	0.3888	0.4152	0.4535	0.4527	0.4668
A427	-666	41.7	149	A-427	-666	-666	carcinoma	A427	lung	ATCC	HTB-53	cancer cell line	-666	-666	fh_A427-Tumor	rnaseq	5.6	25.85	55	0.4312	0.4584	0.4668	0.4248	0.3677	0.3946	0.4243	0.4555	0.4580	0.4644
KYSE180	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_H09_241226	45.4	158	KYSE-180	-666	M	carcinoma,squamous cell	KYSE180	oesophagus	DSMZ	-666	cancer cell line	-666	-666	fh_KYSE180_OESOPHAGUS-Tumor	rnaseq	5.4	24.14	56	0.4306	0.4552	0.4804	0.4315	0.3517	0.3900	0.4130	0.4423	0.4635	0.4590
A253	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_H09_569448	35	125	A-253	-666	M	mucoepidermoid carcinoma	A253	salivary gland,submaxillary	ATCC	HTB-41;CRL-7902	cancer cell line	-666	-666	fh_A253_SALIVARY_GLAND-Tumor	rnaseq	15.7	23.1	56	0.4253	0.4405	0.4739	0.4334	0.3732	0.4020	0.4071	0.4521	0.4605	0.4641
NCIH2291	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_H10_436434	24.4	76	NCI-H2291|H2291	-666	M	adenocarcinoma,NSCLC	NCIH2291	lung	ATCC	CRL-5939	cancer cell line	Y	lymph_node	fh_NCIH2291_LUNG-Tumor	rnaseq	15.7	26.42	58	0.4274	0.4547	0.4702	0.4181	0.3910	0.3998	0.4175	0.4471	0.4573	0.4644
HPAFII	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_A06_383730	31.8	103	HPAF-II	-666	M	carcinoma,ductal	HPAFII	pancreas	ATCC	CRL-1997	cancer cell line	-666	-666	fh_HPAFII_PANCREAS-Tumor	rnaseq	6.9	25.36	58	0.4309	0.4437	0.4748	0.4214	0.3970	0.4026	0.3861	0.4440	0.4669	0.4677
PANC1005	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_D04_240928	37.5	112	Panc 10.05	Identical lines: Panc 10.05 and PL45 were derived from the same sample	M	carcinoma,ductal	PANC1005	pancreas	ATCC	CRL-2547	cancer cell line	-666	-666	fh_PANC1005_PANCREAS-Tumor	rnaseq	7.2	25.6	56	0.4313	0.4492	0.4661	0.4235	0.3827	0.3968	0.4057	0.4489	0.4565	0.4581
SNU16	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_D07_383704	37.7	126	SNU-16|NCI-SNU-16	-666	F	adenocarcinoma,undifferentiated,gastric	SNU16	stomach	ATCC	CRL-5974	cancer cell line	Y	ascites	fh_SNU16_STOMACH-Tumor	rnaseq	6.3	19.71	55	0.4313	0.4400	0.4725	0.4286	0.3628	0.3980	0.4203	0.4453	0.4625	0.4662
HT1080	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_D08_436576	28.8	94	HT-1080	-666	M	fibrosarcoma	HT1080	soft tissue	ATCC	CCL-121	cancer cell line	-666	-666	fh_HT1080_SOFT_TISSUE-Tumor	rnaseq	15.7	18.2	57	0.4309	0.4499	0.4728	0.4212	0.3728	0.3862	0.4297	0.4485	0.4603	0.4691
UO31	-666	31.3	98	UO_31	-666	-666	carcinoma	UO31	kidney	-666	-666	cancer cell line	-666	-666	fh_UO31_KIDNEY-Tumor	rnaseq	15.7	23.47	57	0.4345	0.4530	0.4683	0.4072	0.3896	0.3861	0.4143	0.4482	0.4565	0.4511
SKBR3	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_D06_383700	29.3	92	SK-BR-3	Metastatic pair: SK-BR-3 and AU565 are from the same patient	F	carcinoma	SKBR3	breast	ATCC	HTB-30	cancer cell line	Y	pleural_effusion	fh_SKBR3_BREAST-Tumor	rnaseq	15.7	16.28	56	0.4351	0.4373	0.4580	0.4230	0.3785	0.3972	0.4124	0.4421	0.4479	0.4709
SNUC2A	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_E12_436466	32.4	114	SNU-C2A	-666	F	carcinoma,colorectal	SNUC2A	large intestine,cecum	ATCC	CCL-250.1	cancer cell line	-666	-666	fh_SNUC2A_LARGE_INTESTINE-Tumor	rnaseq	7.2	20.83	57	0.4342	0.4457	0.4730	0.4262	0.3982	0.3965	0.4099	0.4503	0.4473	0.4609
BXPC3	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_H08_383778	35	90	BXPC-3	-666	F	carcinoma,ductal	BXPC3	pancreas	ATCC	CRL-1687	cancer cell line	-666	-666	fh_BXPC3_PANCREAS-Tumor	rnaseq	7.2	17.48	56	0.4406	0.4450	0.4573	0.4158	0.3767	0.4160	0.4145	0.4545	0.4558	0.4553
MKN45	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_D04_474670	31.8	125	-666	-666	F	carcinoma	MKN45	stomach	HSRRB	-666	cancer cell line	-666	-666	fh_MKN45_STOMACH-Tumor	rnaseq	6.9	22.51	57	0.4291	0.4422	0.4706	0.4252	0.3669	0.3986	0.4111	0.4378	0.4722	0.4657
HDMYZ	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_C01_296038	64.5	216	HD-MY-Z	-666	-666	lymphoma,Hodgkins	HDMYZ	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_HDMYZ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.5	27.09	53	0.4310	0.4322	0.4744	0.4198	0.3811	0.3971	0.4058	0.4507	0.4469	0.4624
SF268	-666	28.5	86	-666	-666	-666	glioma	SF268	brain	NCI	-666	cancer cell line	-666	-666	fh_SF268_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.9	19.62	58	0.4360	0.4428	0.4716	0.4196	0.3655	0.3946	0.4251	0.4581	0.4540	0.4633
MELJUSO	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_G03_240998	31.7	118	MEL-JUSO	-666	F	melanoma	MELJUSO	skin	DSMZ	-666	cancer cell line	-666	-666	fh_MELJUSO_SKIN-Tumor	rnaseq	15.7	17.82	56	0.4377	0.4449	0.4728	0.4235	0.3634	0.4056	0.4047	0.4540	0.4477	0.4515
NCIH1581	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_F01_296110	46.5	185	NCI-H1581|H1581	-666	M	carcinoma,large cell	NCIH1581	lung	ATCC	CRL-5878	cancer cell line	-666	-666	fh_NCIH1581_LUNG-Tumor	rnaseq	5.8	21.54	55	0.4337	0.4438	0.4694	0.4303	0.3613	0.3942	0.4249	0.4568	0.4511	0.4631
KYSE510	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_E02_257696	32.8	108	KYSE-510	-666	F	carcinoma,squamous cell	KYSE510	oesophagus	DSMZ	-666	cancer cell line	-666	-666	fh_KYSE510_OESOPHAGUS-Tumor	rnaseq	15.7	19.01	56	0.4327	0.4458	0.4710	0.4345	0.3574	0.3949	0.4066	0.4463	0.4534	0.4571
GAMG	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_B07_296026	44.4	150	-666	-666	F	glioma	GAMG	CNS	DSMZ	-666	cancer cell line	-666	-666	fh_GAMG_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.6	24.31	56	0.4291	0.4483	0.4731	0.4195	0.3646	0.3919	0.4117	0.4468	0.4485	0.4622
FUOV1	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_E12_240968	28	104	FU-OV-1	-666	F	serous carcinoma	FUOV1	ovary	DSMZ	-666	cancer cell line	N	-666	fh_FUOV1_OVARY-Tumor	rnaseq	6.5	26.01	59	0.4190	0.4676	0.4756	0.4350	0.3769	0.3859	0.4061	0.4302	0.4503	0.4647
PECAPJ41CLONED2	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_F05_569454	33.8	80	PE/CA-PJ41 (CLONE D2)	-666	F	carcinoma,squamous cell	PECAPJ41CLONED2	upper aerodigestive tract,mouth	ECACC	-666	cancer cell line	N	-666	fh_PECAPJ41CLONED2_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	7.2	17.84	57	0.4272	0.4468	0.4702	0.4190	0.3908	0.4113	0.4078	0.4517	0.4520	0.4532
SNU449	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_B05_436592	39.6	119	SNU-449|NCI-SNU-449	-666	M	carcinoma,hepatocellular	SNU449	liver	ATCC	CRL-2234	cancer cell line	-666	-666	fh_SNU449_LIVER-Tumor	rnaseq	6.9	21.32	56	0.4320	0.4442	0.4641	0.4176	0.3746	0.3971	0.4102	0.4417	0.4561	0.4655
HEC265	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_F03_419766	25.2	90	HEC-265	-666	F	carcinoma	HEC265	endometrium	HSRRB	-666	cancer cell line	N	-666	fh_HEC265_ENDOMETRIUM-Tumor	rnaseq	15.7	17.4	57	0.4411	0.4540	0.4684	0.4145	0.3529	0.3969	0.4125	0.4404	0.4568	0.4529
HS944T	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_B07_257634	40.7	136	HS 944.T	-666	M	melanoma	HS944T	skin	ATCC	CRL-7693	cancer cell line	Y	lymph_node	fh_HS944T_SKIN-Tumor	rnaseq	7.2	20.95	55	0.4420	0.4558	0.4695	0.4162	0.3605	0.4051	0.3994	0.4529	0.4522	0.4534
PECAPJ49	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_F01_569580	41.3	121	PE/CA-PJ49	-666	M	carcinoma,squamous cell	PECAPJ49	upper aerodigestive tract,mouth	ECACC	-666	cancer cell line	N	-666	fh_PECAPJ49_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	22.29	55	0.4366	0.4457	0.4636	0.4193	0.3707	0.4030	0.4076	0.4625	0.4521	0.4578
IGROV1	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_C04_240904	32.6	102	IGROV-1	-666	F	carcinoma	IGROV1	ovary	NCI/DCTD	-666	cancer cell line	-666	-666	fh_IGROV1_OVARY-Tumor	rnaseq	15.7	19.17	56	0.4303	0.4527	0.4711	0.4163	0.3646	0.3852	0.4201	0.4487	0.4498	0.4566
EFO27	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_C01_240898	25	93	EFO-27	-666	F	mucinous carcinoma	EFO27	ovary	DSMZ	-666	cancer cell line	-666	-666	fh_EFO27_OVARY-Tumor	rnaseq	15.7	21.95	58	0.4263	0.4448	0.4770	0.4151	0.3759	0.3924	0.4086	0.4495	0.4615	0.4484
MDAMB361	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_C08_383600	28.4	107	MDA-MB-361	-666	F	carcinoma	MDAMB361	breast	ATCC	HTB-27	cancer cell line	Y	brain	fh_MDAMB361_BREAST-Tumor	rnaseq	15.7	25.97	57	0.4326	0.4373	0.4551	0.4188	0.3732	0.4009	0.4206	0.4460	0.4489	0.4622
NCIH747	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_H01_296158	27.4	87	NCI-H747|H747	-666	M	adenocarcinoma,colorectal	NCIH747	large intestine,cecum	ATCC	CCL-252	cancer cell line	-666	-666	fh_NCIH747_LARGE_INTESTINE-Tumor	rnaseq	6	22.87	58	0.4273	0.4461	0.4752	0.4272	0.3836	0.4052	0.4014	0.4408	0.4477	0.4516
SNU1041	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_A08_569424	35.6	90	NCI-SNU-1041	-666	-666	carcinoma	SNU1041	upper aerodigestive tract	KCLB	-666	cancer cell line	-666	-666	fh_SNU1041_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	18.09	56	0.4326	0.4353	0.4568	0.4136	0.3889	0.3939	0.4126	0.4509	0.4472	0.4614
JHH4	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_C01_241090	33	114	JHH-4	-666	M	carcinoma,hepatocellular	JHH4	liver	HSRRB	-666	cancer cell line	N	-666	fh_JHH4_LIVER-Tumor	rnaseq	15.7	22.25	57	0.4443	0.4444	0.4606	0.4196	0.3873	0.3975	0.4027	0.4452	0.4449	0.4445
NCIH3255	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_C07_779624	41.9	118	NCI-H3255	Identical lines: NCI-H322 and NCI-H3255 share high SNP identity	F	adenocarcinoma	NCIH3255	lung	-666	-666	cancer cell line	N	-666	fh_NCIH3255_LUNG-Tumor	rnaseq	6.3	26.04	57	0.4310	0.4451	0.4660	0.4190	0.3923	0.4049	0.4162	0.4403	0.4397	0.4480
NCIH292	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_A05_779628	28	86	H292|H292	-666	F	mucoepidermoid carcinoma	NCIH292	lung	ATCC	CRL-1848	cancer cell line	-666	-666	fh_NCIH292_LUNG-Tumor	rnaseq	6.2	28.94	59	0.4271	0.4455	0.4659	0.4085	0.3893	0.4018	0.4109	0.4440	0.4539	0.4431
HOP92	-666	34.1	97	HOP-92	-666	-666	carcinoma	HOP92	lung	NCI	-666	cancer cell line	-666	-666	fh_HOP92_LUNG-Tumor	rnaseq	7.2	24.43	57	0.4278	0.4479	0.4603	0.4120	0.3942	0.4004	0.4189	0.4452	0.4480	0.4562
EPLC272H	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_H05_383766	40.7	119	EPLC-272H	-666	M	carcinoma,squamous cell	EPLC272H	lung	DSMZ	-666	cancer cell line	-666	-666	fh_EPLC272H_LUNG-Tumor	rnaseq	15.7	20.02	56	0.4210	0.4415	0.4745	0.4178	0.3710	0.3961	0.4054	0.4506	0.4650	0.4679
S117	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_D09_474700	24.9	75	S-117	-666	F	sarcoma	S117	sofT tissue,thyroid	DSMZ	-666	cancer cell line	-666	-666	fh_S117_SOFT_TISSUE-Tumor	rnaseq	15.7	19.38	59	0.4281	0.4543	0.4655	0.4131	0.3829	0.3871	0.4143	0.4473	0.4509	0.4585
NCIH2172	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_G09_569586	38.5	140	NCI-H2172|H2172	-666	F	carcinoma,non-small cell	NCIH2172	lung	ATCC	CRL-5930	cancer cell line	-666	-666	fh_NCIH2172_LUNG-Tumor	rnaseq	6.6	19.48	56	0.4319	0.4416	0.4832	0.4284	0.3673	0.3855	0.4017	0.4416	0.4542	0.4672
NCIH441	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_E05_240954	35.6	122	NCI-H441|H441	-666	M	adenocarcinoma,papillary	NCIH441	lung	ATCC	HTB-174	cancer cell line	Y	pericardial_fluid	fh_NCIH441_LUNG-Tumor	rnaseq	6.7	28.02	56	0.4187	0.4521	0.4694	0.4192	0.3918	0.4013	0.4016	0.4352	0.4488	0.4594
253JBV	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_A05_569490	37.8	110	-666	Identical lines: 253J and 253J-BV share high SNP identity	-666	carcinoma,transitional cell	253JBV	urinary tract	KCLB	-666	cancer cell line	-666	-666	fh_253JBV_URINARY_TRACT-Tumor	rnaseq	15.7	19.53	56	0.4313	0.4465	0.4641	0.4169	0.3532	0.3908	0.4159	0.4533	0.4572	0.4542
HEC1A	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_C11_296058	49.9	175	HEC-1-A	Identical lines: HEC-1-A HEC-1-B are subclones of HEC-1 and share high SNP identity	F	carcinoma	HEC1A	endometrium,uterus	ATCC	HTB-112	cancer cell line	-666	-666	fh_HEC1A_ENDOMETRIUM-Tumor	rnaseq	6.7	21.46	55	0.4268	0.4489	0.4726	0.4161	0.3529	0.3889	0.4119	0.4381	0.4534	0.4608
SNU398	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_G05_383642	28.6	125	SNU-398|NCI-SNU-398	-666	M	carcinoma,hepatocellular	SNU398	liver	ATCC	CRL-2233	cancer cell line	-666	-666	fh_SNU398_LIVER-Tumor	rnaseq	7.2	19.19	56	0.4221	0.4453	0.4715	0.4322	0.3409	0.3848	0.4129	0.4444	0.4486	0.4592
SNU213	BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_F04_698822	33.1	95	NCI-SNU-213	-666	M	carcinoma	SNU213	pancreas	KCLB	-666	cancer cell line	-666	-666	fh_SNU213_PANCREAS-Tumor	rnaseq	15.7	23.84	57	0.4275	0.4478	0.4689	0.4119	0.3935	0.4101	0.3964	0.4465	0.4495	0.4521
SKMES1	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_D01_241114	34.9	120	SK-MES-1	-666	M	carcinoma,squamous cell	SKMES1	lung	ATCC	HTB-58	cancer cell line	Y	pleural_effusion	fh_SKMES1_LUNG-Tumor	rnaseq	6.9	26.09	57	0.4341	0.4401	0.4659	0.4058	0.3900	0.3948	0.4092	0.4463	0.4488	0.4577
SCC25	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_A02_523514	30.4	84	SCC-25	-666	M	carcinoma,squamous cell	SCC25	upper aerodigestive tract,tongue	ATCC	CRL-1628	cancer cell line	-666	-666	fh_SCC25_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	20.06	58	0.4285	0.4395	0.4653	0.4181	0.3715	0.4008	0.4016	0.4473	0.4502	0.4638
GP2D	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_E09_569518	33.4	120	-666	-666	F	carcinoma	GP2D	large intestine	ECACC	-666	cancer cell line	-666	-666	fh_GP2D_LARGE_INTESTINE-Tumor	rnaseq	15.7	20.68	56	0.4182	0.4457	0.4670	0.4279	0.3559	0.3928	0.4119	0.4300	0.4502	0.4699
LN464	-666	26.7	98	-666	-666	-666	glioma	LN464	CNS	-666	-666	cancer cell line	-666	-666	fh_LN464_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	19.04	57	0.4366	0.4562	0.4644	0.4209	0.3747	0.3977	0.3981	0.4426	0.4388	0.4430
HS229T	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_E03_454660	36.3	127	HS 229.T	-666	M	adenocarcinoma,bronchogenic	HS229T	lung	ATCC	CRL-7194	cancer cell line	-666	-666	fh_HS229T_LUNG-Tumor	rnaseq	15.7	20.69	56	0.4170	0.4442	0.4743	0.4123	0.3791	0.3828	0.4101	0.4401	0.4487	0.4645
BICR18	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_D05_698858	30.4	90	BICR 18	-666	M	carcinoma,squamous cell	BICR18	upper aerodigestive tract,mouth	ECACC	-666	cancer cell line	N	-666	fh_BICR18_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	22	57	0.4291	0.4490	0.4657	0.4357	0.3628	0.3886	0.4090	0.4448	0.4461	0.4463
CAKI2	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_C04_257652	24.3	89	CAKI-2	-666	M	clear cell renal cell carcinoma	CAKI2	kidney	ATCC	HTB-47	cancer cell line	-666	-666	fh_CAKI2_KIDNEY-Tumor	rnaseq	15.7	19.88	58	0.4410	0.4422	0.4618	0.4185	0.3709	0.3891	0.4195	0.4508	0.4543	0.4511
NCIH2452	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_C08_454624	38.6	124	NCI-H2452|H2452	-666	M	mesothelioma	NCIH2452	pleura	ATCC	CRL-5946	cancer cell line	Y	pleural_effusion	fh_NCIH2452_PLEURA-Tumor	rnaseq	6.2	23.39	57	0.4207	0.4508	0.4588	0.4229	0.3781	0.3859	0.4107	0.4435	0.4486	0.4518
IALM	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_F11_383686	38.2	123	IA-LM	-666	M	carcinoma,large cell	IALM	lung	RIKEN	-666	cancer cell line	-666	-666	fh_IALM_LUNG-Tumor	rnaseq	5.9	29.72	57	0.4223	0.4634	0.4665	0.4097	0.3955	0.3926	0.4116	0.4440	0.4473	0.4522
JHUEM1	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_F09_383678	46.9	138	JHUEM-1	-666	F	carcinoma	JHUEM1	endometrium	RIKEN	-666	cancer cell line	N	-666	fh_JHUEM1_ENDOMETRIUM-Tumor	rnaseq	15.7	22.37	54	0.4239	0.4384	0.4672	0.4174	0.3793	0.3955	0.4070	0.4364	0.4442	0.4615
NCIH1838	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_E04_454658	22.2	78	NCI-H1838|H1838	-666	F	carcinoma,non-small cell	NCIH1838	lung	ATCC	CRL-5899	cancer cell line	-666	-666	fh_NCIH1838_LUNG-Tumor	rnaseq	15.7	20.09	57	0.4196	0.4484	0.4656	0.4057	0.3699	0.3962	0.4124	0.4479	0.4417	0.4603
TE15	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_D11_296082	33.5	95	TE-15	-666	F	carcinoma,squamous cell	TE15	oesophagus	RIKEN	-666	cancer cell line	-666	-666	fh_TE15_OESOPHAGUS-Tumor	rnaseq	15.7	14.83	55	0.4229	0.4328	0.4691	0.4187	0.3548	0.3952	0.3986	0.4419	0.4494	0.4605
ESS1	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_C07_296050	25.7	79	ESS-1	-666	F	carcinosarcoma,mesodermal mixed	ESS1	endometrium,uterus	DSMZ	-666	cancer cell line	-666	-666	fh_ESS1_ENDOMETRIUM-Tumor	rnaseq	6.9	21.03	58	0.4216	0.4395	0.4712	0.4168	0.3627	0.3881	0.4102	0.4439	0.4528	0.4616
HCC1195	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_A11_587596	41.8	117	HCC-1195	-666	M	carcinoma,mixed adenosquamous	HCC1195	lung	KCLB	-666	cancer cell line	N	-666	fh_HCC1195_LUNG-Tumor	rnaseq	6.9	22.69	55	0.4292	0.4430	0.4540	0.4051	0.3819	0.4047	0.4060	0.4386	0.4474	0.4655
HCC1954	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_F08_419788	60.1	194	-666	-666	F	carcinoma,ductal	HCC1954	breast	ATCC	CRL-2338	cancer cell line	-666	-666	fh_HCC1954_BREAST-Tumor	rnaseq	5.9	22.33	54	0.4206	0.4402	0.4691	0.4275	0.3765	0.3957	0.3994	0.4328	0.4471	0.4616
647V	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_H02_474606	30.2	90	647-V	-666	M	carcinoma,transitional cell	647V	urinary tract,bladder	DSMZ	-666	cancer cell line	-666	-666	fh_647V_URINARY_TRACT-Tumor	rnaseq	7.2	14.79	57	0.4280	0.4403	0.4652	0.4114	0.3767	0.3994	0.3965	0.4461	0.4555	0.4502
HCC44	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_B04_302134	27	78	HCC-44	-666	F	carcinoma,non-small cell carcinoma	HCC44	lung	DSMZ	-666	cancer cell line	N	-666	fh_HCC44_LUNG-Tumor	rnaseq	7.2	15.33	58	0.4249	0.4516	0.4752	0.4143	0.3809	0.3894	0.4037	0.4449	0.4501	0.4477
TE1	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_C12_296060	42.3	133	TE-1	-666	M	carcinoma,squamous cell	TE1	oesophagus	RIKEN	-666	cancer cell line	-666	-666	fh_TE1_OESOPHAGUS-Tumor	rnaseq	6.7	23.22	56	0.4162	0.4477	0.4760	0.4184	0.3723	0.3869	0.4136	0.4393	0.4558	0.4543
KLE	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_B11_436604	27.8	106	-666	-666	F	carcinoma	KLE	endometrium,uterus	ATCC	CRL-1622	cancer cell line	-666	-666	fh_KLE_ENDOMETRIUM-Tumor	rnaseq	15.7	19.83	57	0.4266	0.4449	0.4597	0.4121	0.3818	0.4000	0.4050	0.4383	0.4404	0.4661
LCLC97TM1	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_E10_474630	36.1	120	LCLC-97TM1	-666	M	carcinoma,large cell	LCLC97TM1	lung	DSMZ	-666	cancer cell line	-666	-666	fh_LCLC97TM1_LUNG-Tumor	rnaseq	7.2	19.52	56	0.4293	0.4575	0.4638	0.4033	0.3917	0.3914	0.4012	0.4435	0.4483	0.4571
NCIH1869	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_A05_474768	72.5	171	NCI-H1869	-666	M	carcinoma,squamous cell	NCIH1869	lung	ATCC	CRL-5900	cancer cell line	Y	pleural_effusion	fh_NCIH1869_LUNG-Tumor	rnaseq	15.7	16.54	51	0.4219	0.4377	0.4736	0.4193	0.3688	0.4175	0.3941	0.4385	0.4644	0.4828
LS123	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_B03_698798	35.4	99	LS123	-666	F	adenocarcinoma,colorectal	LS123	large intestine,colon	ATCC	CCL-255	cancer cell line	-666	-666	fh_LS123_LARGE_INTESTINE-Tumor	rnaseq	15.7	22.02	57	0.4192	0.4407	0.4665	0.4164	0.3893	0.3998	0.3968	0.4440	0.4462	0.4570
CORL105	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_C04_698816	25	84	COR-L105	-666	M	carcinoma	CORL105	lung	ECACC	-666	cancer cell line	-666	-666	fh_CORL105_LUNG-Tumor	rnaseq	15.7	25.75	58	0.4285	0.4335	0.4547	0.4113	0.3835	0.4020	0.4178	0.4516	0.4450	0.4376
NCIH1703	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_E03_296090	44.5	143	NCI-H1703|H1703	-666	M	adenocarcinoma,squamous cell,non-small cell lung cancer	NCIH1703	lung	ATCC	CRL-5889	cancer cell line	-666	-666	fh_NCIH1703_LUNG-Tumor	rnaseq	7.2	19.25	55	0.4156	0.4327	0.4688	0.4123	0.3578	0.3832	0.4114	0.4472	0.4559	0.4682
SNU886	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_C04_779652	46.1	149	SNU-886|NCI-SNU-886	-666	M	hepatocellular carcinoma	SNU886	liver	KCLB	-666	cancer cell line	N	-666	fh_SNU886_LIVER-Tumor	rnaseq	7.2	21.44	55	0.4300	0.4422	0.4652	0.4107	0.3767	0.3905	0.3929	0.4365	0.4473	0.4470
SF126	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_C07_436540	30.8	119	-666	-666	-666	glioma,astrocytoma	SF126	CNS	HSRRB	-666	cancer cell line	-666	-666	fh_SF126_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	20.3	57	0.4204	0.4430	0.4688	0.4131	0.3654	0.3786	0.4065	0.4429	0.4459	0.4599
HCC2450	-666	30.5	102	-666	-666	-666	carcinoma	HCC2450	lung	-666	-666	cancer cell line	-666	-666	fh_HCC2450-Tumor	rnaseq	7.2	30.6	58	0.4232	0.4481	0.4620	0.4170	0.3665	0.3973	0.4181	0.4410	0.4365	0.4560
HCC2429	-666	34.8	159	-666	-666	-666	carcinoma	HCC2429	lung	-666	-666	cancer cell line	-666	-666	fh_HCC2429-Tumor	rnaseq	15.7	18.45	55	0.4210	0.4390	0.4639	0.4220	0.3386	0.3988	0.4064	0.4404	0.4603	0.4562
HA1E	-666	32.8	111	HA1E	-666	-666	epthelium	HA1E	kidney	-666	-666	imortalized normal	N	-666	CMAP_HA1E_1	rnaseq	15.7	22.12	56	0.4250	0.4480	0.4720	0.4144	0.3582	0.3829	0.4067	0.4424	0.4443	0.4515
786O	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_A07_240862	47.3	135	786-O|786-0	-666	M	clear cell renal cell carcinoma	786O	kidney	ATCC	CRL-1932	cancer cell line	-666	-666	fh_786O_KIDNEY-Tumor	rnaseq	5.5	24.47	56	0.4226	0.4536	0.4720	0.4057	0.3524	0.3860	0.4065	0.4418	0.4535	0.4518
ISHIKAWAHERAKLIO02ER	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_G10_569546	30.7	124	ISHIKAWA (HERAKLIO) 02 ER-	-666	F	carcinoma	ISHIKAWAHERAKLIO02ER	endometrium	ECACC	-666	cancer cell line	N	-666	fh_ISHIKAWAHERAKLIO02ER_ENDOMETRIUM-Tumor	rnaseq	15.7	20.48	56	0.4311	0.4414	0.4636	0.4160	0.3618	0.3851	0.4074	0.4390	0.4467	0.4704
NCIH1819	-666	40	170	NCI-H1819	-666	-666	adenocarcinoma	NCIH1819	lung	ATCC	CRL-5897	cancer cell line	Y	lymph_node	fh_NCIH1819-Tumor	rnaseq	6.9	21.36	55	0.4132	0.4403	0.4726	0.4200	0.3775	0.3891	0.3896	0.4258	0.4466	0.4673
MG63	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_D05_454642	30.5	114	MG-63	-666	M	osteosarcoma	MG63	bone	ATCC	CRL-1427	cancer cell line	-666	-666	fh_MG63_BONE-Tumor	rnaseq	6.9	23.29	57	0.4223	0.4371	0.4676	0.4219	0.3631	0.3865	0.4065	0.4416	0.4424	0.4618
TEN	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_F02_383714	39.7	134	TEN	-666	F	carcinoma,clear cell	TEN	endometrium	RIKEN	-666	cancer cell line	N	-666	fh_TEN_ENDOMETRIUM-Tumor	rnaseq	15.7	25.02	56	0.4252	0.4443	0.4677	0.4172	0.3745	0.3872	0.3935	0.4311	0.4429	0.4536
CAPAN1	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_B04_383742	32.4	96	CAPAN-1	-666	M	carcinoma,ductal	CAPAN1	pancreas	ATCC	HTB-79	cancer cell line	Y	liver	fh_CAPAN1_PANCREAS-Tumor	rnaseq	15.7	18.51	57	0.4219	0.4277	0.4580	0.4091	0.3753	0.3919	0.4044	0.4396	0.4472	0.4666
SNU1196	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_A09_587692	32.9	100	NCI-SNU-1196	-666	-666	carcinoma	SNU1196	biliary tract	KCLB	-666	cancer cell line	-666	-666	fh_SNU1196_BILIARY_TRACT-Tumor	rnaseq	15.7	17.28	57	0.4229	0.4355	0.4606	0.4195	0.3677	0.3952	0.4036	0.4373	0.4485	0.4616
SNU410	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_D04_587678	29	100	SNU-410|NCI-SNU-410	-666	M	carcinoma	SNU410	pancreas	KCLB	-666	cancer cell line	N	-666	fh_SNU410_PANCREAS-Tumor	rnaseq	7.2	22.63	57	0.4169	0.4352	0.4590	0.4246	0.3807	0.3937	0.4164	0.4462	0.4368	0.4498
MDAPCA2B	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_C10_240916	34.5	131	MDA PCA 2B	-666	M	carcinoma	MDAPCA2B	prostate	ATCC	CRL-2422	cancer cell line	Y	bone	fh_MDAPCA2B_PROSTATE-Tumor	rnaseq	15.7	20.99	55	0.4283	0.4383	0.4570	0.4096	0.3709	0.3976	0.4039	0.4326	0.4465	0.4571
GB1	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_B08_779706	33	121	GB-1	-666	M	glioma,astrocytoma,grade IV	GB1	CNS	HSRRB	-666	cancer cell line	N	-666	fh_GB1_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	19.87	57	0.4276	0.4291	0.4673	0.4205	0.3458	0.3774	0.4013	0.4422	0.4469	0.4545
NCIH1666	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_G07_436502	37	103	NCI-H1666|H1666	-666	F	adenocarcinoma,bronchoalveolar	NCIH1666	lung	ATCC	CRL-5885	cancer cell line	Y	pleural_effusion	fh_NCIH1666_LUNG-Tumor	rnaseq	15.7	19.96	56	0.4195	0.4390	0.4570	0.4109	0.4011	0.3916	0.4062	0.4409	0.4467	0.4412
CFPAC1	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_B07_383738	39.2	118	CFPAC-1	-666	M	carcinoma,ductal,cystic fibrosis	CFPAC1	pancreas	ATCC	CRL-1918	cancer cell line	-666	-666	fh_CFPAC1_PANCREAS-Tumor	rnaseq	6.9	28.22	56	0.4234	0.4309	0.4660	0.4139	0.3899	0.4051	0.3799	0.4392	0.4414	0.4413
HT55	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_F07_569566	39.4	126	HT55	-666	-666	carcinoma	HT55	large intestine	ECACC	-666	cancer cell line	-666	-666	fh_HT55_LARGE_INTESTINE-Tumor	rnaseq	15.7	20.41	55	0.4207	0.4408	0.4615	0.4205	0.3818	0.3877	0.3930	0.4249	0.4463	0.4581
NCIH1793	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_B10_383746	32.7	121	NCI-H1793|H1793	-666	F	carcinoma,non-small cell	NCIH1793	lung	ATCC	CRL-5896	cancer cell line	-666	-666	fh_NCIH1793_LUNG-Tumor	rnaseq	7.2	25.07	57	0.4255	0.4398	0.4609	0.4086	0.3671	0.3877	0.3974	0.4416	0.4505	0.4637
SNU423	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_G06_383654	31.5	100	SNU-423|NCI-SNU-423	-666	M	carcinoma,hepatocellular	SNU423	liver	ATCC	CRL-2238	cancer cell line	-666	-666	fh_SNU423_LIVER-Tumor	rnaseq	15.7	20.06	57	0.4216	0.4413	0.4683	0.4107	0.3655	0.3903	0.4028	0.4387	0.4444	0.4556
SNU601	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_B04_779662	31.8	111	SNU-601|NCI-SNU-601	-666	M	carcinoma	SNU601	stomach	KCLB	-666	cancer cell line	N	-666	fh_SNU601_STOMACH-Tumor	rnaseq	15.7	22.04	57	0.4283	0.4318	0.4589	0.4120	0.3613	0.3952	0.3993	0.4441	0.4471	0.4581
59M	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_A10_779748	57	162	59M	-666	F	carcinoma,ovarian epithelial	59M	ovary	ECACC	89081800	cancer cell line	-666	-666	fh_59M_OVARY-Tumor	rnaseq	7.2	18.81	54	0.4252	0.4365	0.4587	0.4106	0.3775	0.3906	0.4011	0.4409	0.4526	0.4525
DAOY	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_E09_587618	31.1	113	-666	-666	M	PNET,medulloblastoma	DAOY	CNS,cerebellum	ATCC	HTB-186	cancer cell line	-666	-666	fh_DAOY_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	4.7	26.88	57	0.4143	0.4461	0.4756	0.4177	0.3610	0.3849	0.4045	0.4376	0.4458	0.4548
RERFLCAD2	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_C08_436518	36.1	107	RERF-LC-AD2	-666	M	carcinoma	RERFLCAD2	lung	HSRRB	-666	cancer cell line	N	-666	fh_RERFLCAD2_LUNG-Tumor	rnaseq	15.7	25.2	57	0.4233	0.4303	0.4647	0.4027	0.3755	0.3920	0.3815	0.4376	0.4471	0.4521
HUCCT1	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_E07_419756	87.9	196	-666	-666	M	carcinoma	HUCCT1	biliary tract	HSRRB	-666	cancer cell line	-666	-666	fh_HUCCT1_BILIARY_TRACT-Tumor	rnaseq	15.7	11.53	49	0.4076	0.4379	0.4872	0.4136	0.3628	0.4000	0.3821	0.4377	0.4636	0.4796
CAOV3	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_A08_240864	26.8	90	CAOV-3	-666	F	carcinoma	CAOV3	ovary	ATCC	HTB-75	cancer cell line	-666	-666	fh_CAOV3_OVARY-Tumor	rnaseq	15.7	18.42	57	0.4126	0.4439	0.4690	0.4093	0.3608	0.3901	0.4037	0.4446	0.4438	0.4512
EFM192A	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_B11_240894	43.6	148	EFM-192A	-666	F	carcinoma	EFM192A	breast	DSMZ	-666	cancer cell line	Y	pleura	fh_EFM192A_BREAST-Tumor	rnaseq	6.6	28.28	56	0.4226	0.4300	0.4540	0.4168	0.3696	0.3929	0.4062	0.4284	0.4397	0.4608
NCIH2077	-666	47.7	180	-666	-666	-666	-666	NCIH2077	-666	-666	-666	cancer cell line	-666	-666	fh_NCI-H2077-Tumor	rnaseq	6.9	23	54	0.4215	0.4378	0.4622	0.4178	0.3487	0.3812	0.4064	0.4444	0.4554	0.4527
SCC4	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_G07_383650	23.1	69	SCC-4	-666	M	carcinoma,squamous cell	SCC4	upper aerodigestive tract,tongue	ATCC	CRL-1624	cancer cell line	-666	-666	fh_SCC4_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	25.9	59	0.4248	0.4403	0.4509	0.4040	0.3688	0.3965	0.4033	0.4399	0.4298	0.4407
RT4	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_H02_296160	46.3	135	-666	-666	M	carcinoma,transitional cell	RT4	urinary tract,bladder	ATCC	HTB-2	cancer cell line	-666	-666	fh_RT4_URINARY_TRACT-Tumor	rnaseq	15.7	19.28	55	0.4211	0.4379	0.4631	0.4192	0.3607	0.3981	0.3998	0.4333	0.4490	0.4489
LMSU	BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_C05_698910	26.4	92	-666	-666	-666	adenocarcinoma	LMSU	stomach	RIKEN	-666	cancer cell line	-666	-666	fh_LMSU_STOMACH-Tumor	rnaseq	6.4	23	59	0.4138	0.4438	0.4638	0.4087	0.3458	0.3796	0.4063	0.4398	0.4423	0.4638
SKCO1	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_H03_569456	33.8	104	SK-CO-1	-666	M	adenocarcinoma,colorectal	SKCO1	large intestine,colon	ATCC	HTB-39	cancer cell line	Y	ascites	fh_SKCO1_LARGE_INTESTINE-Tumor	rnaseq	15.7	21.92	56	0.4200	0.4376	0.4667	0.4075	0.3763	0.3971	0.4005	0.4282	0.4487	0.4500
SW579	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_A01_257598	27.6	90	-666	Identical lines: SW579 and CGTH-W-1 share high SNP identity. CGTH-W-1 really is SW579.	M	carcinoma,anaplastic,squamous	SW579	thyroid	ATCC	HTB-107	cancer cell line	-666	-666	fh_SW579_THYROID-Tumor	rnaseq	7.2	21.39	58	0.4260	0.4293	0.4595	0.4061	0.3682	0.3738	0.4094	0.4384	0.4447	0.4547
U118MG	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_A11_779692	20.4	92	U-118 MG|U118	Identical lines: U-118 MG, U-138 MG and 1321N1 share high SNP identity	M	glioma,astrocytoma	U118MG	CNS	ATCC	HTB-15	cancer cell line	-666	-666	fh_U118MG_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6	27.42	59	0.4240	0.4338	0.4638	0.4123	0.3678	0.3788	0.4104	0.4402	0.4319	0.4497
NIHOVCAR3	-666	39.9	171	NIH:OVCAR-3	-666	-666	adenocarcinoma	NIHOVCAR3	ovary	ATCC	HTB-161	cancer cell line	Y	ascites	fh_NIHOVCAR3_OVARY-Tumor	rnaseq	5.4	33.88	56	0.4109	0.4446	0.4671	0.4151	0.3723	0.3834	0.3921	0.4310	0.4351	0.4650
ACHN	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_E08_296100	22.8	83	-666	-666	M	carcinoma,renal	ACHN	kidney	ATCC	CRL-1611	cancer cell line	-666	-666	fh_ACHN_KIDNEY-Tumor	rnaseq	7.2	25.24	59	0.4220	0.4378	0.4593	0.4064	0.3748	0.3721	0.4109	0.4356	0.4541	0.4391
L33	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_G09_241010	27.1	95	L3.3	-666	-666	carcinoma	L33	pancreas	-666	-666	cancer cell line	N	-666	fh_L33_PANCREAS-Tumor	rnaseq	15.7	18.02	56	0.4382	0.4269	0.4575	0.4199	0.3674	0.3917	0.3978	0.4423	0.4456	0.4452
HS746T	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_E09_436476	17.4	86	HS 746T	-666	M	carcinoma,gastric	HS746T	stomach	ATCC	HTB-135	cancer cell line	Y	muscle	fh_HS746T_STOMACH-Tumor	rnaseq	6.9	29.39	59	0.4163	0.4389	0.4689	0.4075	0.3690	0.3796	0.4048	0.4349	0.4429	0.4551
SF295	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_B10_241084	56.4	192	-666	-666	-666	glioma,astrocytoma,grade IV	SF295	CNS	NCI/DCTD	-666	cancer cell line	-666	-666	fh_SF295_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	7.2	24.2	54	0.4183	0.4306	0.4612	0.4110	0.3576	0.3838	0.4105	0.4454	0.4431	0.4522
LI7	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_F10_698850	70.8	213	Li-7	-666	-666	hepatocellular carcinoma	LI7	liver	RIKEN	-666	cancer cell line	N	-666	fh_LI7_LIVER-Tumor	rnaseq	6.5	27.42	54	0.4279	0.4386	0.4611	0.4083	0.3537	0.3881	0.3998	0.4384	0.4376	0.4343
22RV1	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_F06_296120	16.2	85	-666	-666	M	carcinoma	22RV1	prostate	ATCC	CRL-2505	cancer cell line	-666	-666	fh_22RV1_PROSTATE-Tumor	rnaseq	7.2	14.99	59	0.4136	0.4339	0.4725	0.4220	0.3571	0.3782	0.4100	0.4304	0.4524	0.4547
NCIH2126	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_B02_523522	24.3	79	NCI-H2126|H2126	-666	M	carcinoma,non-small cell carcinoma	NCIH2126	lung	ATCC	CCL-256	cancer cell line	-666	-666	fh_NCIH2126_LUNG-Tumor	rnaseq	15.7	19.03	57	0.4265	0.4239	0.4596	0.4095	0.4042	0.3855	0.3992	0.4376	0.4438	0.4525
SW1417	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_H05_296166	30.8	97	-666	-666	F	adenocarcinoma,colorectal	SW1417	large intestine,colon	ATCC	CCL-238	cancer cell line	-666	-666	fh_SW1417_LARGE_INTESTINE-Tumor	rnaseq	15.7	20.99	57	0.4293	0.4356	0.4539	0.4191	0.3700	0.3851	0.4009	0.4348	0.4420	0.4539
NCIH28	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_B06_436598	58.5	161	NCI-H28|H28	-666	M	mesothelioma	NCIH28	pleura	ATCC	CRL-5820	cancer cell line	Y	pleural_effusion	fh_NCIH28_PLEURA-Tumor	rnaseq	15.7	16.3	54	0.4227	0.4487	0.4617	0.4081	0.3609	0.3761	0.4053	0.4343	0.4508	0.4469
LUDLU1	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_H03_419816	38.3	111	LUDLU-1	-666	M	carcinoma,squamous cell	LUDLU1	lung	ECACC	-666	cancer cell line	N	-666	fh_LUDLU1_LUNG-Tumor	rnaseq	6	22.1	57	0.4345	0.4334	0.4493	0.4191	0.3582	0.3867	0.4006	0.4457	0.4419	0.4416
NCIH716	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_E02_436548	26.3	108	NCI-H716|H716	-666	-666	adenocarcinoma,colorectal	NCIH716	large intestine,cecum	ATCC	CCL-251	cancer cell line	-666	-666	fh_NCIH716_LARGE_INTESTINE-Tumor	rnaseq	6.4	23.35	58	0.4045	0.4340	0.4756	0.4190	0.3516	0.3866	0.3945	0.4331	0.4444	0.4621
BICR16	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_A03_698898	41.3	116	BICR 16	-666	M	carcinoma,squamous cell	BICR16	upper aerodigestive tract,mouth	ECACC	-666	cancer cell line	N	-666	fh_BICR16_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	7.2	26.07	56	0.4133	0.4365	0.4519	0.4120	0.3669	0.3933	0.4024	0.4360	0.4416	0.4509
OELE	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_A05_767916	31	102	-666	-666	-666	immortalized_epithelial	OELE	ovary	-666	-666	immortalized_epithelial	-666	-666	fh_OELE_OVARY-Tumor	rnaseq	15.7	20.62	56	0.4229	0.4404	0.4571	0.4075	0.3534	0.3759	0.4026	0.4399	0.4438	0.4458
HT1197	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_H08_569488	37.7	107	HT-1197	-666	M	carcinoma	HT1197	urinary tract,bladder	ATCC	CRL-1473	cancer cell line	-666	-666	fh_HT1197_URINARY_TRACT-Tumor	rnaseq	6	28.86	56	0.4038	0.4270	0.4610	0.4147	0.3702	0.3899	0.3974	0.4302	0.4437	0.4470
SLR23	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_A03_767956	38.4	107	-666	-666	-666	carcinoma	SLR23	kidney	-666	-666	cancer cell line	-666	-666	fh_SLR23_KIDNEY-Tumor	rnaseq	7.2	20.63	57	0.4253	0.4466	0.4556	0.4065	0.3604	0.3845	0.4072	0.4369	0.4463	0.4362
SNU283	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_B08_587738	35.5	122	SNU-283|NCI-SNU-283	-666	F	carcinoma	SNU283	large intestine,colon	KCLB	-666	cancer cell line	N	-666	fh_SNU283_LARGE_INTESTINE-Tumor	rnaseq	15.7	21.75	56	0.4296	0.4279	0.4570	0.4097	0.3653	0.3925	0.3981	0.4356	0.4538	0.4559
KMRC1	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_D02_257672	69.4	188	KMRC-1	-666	M	clear cell renal cell carcinoma	KMRC1	kidney	HSRRB	-666	cancer cell line	N	-666	fh_KMRC1_KIDNEY-Tumor	rnaseq	15.7	18.07	52	0.4194	0.4443	0.4663	0.4052	0.3560	0.3777	0.3877	0.4363	0.4429	0.4500
LN18	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_A02_240852	24.2	90	LN-18	-666	M	glioma,astrocytoma,grade IV	LN18	CNS	ATCC	CRL-2610	cancer cell line	-666	-666	fh_LN18_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	20.58	58	0.4198	0.4343	0.4574	0.4128	0.3520	0.3892	0.4125	0.4486	0.4381	0.4474
SNUC4	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_G06_698826	32	133	SNU-C4	-666	M	adenocarcinoma	SNUC4	large intestine,colon	KCLB	-666	cancer cell line	N	-666	fh_SNUC4_LARGE_INTESTINE-Tumor	rnaseq	7.2	20.75	56	0.4162	0.4433	0.4698	0.4148	0.3525	0.3854	0.3898	0.4232	0.4563	0.4499
HUG1N	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_H04_419832	24.2	76	-666	-666	M	carcinoma	HUG1N	stomach	RIKEN	-666	cancer cell line	-666	-666	fh_HUG1N_STOMACH-Tumor	rnaseq	15.7	16.64	58	0.4196	0.4233	0.4478	0.4105	0.3549	0.3858	0.4086	0.4342	0.4462	0.4459
WM983B	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_B11_569574	38	128	WM-983B	-666	-666	melanoma	WM983B	skin	-666	-666	cancer cell line	N	-666	fh_WM983B_SKIN-Tumor	rnaseq	6.5	24.17	56	0.4278	0.4481	0.4750	0.4176	0.3581	0.3847	0.3882	0.4360	0.4406	0.4451
NCIH1755	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_F08_454692	25.5	90	NCI-H1755|H1755	-666	F	adenocarcinoma,NSCLC	NCIH1755	lung	ATCC	CRL-5892	cancer cell line	Y	liver	fh_NCIH1755_LUNG-Tumor	rnaseq	6.6	20.75	58	0.4267	0.4464	0.4616	0.4001	0.3565	0.3791	0.4008	0.4420	0.4395	0.4441
EW8	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_D08_767918	38	167	-666	-666	-666	sarcoma,Ewings,PNET	EW8	bone	-666	-666	cancer cell line	-666	-666	fh_EW8_BONE-Tumor	rnaseq	6.5	19.05	55	0.4071	0.4356	0.4578	0.4138	0.3126	0.3709	0.3969	0.4419	0.4491	0.4504
LNZ308	-666	28.4	136	-666	-666	-666	glioma	LNZ308	CNS	-666	-666	cancer cell line	-666	-666	fh_LNZ308_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	7.2	20.26	55	0.4147	0.4236	0.4698	0.4104	0.3473	0.3861	0.3962	0.4336	0.4519	0.4562
LN428	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_A08_767846	25.8	92	-666	-666	-666	glioma	LN428	CNS	-666	-666	cancer cell line	-666	-666	fh_LN428_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.9	29.77	59	0.4185	0.4347	0.4427	0.4120	0.3821	0.3809	0.4124	0.4419	0.4348	0.4468
UACC893	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_E11_523470	39.3	138	UACC-893	-666	F	carcinoma,ductal	UACC893	breast	ATCC	CRL-1902	cancer cell line	-666	-666	fh_UACC893_BREAST-Tumor	rnaseq	7.2	26.37	56	0.4189	0.4301	0.4535	0.4151	0.3946	0.3853	0.3872	0.4214	0.4407	0.4623
ISTMES2	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_D11_454652	46.4	156	IST-MES2	-666	M	mesothelioma	ISTMES2	pleura	ICLC	-666	cancer cell line	Y	pleural_effusion	fh_ISTMES2_PLEURA-Tumor	rnaseq	6.4	21.16	55	0.4164	0.4389	0.4610	0.4072	0.3625	0.3843	0.3990	0.4355	0.4463	0.4438
RERFLCMS	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_G12_241208	29.7	112	RERF-LC-MS	-666	-666	carcinoma,non-small cell	RERFLCMS	lung	HSRRB	-666	cancer cell line	-666	-666	fh_RERFLCMS_LUNG-Tumor	rnaseq	15.7	21.2	56	0.4234	0.4381	0.4545	0.4099	0.3683	0.3840	0.3883	0.4374	0.4373	0.4442
C2BBE1	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_H03_383618	23.4	98	-666	-666	M	adenocarcinoma,colorectal	C2BBE1	large intestine,colon	ATCC	CRL-2102	cancer cell line	-666	-666	fh_C2BBE1_LARGE_INTESTINE-Tumor	rnaseq	6.5	23.16	59	0.4079	0.4464	0.4691	0.4227	0.3548	0.3798	0.3887	0.4257	0.4450	0.4595
NMCG1	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_F01_383710	40.4	126	NMC-G1	-666	-666	glioma	NMCG1	CNS	HSRRB	-666	cancer cell line	-666	-666	fh_NMCG1_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.7	28.15	56	0.4295	0.4275	0.4627	0.4037	0.3714	0.3804	0.4082	0.4378	0.4342	0.4383
SNUC5	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_G02_698914	29.4	114	SNU-C5	-666	F	adenocarcinoma	SNUC5	large intestine,colon	KCLB	-666	cancer cell line	N	-666	fh_SNUC5_LARGE_INTESTINE-Tumor	rnaseq	7.2	22.33	57	0.4143	0.4440	0.4708	0.4078	0.3553	0.3854	0.3941	0.4280	0.4433	0.4524
CCK81	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_C04_241096	49	159	CCK-81	-666	-666	carcinoma	CCK81	large intestine,colon	HSRRB	-666	cancer cell line	N	-666	fh_CCK81_LARGE_INTESTINE-Tumor	rnaseq	6.4	21.22	54	0.4116	0.4349	0.4604	0.4190	0.3450	0.3731	0.3965	0.4198	0.4425	0.4576
SNU1214	BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_C03_698748	42.4	138	NCI-SNU-1214	-666	M	carcinoma,squamous cell	SNU1214	upper aerodigestive tract	KCLB	-666	cancer cell line	-666	-666	fh_SNU1214_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	21.69	55	0.4202	0.4239	0.4500	0.4182	0.3539	0.3962	0.3949	0.4375	0.4364	0.4533
HCC366	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_H10_569572	31	96	HCC-366	-666	F	carcinoma,mixed adenosquamous	HCC366	lung	DSMZ	-666	cancer cell line	N	-666	fh_HCC366_LUNG-Tumor	rnaseq	6.6	24.89	57	0.4155	0.4361	0.4506	0.4026	0.3597	0.3880	0.4012	0.4444	0.4334	0.4542
LOXIMVI	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_D08_257684	56.8	186	LOX	-666	-666	melanoma	LOXIMVI	skin	NCI/DCTD	-666	cancer cell line	-666	-666	fh_LOXIMVI_SKIN-Tumor	rnaseq	5.8	24.38	55	0.4289	0.4333	0.4578	0.4074	0.3587	0.3677	0.4016	0.4431	0.4391	0.4584
HSC2	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_C09_419726	28.4	71	HSC-2	-666	M	carcinoma,squamous cell	HSC2	upper aerodigestive tract	HSRRB	-666	cancer cell line	-666	-666	fh_HSC2_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	24.01	58	0.4178	0.4365	0.4506	0.4022	0.3731	0.3850	0.3889	0.4320	0.4442	0.4308
HUH1	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_H09_241034	63.2	191	HUH-1	-666	M	carcinoma,hepatocellular	HUH1	liver	HSRRB	-666	cancer cell line	N	-666	fh_HUH1_LIVER-Tumor	rnaseq	6.9	22.01	54	0.4216	0.4388	0.4543	0.4128	0.3450	0.3831	0.3998	0.4284	0.4377	0.4485
LNCAPCLONEFGC	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_C03_296042	38.3	134	LNCAPCLONEFGC|LNCap.FGC	-666	M	carcinoma	LNCAPCLONEFGC	prostate	ATCC	CRL-1740	cancer cell line	Y	lymph_node,left_supraclavicular	fh_LNCAPCLONEFGC_PROSTATE-Tumor	rnaseq	7.2	21.89	55	0.4171	0.4265	0.4382	0.3960	0.3741	0.3836	0.4096	0.4299	0.4411	0.4523
NCIH2110	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_C05_569446	35.8	115	NCI-H2110|H2110	-666	-666	carcinoma,non-small cell	NCIH2110	lung	ATCC	CRL-5924	cancer cell line	Y	pleural_effusion	fh_NCIH2110_LUNG-Tumor	rnaseq	6.5	18.62	56	0.4208	0.4374	0.4568	0.4052	0.3805	0.3836	0.3908	0.4306	0.4370	0.4531
BT549	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_A09_257614	54.8	198	BT-549	-666	F	carcinoma,ductal	BT549	breast	ATCC	HTB-122	cancer cell line	-666	-666	fh_BT549_BREAST-Tumor	rnaseq	5.5	27.97	55	0.4062	0.4339	0.4617	0.4076	0.3536	0.3838	0.3923	0.4348	0.4393	0.4653
KYSE520	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_F06_383666	28.1	107	KYSE-520	-666	F	carcinoma,squamous cell	KYSE520	oesophagus	DSMZ	-666	cancer cell line	-666	-666	fh_KYSE520_OESOPHAGUS-Tumor	rnaseq	6.2	28.31	58	0.4170	0.4346	0.4470	0.4058	0.3735	0.3805	0.4006	0.4321	0.4406	0.4404
MKN1	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_C02_419716	26.3	93	-666	-666	M	carcinoma,mixed adenosquamous	MKN1	stomach	HSRRB	-666	cancer cell line	-666	-666	fh_MKN1_STOMACH-Tumor	rnaseq	5.6	24.23	58	0.4159	0.4328	0.4658	0.4086	0.3740	0.3849	0.3973	0.4300	0.4335	0.4436
SNU738	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_D08_587662	31.6	109	NCI-SNU-738	-666	M	oligodendroglioma	SNU738	CNS	KCLB	-666	cancer cell line	-666	-666	fh_SNU738_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.4	23.08	58	0.4125	0.4244	0.4575	0.4110	0.3659	0.3706	0.3958	0.4336	0.4372	0.4528
ONCODG1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_H08_523532	48.4	165	ONCO-DG-1	Identical lines: NIH:OVCAR-3 and ONCO-DG-1 share high SNP identity. Likely to be NIH:OVCAR-3	F	adenocarcinoma,ovary	ONCODG1	ovary	DSMZ	-666	cancer cell line	-666	-666	fh_ONCODG1_OVARY-Tumor	rnaseq	6.1	27.91	55	0.4147	0.4399	0.4568	0.4081	0.3718	0.3792	0.3961	0.4259	0.4349	0.4622
42MGBA	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_B02_296016	42	132	42-MG-BA	-666	M	glioma,astrocytoma,grade IV	42MGBA	CNS	DSMZ	-666	cancer cell line	N	-666	fh_42MGBA_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.7	25.01	56	0.4157	0.4332	0.4563	0.4021	0.3614	0.3796	0.4002	0.4398	0.4390	0.4515
RKN	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_C04_436542	32	104	RKN	-666	F	leiomyosarcoma	RKN	sofT tissue,ovary	HSRRB	IFO50317	cancer cell line	-666	-666	fh_RKN_SOFT_TISSUE-Tumor	rnaseq	5.7	22.31	58	0.4070	0.4407	0.4556	0.4013	0.3684	0.3668	0.3905	0.4389	0.4455	0.4469
SNU899	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_D05_587620	31.9	93	NCI-SNU-899	-666	M	carcinoma,squamous cell	SNU899	upper aerodigestive tract	KCLB	-666	cancer cell line	-666	-666	fh_SNU899_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	24.5	57	0.4210	0.4321	0.4545	0.4085	0.3855	0.3925	0.3766	0.4325	0.4375	0.4423
MDAMB157	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_H12_454750	38.9	160	MDA-MB-157|MB157	-666	F	carcinoma,ductal	MDAMB157	breast	ATCC	HTB-24	cancer cell line	Y	pleural_effusion	fh_MDAMB157_BREAST-Tumor	rnaseq	15.7	18.07	55	0.4031	0.4202	0.4649	0.4100	0.3591	0.3856	0.3912	0.4294	0.4411	0.4604
SF767	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_C04_767784	42.7	149	-666	-666	-666	glioma	SF767	CNS	-666	-666	cancer cell line	-666	-666	fh_SF767_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	23.62	55	0.4138	0.4381	0.4551	0.4302	0.3591	0.3967	0.3915	0.4372	0.4340	0.4463
U87MG	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_C03_257650	33.1	114	U-87 MG	-666	F	glioma,astrocytoma	U87MG	CNS	ATCC	HTB-14	cancer cell line	-666	-666	fh_U87MG_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	22.52	56	0.4326	0.4446	0.4529	0.3926	0.3652	0.3784	0.4088	0.4424	0.4373	0.4452
NCIN87	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_D09_383712	30.9	120	NCI-N87|N87	-666	M	carcinoma,gastric	NCIN87	stomach	ATCC	CRL-5822	cancer cell line	Y	liver	fh_NCIN87_STOMACH-Tumor	rnaseq	6.7	26.52	57	0.4144	0.4318	0.4560	0.4153	0.3673	0.3794	0.3770	0.4227	0.4413	0.4517
IM95	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_C09_257662	34.7	121	-666	-666	M	adenocarcinoma,intestinal	IM95	stomach	HSRRB	-666	cancer cell line	N	-666	fh_IM95_STOMACH-Tumor	rnaseq	15.7	23.13	56	0.4181	0.4203	0.4512	0.3972	0.3443	0.3810	0.4002	0.4310	0.4384	0.4486
BT474	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_E07_296098	30.8	108	BT-474	-666	F	carcinoma,ductal	BT474	breast	ATCC	HTB-20	cancer cell line	-666	-666	fh_BT474_BREAST-Tumor	rnaseq	6.4	18.53	57	0.4137	0.4264	0.4491	0.4170	0.3650	0.3831	0.4044	0.4211	0.4363	0.4615
SNU119	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_F12_698834	31.7	110	SNU-119|NCI-SNU-119	-666	F	adenocarcinoma	SNU119	ovary	KCLB	-666	cancer cell line	N	-666	fh_SNU119_OVARY-Tumor	rnaseq	15.7	24.09	56	0.4087	0.4314	0.4561	0.4069	0.3805	0.3810	0.3901	0.4228	0.4423	0.4595
IGR1	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_E02_569410	24	86	IGR-1	-666	M	melanoma	IGR1	skin	DSMZ	-666	cancer cell line	-666	-666	fh_IGR1_SKIN-Tumor	rnaseq	15.7	20.45	58	0.4257	0.4269	0.4580	0.4046	0.3573	0.3877	0.3979	0.4341	0.4262	0.4291
G401	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_E04_383676	23.3	116	G-401	-666	M	rhabdoid	G401	sofT tissue,kidney	ATCC	CRL-1441	cancer cell line	-666	-666	fh_G401_SOFT_TISSUE-Tumor	rnaseq	6.4	20.59	58	0.4094	0.4406	0.4553	0.4148	0.3377	0.3693	0.3953	0.4299	0.4413	0.4435
KNS60	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_B09_419856	32.4	122	KNS-60	-666	M	glioma,astrocytoma,grade IV	KNS60	CNS	HSRRB	-666	cancer cell line	N	-666	fh_KNS60_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.3	29.23	58	0.4143	0.4337	0.4545	0.4033	0.3758	0.3770	0.4002	0.4298	0.4345	0.4472
CAL78	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_H04_523550	30.4	120	CAL-78	-666	M	chondrosarcoma,dedifferentiated	CAL78	bone	DSMZ	-666	cancer cell line	N	-666	fh_CAL78_BONE-Tumor	rnaseq	5.7	26.2	58	0.4068	0.4349	0.4624	0.4109	0.3645	0.3739	0.3940	0.4288	0.4295	0.4567
JHOC5	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_B12_698934	42.3	108	JHOC-5	-666	-666	clear cell carcinoma	JHOC5	ovary	RIKEN	-666	cancer cell line	N	-666	fh_JHOC5_OVARY-Tumor	rnaseq	6.4	15.09	55	0.4147	0.4372	0.4565	0.4041	0.3621	0.3743	0.3922	0.4383	0.4418	0.4445
NCIH2286	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_D01_569440	26.9	109	NCI-H2286|H2286	-666	F	carcinoma,small cell	NCIH2286	lung	ATCC	CRL-5938	cancer cell line	-666	-666	fh_NCIH2286_LUNG-Tumor	rnaseq	5.7	26.21	58	0.4057	0.4327	0.4532	0.4113	0.3579	0.3685	0.4024	0.4342	0.4355	0.4560
SNU245	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_C05_587588	39.3	118	NCI-SNU-245	-666	-666	carcinoma	SNU245	biliary tract	KCLB	-666	cancer cell line	-666	-666	fh_SNU245_BILIARY_TRACT-Tumor	rnaseq	15.7	23.4	56	0.4095	0.4313	0.4557	0.4145	0.3634	0.3775	0.3826	0.4248	0.4381	0.4520
SNUC1	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_H03_454726	50.4	162	SNU-C1	-666	M	carcinoma	SNUC1	large intestine,colon	ATCC	CRL-5972	cancer cell line	Y	peritoneum	fh_SNUC1_LARGE_INTESTINE-Tumor	rnaseq	6.7	19.84	55	0.4094	0.4213	0.4537	0.4107	0.3636	0.3839	0.3841	0.4238	0.4413	0.4457
SW1116	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_A02_436580	34.1	107	-666	-666	M	adenocarcinoma,colorectal	SW1116	large intestine,colon	ATCC	CCL-233	cancer cell line	-666	-666	fh_SW1116_LARGE_INTESTINE-Tumor	rnaseq	6.6	30.91	57	0.4093	0.4330	0.4516	0.4072	0.3732	0.3800	0.3735	0.4181	0.4383	0.4451
CW2	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_E01_698830	35.8	109	CW-2	-666	-666	carcinoma	CW2	large intestine	RIKEN	-666	cancer cell line	-666	-666	fh_CW2_LARGE_INTESTINE-Tumor	rnaseq	15.7	16.28	55	0.4165	0.4229	0.4453	0.4024	0.3411	0.3877	0.3912	0.4333	0.4406	0.4534
NCIH1648	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_C12_454632	33.4	107	NCI-H1648|H1648	-666	M	carcinoma	NCIH1648	lung	ATCC	CRL-5882	cancer cell line	Y	lymph_node	fh_NCIH1648_LUNG-Tumor	rnaseq	6.2	24.09	57	0.4174	0.4349	0.4478	0.4066	0.3612	0.3868	0.3923	0.4277	0.4417	0.4445
NCIH2030	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_E08_240960	38.1	128	NCI-H2030|H2030	-666	M	carcinoma,non-small cell	NCIH2030	lung	ATCC	CRL-5914	cancer cell line	Y	lymph_node	fh_NCIH2030_LUNG-Tumor	rnaseq	15.7	19.86	56	0.4207	0.4297	0.4511	0.4033	0.3662	0.3774	0.3951	0.4408	0.4423	0.4408
KP3	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_C04_419704	25.6	91	KP-3	-666	-666	pancreatic cancer,adenosquamous carcinoma	KP3	pancreas	JCRB	JCRB0178.0	cancer cell line	-666	-666	fh_KP3_PANCREAS-Tumor	rnaseq	7.2	24.34	58	0.4199	0.4139	0.4500	0.4062	0.3856	0.3849	0.3940	0.4300	0.4366	0.4363
SW948	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_H06_296168	28.1	104	-666	-666	F	adenocarcinoma,colorectal	SW948	large intestine,colon	ATCC	CCL-237	cancer cell line	-666	-666	fh_SW948_LARGE_INTESTINE-Tumor	rnaseq	15.7	23.12	57	0.4132	0.4336	0.4596	0.4067	0.3747	0.3793	0.3856	0.4247	0.4407	0.4416
LN340	-666	41.3	154	-666	-666	-666	glioma	LN340	CNS	-666	-666	cancer cell line	-666	-666	fh_LN340_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	7.2	22.56	55	0.4120	0.4257	0.4554	0.4092	0.3605	0.3790	0.4037	0.4324	0.4300	0.4454
COV318	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_D10_436572	27.8	91	-666	-666	F	carcinoma	COV318	ovary	ECACC	-666	cancer cell line	N	-666	fh_COV318_OVARY-Tumor	rnaseq	6.6	18.85	57	0.3993	0.4405	0.4607	0.4079	0.3614	0.3776	0.3793	0.4238	0.4382	0.4556
JHESOAD1	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_D10_767922	30.2	84	-666	-666	-666	carcinoma	JHESOAD1	oesophagus	-666	-666	cancer cell line	-666	-666	fh_JHESOAD1_OESOPHAGUS-Tumor	rnaseq	15.7	20.65	57	0.4095	0.4222	0.4618	0.4049	0.3627	0.3818	0.3951	0.4247	0.4372	0.4554
HMCB	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_E10_240964	36.8	132	-666	Identical lines: COLO-699, CHL-1 and HMCB share high SNP identity and are likely to be melanoma	-666	melanoma	HMCB	skin	ATCC	-666	cancer cell line	N	-666	fh_HMCB_SKIN-Tumor	rnaseq	6.6	17.17	55	0.4066	0.4368	0.4557	0.4107	0.3372	0.3708	0.3972	0.4340	0.4343	0.4414
CAPAN2	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_B09_240890	28.7	87	CAPAN-2	-666	M	carcinoma,ductal	CAPAN2	pancreas	ATCC	HTB-80	cancer cell line	-666	-666	fh_CAPAN2_PANCREAS-Tumor	rnaseq	15.7	27.79	58	0.4129	0.4252	0.4528	0.4003	0.3666	0.3942	0.3760	0.4254	0.4444	0.4444
HS870T	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_H07_436444	32.9	124	HS 870.T	-666	-666	osteosarcoma	HS870T	bone	ATCC	CRL-7606	cancer cell line	-666	-666	fh_HS870T_BONE-Tumor	rnaseq	6.3	24.87	57	0.4105	0.4303	0.4643	0.4045	0.3813	0.3748	0.3948	0.4285	0.4355	0.4562
HS618T	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_H06_436442	26.3	92	HS 618.T	-666	F	carcinoma	HS618T	lung	ATCC	CRL-7380	cancer cell line	-666	-666	fh_HS618T_LUNG-Tumor	rnaseq	15.7	28.9	58	0.4083	0.4292	0.4537	0.4053	0.3852	0.3736	0.3972	0.4309	0.4311	0.4432
DBTRG05MG	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_F10_240988	42.9	158	DBTRG-05MG	-666	F	glioma,astrocytoma,grade IV	DBTRG05MG	CNS,glial cell	ATCC	CRL-2020	cancer cell line	-666	-666	fh_DBTRG05MG_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.7	26.55	55	0.4185	0.4277	0.4541	0.3974	0.3730	0.3820	0.4013	0.4252	0.4276	0.4352
KYSE140	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_H06_241220	27	93	KYSE-140	-666	M	carcinoma,squamous cell	KYSE140	oesophagus	DSMZ	-666	cancer cell line	-666	-666	fh_KYSE140_OESOPHAGUS-Tumor	rnaseq	15.7	15.19	56	0.4096	0.4284	0.4527	0.4056	0.3491	0.3772	0.3982	0.4317	0.4373	0.4270
NCIH2405	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_B12_474708	31.7	101	NCI-H2405|H2405	-666	M	adenocarcinoma,NSCLC	NCIH2405	lung	ATCC	CRL-5944	cancer cell line	Y	ascites	fh_NCIH2405_LUNG-Tumor	rnaseq	15.7	25.05	58	0.4230	0.4243	0.4494	0.4091	0.3679	0.3819	0.3920	0.4255	0.4362	0.4359
SNU182	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_C03_383636	36.5	124	SNU-182|NCI-SNU-182	-666	M	carcinoma,hepatocellular	SNU182	liver	ATCC	CRL-2235	cancer cell line	-666	-666	fh_SNU182_LIVER-Tumor	rnaseq	6.9	22.03	56	0.3957	0.4278	0.4582	0.4025	0.3686	0.3896	0.3885	0.4213	0.4373	0.4440
SNU878	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_D11_587608	44.8	131	SNU-878|NCI-SNU-878	-666	F	carcinoma,hepatocellular	SNU878	liver	KCLB	-666	cancer cell line	N	-666	fh_SNU878_LIVER-Tumor	rnaseq	15.7	19.14	54	0.4169	0.4339	0.4559	0.4100	0.3506	0.3749	0.3796	0.4245	0.4383	0.4380
SNU1197	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_C06_698904	30.5	90	SNU-1197|NCI-SNU-1197	-666	M	carcinoma	SNU1197	large intestine,colon	KCLB	-666	cancer cell line	N	-666	fh_SNU1197_LARGE_INTESTINE-Tumor	rnaseq	7.2	20.48	58	0.4101	0.4289	0.4474	0.4040	0.3700	0.3933	0.3817	0.4319	0.4243	0.4447
GI1	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_F10_241180	33	113	GI-1	-666	M	gliosarcoma	GI1	CNS	RIKEN	-666	cancer cell line	-666	-666	fh_GI1_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	7.2	18.65	57	0.4082	0.4351	0.4507	0.4093	0.3558	0.3704	0.3982	0.4282	0.4349	0.4460
NCIH2004RT2	-666	35.3	149	-666	-666	-666	-666	NCIH2004RT2	-666	-666	-666	cancer cell line	-666	-666	fh_NCI-H2004RT_2-Tumor	rnaseq	6.6	26.95	56	0.4076	0.4279	0.4444	0.4106	0.3709	0.3735	0.4008	0.4287	0.4327	0.4431
NCIH841	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_B09_474584	25.3	100	NCI-H841|H841	-666	M	carcinoma,small cell	NCIH841	lung	ATCC	CRL-5845	cancer cell line	Y	lymph_node	fh_NCIH841_LUNG-Tumor	rnaseq	7.2	16.96	56	0.4029	0.4241	0.4541	0.4129	0.3546	0.3786	0.3945	0.4324	0.4347	0.4383
BFTC905	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_C07_474578	33.1	105	BFTC-905	-666	F	carcinoma,transitional cell	BFTC905	urinary tract,bladder	DSMZ	-666	cancer cell line	-666	-666	fh_BFTC905_URINARY_TRACT-Tumor	rnaseq	6.9	21.09	57	0.4175	0.4313	0.4472	0.4026	0.3649	0.3776	0.3918	0.4276	0.4478	0.4403
JHH5	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_D04_241120	29.6	114	JHH-5	-666	M	carcinoma,hepatocellular	JHH5	liver	HSRRB	-666	cancer cell line	N	-666	fh_JHH5_LIVER-Tumor	rnaseq	15.7	23.37	57	0.4209	0.4333	0.4443	0.4083	0.3479	0.3798	0.3878	0.4187	0.4406	0.4399
HCC2157	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_B01_436616	37.4	128	-666	-666	F	carcinoma,ductal,primary	HCC2157	breast	ATCC	CRL-2340	cancer cell line	-666	-666	fh_HCC2157_BREAST-Tumor	rnaseq	5.6	24.48	57	0.4100	0.4270	0.4443	0.4071	0.3503	0.3857	0.3933	0.4295	0.4352	0.4414
MORCPR	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_A02_383724	37.8	114	MOR/CPR	-666	-666	carcinoma	MORCPR	lung	ECACC	-666	cancer cell line	N	-666	fh_MORCPR_LUNG-Tumor	rnaseq	7.2	17.81	56	0.4176	0.4202	0.4483	0.4113	0.3590	0.3759	0.3821	0.4294	0.4414	0.4593
COLO679	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_H06_241028	27.5	98	COLO-679	-666	F	melanoma	COLO679	skin	DSMZ	-666	cancer cell line	-666	-666	fh_COLO679_SKIN-Tumor	rnaseq	7.2	19.29	57	0.4237	0.4410	0.4487	0.4052	0.3514	0.3721	0.4021	0.4356	0.4315	0.4361
CJM	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_C11_698758	34.3	88	CJM	-666	-666	melanoma	CJM	skin	RIKEN	-666	cancer cell line	Y	-666	fh_CJM_SKIN-Tumor	rnaseq	7.2	22.23	57	0.4039	0.4224	0.4498	0.4047	0.3973	0.3870	0.3878	0.4303	0.4441	0.4369
LN443	-666	18.4	74	-666	-666	-666	glioma	LN443	CNS	-666	-666	cancer cell line	-666	-666	fh_LN443_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	7.2	19.74	60	0.4129	0.4278	0.4505	0.4024	0.3546	0.3714	0.3991	0.4345	0.4327	0.4417
HCC78	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_C05_296046	43.8	123	HCC-78	-666	M	carcinoma	HCC78	lung	DSMZ	-666	cancer cell line	N	-666	fh_HCC78_LUNG-Tumor	rnaseq	15.7	19.53	55	0.4113	0.4252	0.4458	0.3951	0.3597	0.3880	0.3894	0.4370	0.4416	0.4545
CAL29	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_H11_523578	40.5	111	CAL-29	-666	F	carcinoma,transitional cell	CAL29	urinary tract,bladder	DSMZ	-666	cancer cell line	N	-666	fh_CAL29_URINARY_TRACT-Tumor	rnaseq	15.7	19.1	56	0.4091	0.4298	0.4623	0.3996	0.3590	0.3925	0.3881	0.4228	0.4360	0.4432
NCIH661	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_C02_296040	29.4	99	NCI-H661|H661	-666	M	carcinoma,large cell	NCIH661	lung	ATCC	HTB-183	cancer cell line	Y	lymph_node	fh_NCIH661_LUNG-Tumor	rnaseq	6.6	24.62	57	0.4079	0.4332	0.4579	0.4150	0.3552	0.3686	0.3939	0.4226	0.4268	0.4484
SKRC20	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_C03_767890	29.4	119	-666	-666	-666	carcinoma	SKRC20	kidney	-666	-666	cancer cell line	-666	-666	fh_SKRC20_KIDNEY-Tumor	rnaseq	6	29.1	58	0.4105	0.4351	0.4410	0.4001	0.3610	0.3776	0.3898	0.4241	0.4363	0.4301
EKVX	-666	21.8	77	-666	-666	-666	carcinoma	EKVX	lung	NCI	-666	cancer cell line	-666	-666	fh_EKVX_LUNG-Tumor	rnaseq	15.7	23.97	58	0.4022	0.4322	0.4603	0.3991	0.3841	0.3756	0.3920	0.4165	0.4353	0.4389
JMSU1	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_G01_587622	38.3	136	JMSU-1	-666	M	carcinoma	JMSU1	urinary tract,bladder	DSMZ	-666	cancer cell line	N	-666	fh_JMSU1_URINARY_TRACT-Tumor	rnaseq	5.2	19.41	57	0.4088	0.4239	0.4506	0.4066	0.3399	0.3747	0.4025	0.4394	0.4320	0.4443
M059K	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_E03_241142	29.1	102	-666	-666	M	glioma,astrocytoma,grade IV	M059K	CNS,glial cell	ATCC	CRL-2365	cancer cell line	-666	-666	fh_M059K_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	5.3	32.76	59	0.4014	0.4343	0.4612	0.4023	0.3580	0.3872	0.3914	0.4227	0.4265	0.4449
RH30	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_B02_779634	49.4	151	RH-30	Identical lines: SJRH30 and RH30 share high SNP identity	M	rhabdomyosarcoma,alveolar	RH30	sofT tissue,striated muscle	DSMZ	-666	cancer cell line	N	-666	fh_RH30_SOFT_TISSUE-Tumor	rnaseq	15.7	19.25	54	0.4100	0.4160	0.4425	0.4101	0.3267	0.3765	0.3890	0.4402	0.4386	0.4558
SKMEL30	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_F04_296116	40	122	SK-MEL-30	-666	M	melanoma	SKMEL30	skin	DSMZ	-666	cancer cell line	-666	-666	fh_SKMEL30_SKIN-Tumor	rnaseq	15.7	18.54	55	0.4254	0.4325	0.4484	0.4006	0.3483	0.3882	0.3861	0.4300	0.4340	0.4336
HCC2218	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_B03_419876	67.7	199	-666	-666	F	carcinoma,ductal,primary	HCC2218	breast	ATCC	CRL-2343	cancer cell line	-666	-666	fh_HCC2218_BREAST-Tumor	rnaseq	6.9	28.25	54	0.4127	0.4250	0.4373	0.4045	0.3800	0.3910	0.3832	0.4207	0.4248	0.4439
HS840T	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_D07_454646	30	87	HS 840.T	-666	M	papilloma	HS840T	upper aerodigestive tract,pharynx	ATCC	CRL-7573	cancer cell line	-666	-666	fh_HS840T_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	27.65	58	0.4068	0.4286	0.4504	0.4011	0.3801	0.3721	0.3961	0.4278	0.4294	0.4401
SW1573	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_H01_569452	24.3	99	SW 1573	-666	F	carcinoma,alveolar cell	SW1573	lung	ATCC	CRL-2170	cancer cell line	-666	-666	fh_SW1573_LUNG-Tumor	rnaseq	6.9	25.61	58	0.3990	0.4220	0.4627	0.4083	0.3596	0.3734	0.3994	0.4272	0.4329	0.4391
HGC27	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_H01_419820	47.1	158	HGC-27	-666	-666	adenocarcinoma,undifferentiated	HGC27	stomach	ECACC	-666	cancer cell line	-666	-666	fh_HGC27_STOMACH-Tumor	rnaseq	7.2	18.92	55	0.4009	0.4343	0.4491	0.4096	0.3098	0.3761	0.3844	0.4291	0.4326	0.4491
KYSE450	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_B09_436600	29.9	91	KYSE-450	-666	M	carcinoma,squamous cell	KYSE450	oesophagus	DSMZ	-666	cancer cell line	-666	-666	fh_KYSE450_OESOPHAGUS-Tumor	rnaseq	15.7	10.43	55	0.4022	0.4263	0.4480	0.4100	0.3716	0.3736	0.3942	0.4211	0.4402	0.4331
HCC2279	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_E07_698836	34.2	116	HCC-2279	-666	F	adenocarcinoma	HCC2279	lung	KCLB	-666	cancer cell line	N	-666	fh_HCC2279_LUNG-Tumor	rnaseq	15.7	25.63	56	0.4185	0.4204	0.4416	0.3969	0.3795	0.3825	0.3954	0.4240	0.4334	0.4397
BICR6	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_A07_698844	28.9	70	BICR 6	-666	M	carcinoma,squamous cell	BICR6	upper aerodigestive tract,pharynx	ECACC	-666	cancer cell line	N	-666	fh_BICR6_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	19.03	58	0.4165	0.4170	0.4477	0.3992	0.3703	0.3853	0.3738	0.4249	0.4373	0.4374
LS513	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_C01_569564	28.3	100	-666	Identical lines: HCC-1588 and LS513 share high SNP identity. Really is LS513	M	carcinoma,colorectal	LS513	large intestine,cecum	ATCC	CRL-2134	cancer cell line	-666	-666	fh_LS513_LARGE_INTESTINE-Tumor	rnaseq	15.7	20.66	57	0.4089	0.4242	0.4486	0.4025	0.3714	0.3827	0.3766	0.4227	0.4317	0.4398
DV90	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_C03_454616	29.8	122	DV-90	-666	M	carcinoma	DV90	lung	DSMZ	-666	cancer cell line	-666	-666	fh_DV90_LUNG-Tumor	rnaseq	6.9	26.85	57	0.4139	0.4256	0.4473	0.4005	0.3314	0.3813	0.4006	0.4259	0.4272	0.4378
HCC1171	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_G05_698912	28.7	94	HCC-1171	-666	M	carcinoma,non-small cell	HCC1171	lung	KCLB	-666	cancer cell line	N	-666	fh_HCC1171_LUNG-Tumor	rnaseq	7.2	19.05	57	0.4089	0.4214	0.4511	0.3913	0.3805	0.3770	0.3921	0.4233	0.4312	0.4291
CL40	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_D07_523580	37.7	119	CL-40	established from the primary colorectal cancer (TNM stage 3) of the right colon of a woman; cells were described to be well differentiated	F	carcinoma,colon	CL40	large intestine	DSMZ	-666	cancer cell line	-666	-666	fh_CL40_LARGE_INTESTINE-Tumor	rnaseq	15.7	24.66	56	0.4157	0.4254	0.4463	0.3938	0.3779	0.3845	0.3823	0.4193	0.4366	0.4384
NCIH1395	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_G03_296138	25.7	80	NCI-H1395|H1395	-666	F	carcinoma	NCIH1395	lung	ATCC	CRL-5868	cancer cell line	-666	-666	fh_NCIH1395_LUNG-Tumor	rnaseq	15.7	20.84	57	0.4175	0.4144	0.4382	0.3964	0.3737	0.3900	0.3886	0.4274	0.4292	0.4314
PATU8988S	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_C05_436544	28.5	97	PA-TU-8988S	Identical lines: PA-TU-8988T and PA-TU-8988S are from the same patient	F	carcinoma,ductal	PATU8988S	pancreas	DSMZ	-666	cancer cell line	N	-666	fh_PATU8988S_PANCREAS-Tumor	rnaseq	7.2	24.17	58	0.4046	0.4243	0.4499	0.3999	0.3642	0.3766	0.3821	0.4185	0.4310	0.4396
HCC38	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_F09_436452	30.3	93	-666	-666	F	carcinoma,ductal,primary	HCC38	breast	ATCC	CRL-2314	cancer cell line	-666	-666	fh_HCC38_BREAST-Tumor	rnaseq	5.4	27.3	58	0.4008	0.4235	0.4440	0.4030	0.3631	0.3813	0.4020	0.4229	0.4300	0.4297
OV90	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_A02_241044	39.4	126	OV-90	-666	F	mixed carcinoma	OV90	ovary	ATCC	CRL-11732	cancer cell line	Y	ascites	fh_OV90_OVARY-Tumor	rnaseq	15.7	18.87	55	0.4164	0.4152	0.4477	0.4055	0.3469	0.3735	0.3882	0.4194	0.4213	0.4398
TIG3TD	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_B02_767868	28.2	97	-666	-666	-666	immortalized_embryonic_fibroblast	TIG3TD	lung	-666	-666	immortalized_embryonic_fibroblast	-666	-666	fh_TIG3TD_LUNG-Tumor	rnaseq	15.7	22.24	57	0.4065	0.4247	0.4498	0.3928	0.3717	0.3672	0.3996	0.4225	0.4266	0.4401
HEC6	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_F10_419784	25.4	98	HEC-6	-666	F	carcinoma	HEC6	endometrium	HSRRB	-666	cancer cell line	N	-666	fh_HEC6_ENDOMETRIUM-Tumor	rnaseq	15.7	16.96	57	0.4061	0.4363	0.4399	0.3924	0.3435	0.3759	0.4130	0.4330	0.4355	0.4352
YD10B	BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_E06_698900	21.1	67	-666	-666	M	carcinoma,squamous cell	YD10B	upper aerodigestive tract	KCLB	-666	cancer cell line	-666	-666	fh_YD10B_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	16.77	59	0.4052	0.4124	0.4472	0.4101	0.3529	0.3804	0.3830	0.4244	0.4324	0.4373
SNU475	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_H11_383774	40.7	122	SNU-475|NCI-SNU-475	-666	M	carcinoma,hepatocellular	SNU475	liver	ATCC	CRL-2236	cancer cell line	-666	-666	fh_SNU475_LIVER-Tumor	rnaseq	7.2	21.15	56	0.4175	0.4236	0.4460	0.3913	0.3582	0.3757	0.3884	0.4181	0.4273	0.4368
HEC59	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_H01_587734	39.4	136	HEC-59	-666	F	carcinoma	HEC59	endometrium	HSRRB	-666	cancer cell line	N	-666	fh_HEC59_ENDOMETRIUM-Tumor	rnaseq	7.2	19.97	56	0.4005	0.4354	0.4542	0.4070	0.3331	0.3661	0.3872	0.4215	0.4410	0.4361
SIHA	-666	42.7	139	-666	-666	-666	carcinoma,squamous cell	SIHA	cervix	ATCC	HTB-35	cancer cell line	-666	-666	fh_SiHa-Tumor	rnaseq	6.5	24.65	56	0.3982	0.4251	0.4432	0.4061	0.3660	0.3639	0.3871	0.4288	0.4242	0.4375
IGR37	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_E12_257716	38	123	IGR-37	Metastatic pair: IGR-37 and IGR-39 are from the same patient. IGR-37 is a metastasis	M	melanoma	IGR37	skin	DSMZ	-666	cancer cell line	N	-666	fh_IGR37_SKIN-Tumor	rnaseq	15.7	15.44	55	0.4076	0.4245	0.4515	0.3994	0.3470	0.3769	0.3853	0.4289	0.4286	0.4259
SNU1	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_C09_454626	32.2	122	SNU-1|NCI-SNU-1	-666	M	adenocarcinoma,undifferentiated,gastric	SNU1	stomach	ATCC	CRL-5971	cancer cell line	-666	-666	fh_SNU1_STOMACH-Tumor	rnaseq	15.7	13.04	56	0.4050	0.4127	0.4473	0.4035	0.3439	0.3797	0.3967	0.4190	0.4271	0.4513
HS895T	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_B12_436534	44.9	163	HS 895.T	-666	F	melanoma	HS895T	skin	ATCC	CRL-7637	cancer cell line	Y	lung	fh_HS895T_SKIN-Tumor	rnaseq	6.9	24.74	55	0.4040	0.4282	0.4615	0.3987	0.3942	0.3673	0.3852	0.4184	0.4299	0.4481
MFE296	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_E12_241160	28.5	123	MFE-296	-666	F	carcinoma	MFE296	endometrium,uterus	DSMZ	-666	cancer cell line	-666	-666	fh_MFE296_ENDOMETRIUM-Tumor	rnaseq	15.7	20.51	57	0.4043	0.4155	0.4430	0.4005	0.3358	0.3706	0.3960	0.4272	0.4360	0.4490
JHOS4	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_B08_436602	25.6	88	JHOS-4	-666	F	carcinoma	JHOS4	ovary	RIKEN	-666	cancer cell line	N	-666	fh_JHOS4_OVARY-Tumor	rnaseq	6.7	22.25	59	0.4100	0.4211	0.4447	0.3903	0.3566	0.3722	0.3878	0.4220	0.4259	0.4437
NCIH1781	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_G04_296140	38.9	127	NCI-H1781|H1781	-666	F	adenocarcinoma,bronchoalveolar	NCIH1781	lung	ATCC	CRL-5894	cancer cell line	Y	pleural_effusion	fh_NCIH1781_LUNG-Tumor	rnaseq	6.7	22.52	56	0.4110	0.4200	0.4414	0.4030	0.3590	0.3850	0.3802	0.4130	0.4153	0.4462
NCIH1339	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_D02_569406	29.2	104	H-1339|H1339	-666	F	carcinoma,small cell	NCIH1339	lung	ATCC	-666	cancer cell line	Y	pleural_effusion	fh_NCIH1339_LUNG-Tumor	rnaseq	6.7	22.06	58	0.4188	0.4317	0.4393	0.3843	0.3365	0.3625	0.4012	0.4325	0.4281	0.4376
JHUEM7	-666	27.7	72	JHUEM-7	-666	F	adenocarcinoma	JHUEM7	endometrium	RIKEN	-666	cancer cell line	N	-666	fh_JHUEM7_ENDOMETRIUM-Tumor	rnaseq	15.7	17.9	58	0.4132	0.4244	0.4435	0.3874	0.3448	0.3729	0.3842	0.4348	0.4285	0.4201
769P	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_A05_240858	44	131	769-P	-666	F	clear cell renal cell carcinoma	769P	kidney	ATCC	CRL-1933	cancer cell line	-666	-666	fh_769P_KIDNEY-Tumor	rnaseq	15.7	20.05	55	0.4085	0.4345	0.4462	0.3976	0.3485	0.3666	0.3901	0.4160	0.4297	0.4277
MDAMB453	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_H10_241036	41.5	158	MDA-MB-453	-666	F	carcinoma	MDAMB453	breast	ATCC	HTB-131	cancer cell line	Y	pleural_effusion	fh_MDAMB453_BREAST-Tumor	rnaseq	6.9	17	55	0.4084	0.4191	0.4346	0.4009	0.3463	0.3839	0.3953	0.4198	0.4207	0.4577
SNU1077	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_F02_698930	40.7	114	SNU-1077|NCI-SNU-1077	-666	F	carcinosarcoma,mesodermal mixed	SNU1077	endometrium	KCLB	-666	cancer cell line	N	-666	fh_SNU1077_ENDOMETRIUM-Tumor	rnaseq	15.7	22.67	56	0.4091	0.4335	0.4468	0.4029	0.3767	0.3683	0.3775	0.4183	0.4259	0.4287
KYSE270	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_F08_383674	23.7	70	KYSE-270	-666	M	carcinoma,squamous cell	KYSE270	oesophagus	DSMZ	-666	cancer cell line	-666	-666	fh_KYSE270_OESOPHAGUS-Tumor	rnaseq	6.1	24.15	59	0.4106	0.4298	0.4362	0.4017	0.3461	0.3718	0.3837	0.4288	0.4283	0.4172
CAL27	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_D01_383612	26.9	81	CAL 27	-666	M	carcinoma,squamous cell	CAL27	upper aerodigestive tract,tongue	ATCC	CRL-2095	cancer cell line	-666	-666	fh_CAL27_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	19.14	56	0.4013	0.4233	0.4427	0.3995	0.3597	0.3746	0.3661	0.4185	0.4285	0.4234
TOV21G	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_D12_240944	31.9	126	TOV-21G	-666	F	carcinoma,clearcell	TOV21G	ovary	ATCC	CRL-11730	cancer cell line	-666	-666	fh_TOV21G_OVARY-Tumor	rnaseq	15.7	26.04	56	0.4074	0.4252	0.4396	0.3855	0.3570	0.3602	0.3894	0.4222	0.4277	0.4129
UMUC1	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_A02_779658	42.5	117	UM-UC-1	-666	M	carcinoma,transitional cell	UMUC1	urinary tract,bladder	ECACC	-666	cancer cell line	N	-666	fh_UMUC1_URINARY_TRACT-Tumor	rnaseq	15.7	22.6	55	0.4228	0.4233	0.4377	0.3955	0.3757	0.3958	0.3837	0.4205	0.4339	0.4349
HS729	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_G03_454706	31	111	HS 729	-666	M	rhabdomyosarcoma	HS729	sofT tissue,muscle	ATCC	HTB-153	cancer cell line	-666	-666	fh_HS729_SOFT_TISSUE-Tumor	rnaseq	5.2	32.81	58	0.3993	0.4298	0.4476	0.3995	0.3599	0.3701	0.3832	0.4204	0.4185	0.4432
NCIH1651	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_G01_436506	27.2	112	NCI-H1651|H1651	-666	M	adenocarcinoma,NSCLC	NCIH1651	lung	ATCC	CRL-5884	cancer cell line	-666	-666	fh_NCIH1651_LUNG-Tumor	rnaseq	5	25.29	58	0.3872	0.4283	0.4517	0.4006	0.3592	0.3554	0.3935	0.4076	0.4247	0.4316
LCLC103H	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_E02_474726	42.4	123	LCLC-103H	-666	M	carcinoma,large cell	LCLC103H	lung	DSMZ	-666	cancer cell line	-666	-666	fh_LCLC103H_LUNG-Tumor	rnaseq	7.2	24	56	0.4047	0.4224	0.4418	0.3939	0.3618	0.3711	0.3887	0.4295	0.4329	0.4323
HUH6	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_C09_698870	32.8	109	HuH-6	-666	-666	hepatoblastoma	HUH6	liver	RIKEN	-666	cancer cell line	N	-666	fh_HUH6_LIVER-Tumor	rnaseq	7.2	23.63	57	0.3966	0.4251	0.4413	0.4039	0.3485	0.3709	0.3858	0.4155	0.4318	0.4423
LN235	-666	31.4	114	-666	-666	-666	glioma	LN235	CNS	-666	-666	cancer cell line	-666	-666	fh_LN235_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	7.2	20.6	57	0.4048	0.4222	0.4505	0.4004	0.3612	0.3710	0.3974	0.4196	0.4193	0.4313
A101D	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_F07_454690	33.1	107	-666	Isolated from the same donor tissue as Hs 294T	M	melanoma	A101D	skin	ATCC	CRL-7898	cancer cell line	-666	-666	fh_A101D_SKIN-Tumor	rnaseq	15.7	18.71	56	0.4216	0.4282	0.4382	0.3901	0.3443	0.3754	0.3877	0.4281	0.4221	0.4307
A498	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_A11_383760	34.7	112	A-498	-666	F	carcinoma,renal	A498	kidney	ATCC	HTB-44	cancer cell line	-666	-666	fh_A498_KIDNEY-Tumor	rnaseq	15.7	19.94	57	0.4100	0.4219	0.4329	0.3881	0.3611	0.3695	0.3937	0.4269	0.4269	0.4220
HCC1833	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_B01_779640	20.6	65	HCC-1833	-666	-666	adenocarcinoma	HCC1833	lung	KCLB	-666	cancer cell line	N	-666	fh_HCC1833_LUNG-Tumor	rnaseq	6.4	16.08	58	0.4127	0.4106	0.4397	0.3932	0.3598	0.3595	0.3871	0.4255	0.4189	0.4457
SKLU1	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_E06_241148	34	113	SK-LU-1	-666	F	carcinoma	SKLU1	lung	ATCC	HTB-57	cancer cell line	-666	-666	fh_SKLU1_LUNG-Tumor	rnaseq	5	25.99	58	0.4102	0.4080	0.4421	0.4032	0.3364	0.3643	0.3858	0.4202	0.4202	0.4401
NCIH1048	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_A12_454764	39.1	139	NCI-H1048|H1048	-666	F	carcinoma,small cell	NCIH1048	lung	ATCC	CRL-5853	cancer cell line	Y	pleural_effusion	fh_NCIH1048_LUNG-Tumor	rnaseq	6.2	15.5	55	0.4054	0.4125	0.4438	0.3976	0.3403	0.3767	0.3909	0.4232	0.4262	0.4280
SW48	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_G09_296150	39.2	132	-666	-666	F	adenocarcinoma,colorectal	SW48	large intestine,colon	ATCC	CCL-231	cancer cell line	-666	-666	fh_SW48_LARGE_INTESTINE-Tumor	rnaseq	7.2	18.32	56	0.3985	0.4241	0.4526	0.3955	0.3575	0.3639	0.3908	0.4086	0.4321	0.4283
CAL148	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_D02_523558	30.6	116	CAL-148	-666	F	carcinoma,ductal	CAL148	breast	DSMZ	-666	cancer cell line	-666	-666	fh_CAL148_BREAST-Tumor	rnaseq	6.5	17.06	56	0.4099	0.4027	0.4222	0.3875	0.3487	0.3771	0.3909	0.4142	0.4336	0.4398
SHP77	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_B02_474740	34.2	149	SHP-77	-666	M	carcinoma,small cell	SHP77	lung	ATCC	CRL-2195	cancer cell line	-666	-666	fh_SHP77_LUNG-Tumor	rnaseq	6.9	19.55	56	0.4109	0.4176	0.4445	0.3965	0.3274	0.3666	0.3863	0.4316	0.4265	0.4268
T98G	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_F06_240980	32.4	103	-666	-666	M	glioma,astrocytoma,grade IV	T98G	CNS	ATCC	CRL-1690	cancer cell line	-666	-666	fh_T98G_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	19.55	56	0.4024	0.4052	0.4361	0.3949	0.3572	0.3737	0.3883	0.4249	0.4237	0.4398
UACC257	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_E01_257694	40.4	129	UACC-257	-666	-666	melanoma	UACC257	skin	NCI/DCTD	-666	cancer cell line	-666	-666	fh_UACC257_SKIN-Tumor	rnaseq	15.7	19.18	55	0.4210	0.4263	0.4394	0.3972	0.3555	0.3733	0.3818	0.4260	0.4198	0.4257
SW1710	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_A09_523492	26.9	97	-666	-666	F	carcinoma,transitional cell	SW1710	urinary tract,bladder	DSMZ	-666	cancer cell line	-666	-666	fh_SW1710_URINARY_TRACT-Tumor	rnaseq	6.9	22.23	58	0.4110	0.4255	0.4374	0.3943	0.3811	0.3600	0.3838	0.4196	0.4289	0.4139
RMUGS	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_B10_436606	25.9	87	RMUG-S	-666	F	carcinoma	RMUGS	ovary	HSRRB	-666	cancer cell line	N	-666	fh_RMUGS_OVARY-Tumor	rnaseq	15.7	19.56	57	0.4119	0.4050	0.4308	0.4028	0.3397	0.3806	0.3813	0.4211	0.4227	0.4372
JHOM1	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_B07_698766	19	69	JHOM-1	-666	-666	adenocarcinoma	JHOM1	ovary	RIKEN	-666	cancer cell line	N	-666	fh_JHOM1_OVARY-Tumor	rnaseq	15.7	26.3	59	0.4068	0.4288	0.4383	0.3884	0.3712	0.3723	0.3859	0.4118	0.4070	0.4219
YAPC	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_H05_569442	43.5	147	-666	-666	M	carcinoma	YAPC	pancreas	DSMZ	-666	cancer cell line	-666	-666	fh_YAPC_PANCREAS-Tumor	rnaseq	6.9	36.78	56	0.3912	0.4172	0.4521	0.3979	0.3553	0.3707	0.3745	0.4104	0.4285	0.4336
RERFLCKJ	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_F10_454704	25.8	92	RERF-LC-KJ	-666	M	carcinoma,non-small cell	RERFLCKJ	lung	HSRRB	-666	cancer cell line	N	-666	fh_RERFLCKJ_LUNG-Tumor	rnaseq	15.7	20.26	57	0.4098	0.4037	0.4409	0.3894	0.3934	0.3727	0.3834	0.4198	0.4165	0.4243
HT1376	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_D01_240922	23.1	83	HT-1376	-666	F	carcinoma,transitional cell	HT1376	urinary tract,bladder	ATCC	CRL-1472	cancer cell line	-666	-666	fh_HT1376_URINARY_TRACT-Tumor	rnaseq	15.7	20.2	58	0.4034	0.3997	0.4373	0.4021	0.3530	0.3859	0.3840	0.4200	0.4223	0.4431
RMGI	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_B10_257640	41.2	112	RMG-I|RMG-1	-666	F	carcinoma,clearcell	RMGI	ovary	HSRRB	-666	cancer cell line	-666	-666	fh_RMGI_OVARY-Tumor	rnaseq	6.9	17.98	56	0.4085	0.4163	0.4298	0.3976	0.3616	0.3739	0.3699	0.4314	0.4229	0.4246
LN382	-666	24.6	95	-666	-666	-666	glioma	LN382	CNS	-666	-666	cancer cell line	-666	-666	fh_LN382_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	26.79	58	0.4035	0.4091	0.4427	0.3962	0.3508	0.3735	0.3952	0.4244	0.4215	0.4314
COLO741	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_B12_296036	36	125	COLO-741	-666	F	carcinoma,melanoma	COLO741	large intestine,skin	ECACC	-666	cancer cell line	-666	-666	fh_COLO741_SKIN-Tumor	rnaseq	15.7	17.9	55	0.4142	0.4378	0.4348	0.3947	0.3563	0.3681	0.3899	0.4196	0.4135	0.4130
HCC1806	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_A05_523512	27.6	80	-666	-666	F	carcinoma,primaryacantholyticsquamouscell	HCC1806	breast	ATCC	CRL-2335	cancer cell line	-666	-666	fh_HCC1806_BREAST-Tumor	rnaseq	6.4	28.49	59	0.4146	0.4139	0.4323	0.4026	0.3684	0.3645	0.3846	0.4193	0.4233	0.4100
HT144	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_B08_454598	33.8	108	HT-144	-666	M	melanoma	HT144	skin	ATCC	HTB-63	cancer cell line	-666	-666	fh_HT144_SKIN-Tumor	rnaseq	15.7	17.98	57	0.4153	0.4271	0.4379	0.3944	0.3497	0.3707	0.3843	0.4224	0.4141	0.4205
SW1088	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_D10_454654	30.4	124	SW 1088	-666	M	astrocytoma	SW1088	CNS	ATCC	HTB-12	cancer cell line	-666	-666	fh_SW1088_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.6	26.09	57	0.3938	0.4174	0.4574	0.3971	0.3489	0.3671	0.3865	0.4155	0.4253	0.4380
A673	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_B01_383784	33.7	133	A-673	-666	F	sarcoma,Ewings,PNET	A673	bone,muscle	ATCC	CRL-1598	cancer cell line	-666	-666	fh_A673_BONE-Tumor	rnaseq	5.9	20.93	57	0.4004	0.4142	0.4449	0.3990	0.3146	0.3561	0.3793	0.4288	0.4377	0.4451
NCIH684	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_E06_587650	35	107	H684	-666	-666	hepatoblastoma	NCIH684	liver	KCLB	-666	cancer cell line	-666	-666	fh_NCIH684_LIVER-Tumor	rnaseq	15.7	20.95	56	0.4076	0.4127	0.4375	0.3957	0.3436	0.3790	0.3809	0.4179	0.4321	0.4398
NCIH1734	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_G10_436496	32.9	119	NCI-H1734|H1734	-666	F	adenocarcinoma,NSCLC	NCIH1734	lung	ATCC	CRL-5891	cancer cell line	-666	-666	fh_NCIH1734_LUNG-Tumor	rnaseq	6.3	20.58	57	0.4018	0.4231	0.4417	0.3796	0.3433	0.3761	0.3846	0.4193	0.4179	0.4245
ONS76	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_H01_454722	26.3	86	ONS-76	-666	F	PNET,medulloblastoma	ONS76	CNS	HSRRB	-666	cancer cell line	-666	-666	fh_ONS76_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.7	23.66	58	0.4017	0.4195	0.4329	0.3926	0.3767	0.3765	0.3910	0.4208	0.4135	0.4200
SW780	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_F12_454700	37.1	122	SW 780	-666	F	carcinoma,transitional cell	SW780	urinary tract,bladder	ATCC	CRL-2169	cancer cell line	-666	-666	fh_SW780_URINARY_TRACT-Tumor	rnaseq	6.9	24.92	56	0.4117	0.4179	0.4385	0.4036	0.3546	0.3811	0.3833	0.4119	0.4205	0.4248
EWS502	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_A10_767880	47.2	164	-666	-666	-666	sarcoma,Ewings,PNET	EWS502	bone	-666	-666	cancer cell line	-666	-666	fh_EWS502_BONE-Tumor	rnaseq	6.7	16.9	54	0.3944	0.4175	0.4396	0.4046	0.3022	0.3525	0.3780	0.4247	0.4356	0.4406
NCIH2085	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_D11_436570	24.2	74	NCI-H2085|H2085	-666	M	adenocarcinoma,NSCLC	NCIH2085	lung	ATCC	CRL-5921	cancer cell line	-666	-666	fh_NCIH2085_LUNG-Tumor	rnaseq	15.7	22.02	59	0.3894	0.4223	0.4520	0.3978	0.3472	0.3747	0.3792	0.4153	0.4239	0.4295
HCC1569	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_E06_383684	38.8	116	HCC1569	-666	F	carcinoma,metaplastic	HCC1569	breast	ATCC	CRL-2330	cancer cell line	-666	-666	fh_HCC1569_BREAST-Tumor	rnaseq	15.7	17.72	56	0.3970	0.4255	0.4371	0.4023	0.3292	0.3699	0.3781	0.4208	0.4255	0.4288
HS343T	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_D01_474640	23.5	75	HS 343.T	-666	F	carcinoma	HS343T	breast	ATCC	CRL-7245	cancer cell line	-666	-666	fh_HS343T_BREAST-Tumor	rnaseq	15.7	25.32	59	0.3991	0.4234	0.4423	0.3910	0.3713	0.3644	0.3863	0.4148	0.4247	0.4283
TE9	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_F04_383658	24.4	84	TE-9	-666	M	carcinoma,squamous cell	TE9	oesophagus	RIKEN	-666	cancer cell line	-666	-666	fh_TE9_OESOPHAGUS-Tumor	rnaseq	15.7	19.06	57	0.4060	0.4185	0.4372	0.4055	0.3539	0.3685	0.3770	0.4208	0.4290	0.4290
HS683	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_G01_454710	35.1	109	HS 683	-666	M	glioma	HS683	CNS	ATCC	HTB-138	cancer cell line	-666	-666	fh_HS683_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	22.75	57	0.4020	0.4240	0.4426	0.3873	0.3559	0.3687	0.3876	0.4163	0.4160	0.4291
RPMI7951	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_A06_569534	23.5	89	RPMI-7951	-666	F	melanoma	RPMI7951	skin	ATCC	HTB-66	cancer cell line	-666	-666	fh_RPMI7951_SKIN-Tumor	rnaseq	6.9	24.98	59	0.3999	0.4190	0.4311	0.3947	0.3633	0.3639	0.3701	0.4164	0.4259	0.4348
NCIH1341	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_E04_436560	33	121	NCI-H1341|H1341	-666	F	carcinoma,small cell	NCIH1341	lung	ATCC	CRL-5864	cancer cell line	Y	cervix	fh_NCIH1341_LUNG-Tumor	rnaseq	5.4	20.4	56	0.3949	0.4324	0.4506	0.4033	0.3297	0.3664	0.3741	0.4151	0.4234	0.4414
SKES1	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_H04_383762	31.1	135	SK-ES-1	-666	M	sarcoma,anaplastic,osteosarcoma or Ewings	SKES1	bone	ATCC	HTB-86	cancer cell line	-666	-666	fh_SKES1_BONE-Tumor	rnaseq	5.5	20.26	57	0.3937	0.4170	0.4389	0.4034	0.3031	0.3483	0.3786	0.4197	0.4296	0.4418
G292CLONEA141B1	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_F01_454686	24.8	82	G-292, CLONE A141B1	-666	F	osteosarcoma	G292CLONEA141B1	bone	ATCC	CRL-1423	cancer cell line	-666	-666	fh_G292CLONEA141B1_BONE-Tumor	rnaseq	7.2	17.28	58	0.4028	0.4153	0.4425	0.3867	0.3379	0.3603	0.3752	0.4174	0.4275	0.4424
SH4	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_A11_698760	34.4	104	SH-4	-666	F	melanoma	SH4	skin	ATCC	CRL-7724	cancer cell line	Y	pleural_effusion	fh_SH4_SKIN-Tumor	rnaseq	5.8	19.13	57	0.4079	0.4241	0.4365	0.3948	0.3634	0.3708	0.3750	0.4142	0.4107	0.4025
K029AX	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_C12_240920	48.4	134	-666	-666	-666	melanoma	K029AX	skin	-666	-666	cancer cell line	N	-666	fh_K029AX_SKIN-Tumor	rnaseq	15.7	17	54	0.4087	0.4228	0.4313	0.3928	0.3545	0.3720	0.3716	0.4220	0.4070	0.4126
YKG1	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_C06_296048	36.7	132	YKG-1	-666	F	glioma,astrocytoma,grade IV	YKG1	CNS	HSRRB	-666	cancer cell line	-666	-666	fh_YKG1_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.3	23.32	56	0.4114	0.4167	0.4363	0.3941	0.3724	0.3662	0.4027	0.4240	0.4182	0.4242
A2780	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_C02_240900	25.6	105	-666	-666	F	carcinoma	A2780	ovary	ECACC	-666	cancer cell line	-666	-666	fh_A2780_OVARY-Tumor	rnaseq	15.7	18.84	57	0.3984	0.4203	0.4419	0.4002	0.3214	0.3612	0.3944	0.4162	0.4203	0.4281
SNU620	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_G09_698890	30.2	97	SNU-620|NCI-SNU-620	-666	F	carcinoma	SNU620	stomach	KCLB	-666	cancer cell line	N	-666	fh_SNU620_STOMACH-Tumor	rnaseq	6.9	18.82	57	0.4044	0.4009	0.4341	0.3889	0.3584	0.3708	0.3806	0.4080	0.4248	0.4288
NCIH1155	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_D10_296080	43.3	149	NCI-H1155|H1155	-666	M	carcinoma,large cell	NCIH1155	lung	ATCC	CRL-5818	cancer cell line	Y	lymph_node	fh_NCIH1155_LUNG-Tumor	rnaseq	7.2	14	54	0.3981	0.4136	0.4505	0.3918	0.3225	0.3665	0.3802	0.4345	0.4294	0.4489
NCIH196	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_C03_240902	25.2	90	NCI-H196|H196	-666	M	carcinoma,small cell	NCIH196	lung	ATCC	CRL-5823	cancer cell line	Y	pleural_effusion	fh_NCIH196_LUNG-Tumor	rnaseq	4.6	34.23	60	0.3899	0.4186	0.4515	0.3998	0.3522	0.3675	0.3887	0.4125	0.4173	0.4277
WM793	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_D03_569540	32.5	95	WM-793	-666	-666	melanoma	WM793	skin	-666	-666	cancer cell line	N	-666	fh_WM793_SKIN-Tumor	rnaseq	7.2	22.45	57	0.4010	0.4259	0.4420	0.3963	0.3494	0.3690	0.3791	0.4140	0.4203	0.4242
HMC18	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_H08_419840	41.4	121	HMC-1-8	Identical lines: HMC-1-8 and HLC-1 share high SNP identity and are probably lung.	F	carcinoma	HMC18	breast	HSRRB	-666	cancer cell line	N	-666	fh_HMC18_BREAST-Tumor	rnaseq	15.7	19.96	55	0.4056	0.4098	0.4348	0.4004	0.3468	0.3465	0.3864	0.4180	0.4139	0.4419
KE39	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_G07_419800	20	84	-666	-666	M	carcinoma	KE39	stomach	RIKEN	-666	cancer cell line	-666	-666	fh_KE39_STOMACH-Tumor	rnaseq	15.7	16.82	58	0.4029	0.3986	0.4386	0.3868	0.3602	0.3694	0.3665	0.4025	0.4205	0.4282
KPL1	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_A12_698746	33.3	102	KPL-1	Identical lines: MCF-7 and KPL-1 share high SNP identity	F	carcinoma,ductal	KPL1	breast	DSMZ	-666	cancer cell line	-666	-666	fh_KPL1_BREAST-Tumor	rnaseq	15.7	21.79	57	0.4018	0.4030	0.4265	0.3951	0.3617	0.3675	0.3787	0.4116	0.4162	0.4385
COLO320	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_C03_474728	23.7	104	COLO-320|COLO-320-HSR	-666	F	carcinoma	COLO320	large intestine,colon	DSMZ	-666	cancer cell line	N	-666	fh_COLO320_LARGE_INTESTINE-Tumor	rnaseq	15.7	15.33	57	0.3848	0.4134	0.4258	0.3965	0.3282	0.3654	0.3801	0.4231	0.4212	0.4313
SLR26	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_C02_767920	48.2	139	-666	-666	-666	carcinoma	SLR26	kidney	-666	-666	cancer cell line	-666	-666	fh_SLR26_KIDNEY-Tumor	rnaseq	15.7	21.39	55	0.4097	0.4203	0.4359	0.3883	0.3530	0.3604	0.3840	0.4115	0.4290	0.4273
UOK101	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_D09_767866	46.4	149	-666	-666	-666	carcinoma	UOK101	kidney	-666	-666	cancer cell line	-666	-666	fh_UOK101_KIDNEY-Tumor	rnaseq	7.2	24.29	55	0.4049	0.4184	0.4320	0.3834	0.3512	0.3603	0.3831	0.4144	0.4200	0.4286
EN	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_B09_296030	25.5	113	-666	-666	F	carcinoma	EN	endometrium	DSMZ	-666	cancer cell line	N	-666	fh_EN_ENDOMETRIUM-Tumor	rnaseq	15.7	21.92	57	0.3950	0.4151	0.4360	0.4001	0.3427	0.3554	0.3839	0.4242	0.4244	0.4257
NCIH1568	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_A08_383764	34.1	111	NCI-H1568|H1568	-666	F	carcinoma,non-small cell	NCIH1568	lung	ATCC	CRL-5876	cancer cell line	Y	lymph_node	fh_NCIH1568_LUNG-Tumor	rnaseq	7.2	24.35	57	0.3920	0.4138	0.4481	0.3931	0.3554	0.3534	0.3774	0.4073	0.4314	0.4325
LC1F	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_F02_587572	24.9	85	LC-1F	Identical lines: LC-1/sq-SF and LC-1F share high SNP identity.	M	carcinoma,squamous cell	LC1F	lung	RIKEN	-666	cancer cell line	-666	-666	fh_LC1F_LUNG-Tumor	rnaseq	6.1	16.21	58	0.4113	0.4172	0.4292	0.4049	0.3431	0.3593	0.3886	0.4206	0.4168	0.4127
SLR24	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_A09_767854	38.9	108	-666	-666	-666	carcinoma	SLR24	kidney	-666	-666	cancer cell line	-666	-666	fh_SLR24_KIDNEY-Tumor	rnaseq	6.5	29.04	57	0.4069	0.4289	0.4311	0.3886	0.3484	0.3621	0.3829	0.4144	0.4253	0.4180
BT20	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_C02_383640	38.9	142	BT-20	-666	F	carcinoma,ductal	BT20	breast	ATCC	HTB-19	cancer cell line	-666	-666	fh_BT20_BREAST-Tumor	rnaseq	6	18.94	56	0.3917	0.4060	0.4324	0.3945	0.3564	0.3624	0.3788	0.4140	0.4312	0.4272
KS1	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_C10_296056	35.8	131	KS-1	-666	F	glioma,astrocytoma,grade IV	KS1	CNS	HSRRB	-666	cancer cell line	-666	-666	fh_KS1_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.3	28.07	57	0.4011	0.4193	0.4383	0.3916	0.3477	0.3639	0.3872	0.4094	0.4150	0.4165
253J	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_A03_569510	43.4	116	-666	Identical lines: 253J and 253J-BV share high SNP identity	-666	carcinoma,transitional cell	253J	urinary tract	KCLB	-666	cancer cell line	-666	-666	fh_253J_URINARY_TRACT-Tumor	rnaseq	15.7	21.99	55	0.4037	0.4105	0.4278	0.3912	0.3517	0.3612	0.3833	0.4143	0.4228	0.4222
ISTMES1	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_G09_436490	42.6	125	IST-MES1	-666	F	mesothelioma	ISTMES1	pleura	ICLC	-666	cancer cell line	-666	-666	fh_ISTMES1_PLEURA-Tumor	rnaseq	15.7	20.44	55	0.3883	0.4136	0.4344	0.3941	0.3577	0.3705	0.3818	0.4125	0.4144	0.4206
COLO201	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_B03_383776	26.5	94	COLO 201	Identical lines: COLO 201, COLO 205, and COLO 206 were established from the same patient.	M	adenocarcinoma,colorectal	COLO201	large intestine,colon	ATCC	CCL-224	cancer cell line	Y	ascites	fh_COLO201_LARGE_INTESTINE-Tumor	rnaseq	15.7	19.88	57	0.3970	0.4107	0.4369	0.3928	0.3497	0.3712	0.3717	0.4198	0.4143	0.4432
HS939T	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_B11_454608	33.5	109	HS 939.T	-666	F	melanoma	HS939T	skin	ATCC	CRL-7690	cancer cell line	-666	-666	fh_HS939T_SKIN-Tumor	rnaseq	15.7	21.06	56	0.4065	0.4212	0.4377	0.3879	0.3471	0.3719	0.3752	0.4179	0.4128	0.4145
HCC202	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_G10_454732	28.7	106	-666	-666	F	carcinoma,ductal,primary	HCC202	breast	ATCC	CRL-2316	cancer cell line	-666	-666	fh_HCC202_BREAST-Tumor	rnaseq	5.2	22.89	58	0.3965	0.4014	0.4235	0.3925	0.3411	0.3733	0.3861	0.4063	0.4209	0.4413
JHUEM3	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_F09_698838	38.1	110	JHUEM-3	-666	-666	adenocarcinoma	JHUEM3	endometrium	RIKEN	-666	cancer cell line	N	-666	fh_JHUEM3_ENDOMETRIUM-Tumor	rnaseq	15.7	30.57	56	0.4063	0.4173	0.4308	0.3748	0.3519	0.3646	0.3798	0.4107	0.4139	0.4128
KATOIII	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_H03_296162	29.3	95	KATO III	-666	M	carcinoma,gastric	KATOIII	stomach	ATCC	HTB-103	cancer cell line	Y	pleural_effusion	fh_KATOIII_STOMACH-Tumor	rnaseq	15.7	19.53	57	0.3986	0.4018	0.4448	0.3948	0.3315	0.3628	0.3719	0.4051	0.4247	0.4374
U178	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_B11_767924	28.6	92	-666	-666	-666	glioma	U178	CNS	-666	-666	cancer cell line	-666	-666	fh_U178_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	24.88	58	0.3941	0.4028	0.4372	0.3883	0.3394	0.3546	0.3793	0.4137	0.4197	0.4337
COLO829	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_B05_240882	28.8	87	COLO 829	Identical lines: COLO 829 and COLO-849 share high SNP identity	M	melanoma	COLO829	skin	ATCC	CRL-1974	cancer cell line	-666	-666	fh_COLO829_SKIN-Tumor	rnaseq	15.7	19.17	57	0.4096	0.4219	0.4186	0.3760	0.3799	0.3697	0.3777	0.4111	0.4093	0.3986
VCAP	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_B06_240884	45.7	141	-666	-666	M	carcinoma	VCAP	prostate	ATCC	-666	cancer cell line	Y	vertebra	fh_VCAP_PROSTATE-Tumor	rnaseq	7.2	23.03	55	0.3979	0.4116	0.4320	0.3868	0.3341	0.3637	0.3869	0.4127	0.4198	0.4311
HCC56	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_C11_454630	34.7	114	HCC-56	-666	-666	carcinoma	HCC56	large intestine,colon	HSRRB	-666	cancer cell line	N	-666	fh_HCC56_LARGE_INTESTINE-Tumor	rnaseq	6.9	25.22	57	0.3924	0.4137	0.4322	0.3951	0.3573	0.3620	0.3671	0.4011	0.4219	0.4344
LK2	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_D11_240942	50.2	169	LK-2	-666	M	carcinoma,squamous cell	LK2	lung	RIKEN	-666	cancer cell line	-666	-666	fh_LK2_LUNG-Tumor	rnaseq	7.2	18.04	54	0.3878	0.4229	0.4398	0.4069	0.3239	0.3537	0.3746	0.4106	0.4205	0.4259
DMS273	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_C10_569430	39.3	134	DMS-273	-666	F	carcinoma,small cell	DMS273	lung	ECACC	-666	cancer cell line	-666	-666	fh_DMS273_LUNG-Tumor	rnaseq	6.7	18.08	56	0.3752	0.4071	0.4293	0.3888	0.3002	0.3635	0.3793	0.4129	0.4220	0.4301
KMRC2	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_C07_257658	49.6	161	KMRC-2	-666	M	clear cell renal cell carcinoma	KMRC2	kidney	HSRRB	-666	cancer cell line	N	-666	fh_KMRC2_KIDNEY-Tumor	rnaseq	6.6	23.06	55	0.3998	0.4205	0.4336	0.3890	0.3350	0.3585	0.3678	0.4028	0.4195	0.4276
SNU668	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_B06_779782	37.8	141	SNU-668|NCI-SNU-668	-666	M	adenocarcinoma,signet ring	SNU668	stomach	KCLB	-666	cancer cell line	N	-666	fh_SNU668_STOMACH-Tumor	rnaseq	6.5	28.34	56	0.4014	0.3967	0.4263	0.3872	0.3535	0.3622	0.3778	0.4199	0.4091	0.4378
OCUM1	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_E07_383688	29	101	OCUM-1	-666	F	adenocarcinoma,diffuse	OCUM1	stomach	HSRRB	-666	cancer cell line	N	-666	fh_OCUM1_STOMACH-Tumor	rnaseq	7.2	27.85	58	0.3908	0.4138	0.4311	0.3874	0.3625	0.3693	0.3692	0.4063	0.4211	0.4336
OV56	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_B07_436596	46.9	123	-666	-666	F	carcinoma	OV56	ovary	ECACC	-666	cancer cell line	N	-666	fh_OV56_OVARY-Tumor	rnaseq	7.2	20.66	55	0.3926	0.4106	0.4324	0.3923	0.3766	0.3637	0.3629	0.4132	0.4178	0.4172
SNU503	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_D06_587666	43.8	148	SNU-503|NCI-SNU-503	-666	M	carcinoma	SNU503	large intestine,colon	KCLB	-666	cancer cell line	N	-666	fh_SNU503_LARGE_INTESTINE-Tumor	rnaseq	6.4	22.43	56	0.4000	0.4186	0.4319	0.4115	0.3420	0.3639	0.3681	0.4169	0.4097	0.4159
TCCSUP	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_B03_779770	30.5	110	-666	-666	F	carcinoma,transitional cell	TCCSUP	urinary tract,bladder	ATCC	HTB-5	cancer cell line	-666	-666	fh_TCCSUP_URINARY_TRACT-Tumor	rnaseq	6.7	21.31	57	0.4063	0.4125	0.4307	0.3876	0.3674	0.3713	0.3856	0.4090	0.4082	0.4145
HS936T	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_H03_436486	40.5	144	HS 936.T	-666	M	melanoma	HS936T	skin	ATCC	CRL-7686	cancer cell line	-666	-666	fh_HS936T_SKIN-Tumor	rnaseq	15.7	18.06	54	0.3922	0.4148	0.4338	0.3871	0.3406	0.3708	0.3759	0.4138	0.4176	0.4188
HEC1B	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_E10_698932	35.4	116	HEC-1-B	Identical lines: HEC-1-A HEC-1-B are subclones of HEC-1 and share high SNP identity	F	adenocarcinoma	HEC1B	endometrium,uterus	ATCC	HTB-113	cancer cell line	-666	-666	fh_HEC1B_ENDOMETRIUM-Tumor	rnaseq	7.2	20.41	57	0.4010	0.4115	0.4294	0.3883	0.3410	0.3455	0.3860	0.4114	0.4235	0.4236
RD	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_B06_523544	23.4	98	-666	-666	F	rhabdomyosarcoma,embryonal	RD	sofT tissue,muscle	ATCC	CCL-136	cancer cell line	-666	-666	fh_RD_SOFT_TISSUE-Tumor	rnaseq	7.2	20.28	58	0.3900	0.4180	0.4375	0.3960	0.3346	0.3523	0.3832	0.4109	0.4146	0.4224
A204	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_G04_241192	38.4	134	A-204	-666	F	rhabdoid	A204	sofT tissue,muscle	ATCC	HTB-82	cancer cell line	-666	-666	fh_A204_SOFT_TISSUE-Tumor	rnaseq	15.7	22.36	56	0.3935	0.4195	0.4324	0.3978	0.3502	0.3619	0.3766	0.4046	0.4134	0.4172
ZR7530	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_B07_474632	53.1	158	ZR-75-30	-666	F	carcinoma,ductal	ZR7530	breast	ATCC	CRL-1504	cancer cell line	Y	ascites	fh_ZR7530_BREAST-Tumor	rnaseq	7.2	23.5	54	0.4009	0.4047	0.4197	0.3879	0.3682	0.3767	0.3862	0.4060	0.4038	0.4240
MEWO	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_D07_569498	39.1	134	-666	-666	M	melanoma	MEWO	skin	ATCC	HTB-65	cancer cell line	Y	lymph_node	fh_MEWO_SKIN-Tumor	rnaseq	7.2	19.77	56	0.4078	0.4323	0.4324	0.3871	0.3530	0.3601	0.3704	0.4181	0.4150	0.4144
SNU869	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_D10_587722	28.6	95	NCI-SNU-869	-666	-666	carcinoma	SNU869	biliary tract	KCLB	-666	cancer cell line	-666	-666	fh_SNU869_BILIARY_TRACT-Tumor	rnaseq	15.7	24.61	57	0.4003	0.4056	0.4344	0.3946	0.3660	0.3658	0.3630	0.4048	0.4135	0.4210
RERFLCAD1	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_D07_296074	38.2	114	RERF-LC-AD1	-666	M	carcinoma	RERFLCAD1	lung	HSRRB	-666	cancer cell line	N	-666	fh_RERFLCAD1_LUNG-Tumor	rnaseq	5.6	25.57	56	0.3935	0.4196	0.4294	0.3741	0.3690	0.3777	0.3867	0.4075	0.4161	0.4224
NCIH211	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_C06_240908	41.4	157	NCI-H211|H211	-666	F	carcinoma,small cell	NCIH211	lung	ATCC	CRL-5824	cancer cell line	Y	bone_marrow	fh_NCIH211_LUNG-Tumor	rnaseq	5.5	22.7	56	0.3938	0.4085	0.4408	0.3898	0.3176	0.3562	0.3775	0.4112	0.4258	0.4188
TE125T	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_B11_523524	43.5	152	TE 125.T	-666	F	rhabdomyosarcoma	TE125T	sofT tissue	ATCC	CRL-7945	cancer cell line	-666	-666	fh_TE125T_SOFT_TISSUE-Tumor	rnaseq	5.2	24.71	56	0.3773	0.4054	0.4407	0.3869	0.3700	0.3486	0.3777	0.3933	0.4157	0.4334
AN3CA	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_D11_257690	26.1	131	AN3 CA	-666	F	carcinoma	AN3CA	endometrium,uterus	ATCC	HTB-111	cancer cell line	Y	lymph_node	fh_AN3CA_ENDOMETRIUM-Tumor	rnaseq	6.7	26.21	57	0.3914	0.4098	0.4314	0.3889	0.3263	0.3640	0.3758	0.4136	0.4119	0.4289
SNU175	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_A03_587658	31.5	124	SNU-175|NCI-SNU-175	-666	F	carcinoma	SNU175	large intestine,colon	KCLB	-666	cancer cell line	N	-666	fh_SNU175_LARGE_INTESTINE-Tumor	rnaseq	6.4	17.49	56	0.3934	0.4148	0.4416	0.3936	0.3463	0.3588	0.3774	0.4050	0.4294	0.4146
SNU1272	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_D03_698774	35.5	105	SNU-1272|NCI-SNU-1272	-666	F	clear cell renal cell carcinoma	SNU1272	kidney	KCLB	-666	cancer cell line	N	-666	fh_SNU1272_KIDNEY-Tumor	rnaseq	7.2	24.17	56	0.4005	0.4226	0.4263	0.3748	0.3575	0.3614	0.3752	0.4069	0.4178	0.4203
HCC70	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_C07_454622	25.6	78	-666	-666	F	carcinoma,ductal,primary	HCC70	breast	ATCC	CRL-2315	cancer cell line	-666	-666	fh_HCC70_BREAST-Tumor	rnaseq	6.6	15.82	57	0.3882	0.3992	0.4349	0.3836	0.3582	0.3654	0.3671	0.3998	0.4289	0.4343
SAOS2	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_E08_383690	47.3	153	Saos-2	-666	F	osteosarcoma	SAOS2	bone	ATCC	HTB-85	cancer cell line	-666	-666	fh_SAOS2_BONE-Tumor	rnaseq	5.9	32.47	56	0.3870	0.4027	0.4432	0.3827	0.3243	0.3655	0.3820	0.4090	0.4138	0.4339
TOV112D	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_A08_257612	26.9	111	TOV-112D	Identical lines: TOV-112D and Hs 571.T share high SNP identity	F	endometrioid carcinoma	TOV112D	ovary	ATCC	CRL-11731	cancer cell line	-666	-666	fh_TOV112D_OVARY-Tumor	rnaseq	6.4	19.4	57	0.3936	0.4099	0.4312	0.3972	0.3256	0.3490	0.3795	0.4140	0.4214	0.4145
VMRCRCZ	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_G06_241004	36.7	111	VMRC-RCZ	-666	-666	carcinoma,renal	VMRCRCZ	kidney	HSRRB	-666	cancer cell line	-666	-666	fh_VMRCRCZ_KIDNEY-Tumor	rnaseq	6.6	29.4	57	0.3945	0.4192	0.4313	0.3858	0.3574	0.3511	0.3818	0.3974	0.4219	0.4002
DMS53	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_A01_436578	26	114	DMS 53	-666	M	carcinoma,small cell	DMS53	lung	ATCC	CRL-2062	cancer cell line	-666	-666	fh_DMS53_LUNG-Tumor	rnaseq	5.9	23.15	58	0.3982	0.4049	0.4361	0.3826	0.3256	0.3567	0.3748	0.4090	0.4159	0.4297
G361	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_A08_296004	33.2	109	G-361	-666	M	melanoma	G361	skin	ATCC	CRL-1424	cancer cell line	-666	-666	fh_G361_SKIN-Tumor	rnaseq	6.9	18.26	56	0.3935	0.4255	0.4404	0.3882	0.3433	0.3584	0.3765	0.4119	0.4105	0.4112
WM88	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_D08_569582	47.3	160	WM-88	-666	-666	melanoma	WM88	skin	-666	-666	cancer cell line	N	-666	fh_WM88_SKIN-Tumor	rnaseq	5.9	26.7	56	0.4073	0.4103	0.4348	0.3815	0.3645	0.3673	0.3745	0.4056	0.4021	0.4051
KALS1	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_E10_419776	37.3	128	KALS-1	-666	F	glioma	KALS1	CNS	HSRRB	-666	cancer cell line	-666	-666	fh_KALS1_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	5	32.54	57	0.3848	0.4145	0.4427	0.3888	0.3487	0.3541	0.3744	0.4045	0.4075	0.4268
8MGBA	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_E02_296088	23.4	92	8-MG-BA	-666	F	glioma,astrocytoma,grade IV	8MGBA	CNS	DSMZ	-666	cancer cell line	-666	-666	fh_8MGBA_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	19.42	57	0.3917	0.4086	0.4176	0.3628	0.3487	0.3645	0.3763	0.4109	0.3998	0.4247
ML1	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_H10_474614	33.9	126	ML-1	-666	F	carcinoma,follicular	ML1	thyroid	DSMZ	-666	cancer cell line	N	-666	fh_ML1_THYROID-Tumor	rnaseq	6.9	28.9	57	0.3976	0.4133	0.4320	0.3863	0.3816	0.3572	0.3716	0.4057	0.4050	0.4223
CAL51	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_F02_474714	32.6	119	CAL-51	-666	F	carcinoma	CAL51	breast	DSMZ	-666	cancer cell line	-666	-666	fh_CAL51_BREAST-Tumor	rnaseq	7.2	20.52	57	0.3969	0.4105	0.4426	0.3933	0.3442	0.3522	0.3728	0.4004	0.4114	0.4264
KYSE150	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_E07_257706	28.9	108	KYSE-150	-666	F	carcinoma,squamous cell	KYSE150	oesophagus	DSMZ	-666	cancer cell line	-666	-666	fh_KYSE150_OESOPHAGUS-Tumor	rnaseq	15.7	16.95	56	0.3945	0.4102	0.4254	0.3815	0.3600	0.3584	0.3690	0.4063	0.4276	0.4234
C32	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_F07_296122	28.9	100	-666	-666	M	melanoma,amelanotic	C32	skin	ATCC	CRL-1585	cancer cell line	-666	-666	fh_C32_SKIN-Tumor	rnaseq	6	19.04	57	0.4021	0.4149	0.4371	0.3739	0.3444	0.3716	0.3731	0.4085	0.3984	0.3968
CAL33	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_B05_779738	26.4	79	CAL-33	-666	M	carcinoma,squamous cell	CAL33	upper aerodigestive tract	DSMZ	-666	cancer cell line	-666	-666	fh_CAL33_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	7.2	28.54	58	0.4011	0.3981	0.4115	0.3860	0.3567	0.3666	0.3744	0.4097	0.4042	0.4018
NCIH1573	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_F11_436456	23.4	93	NCI-H1573|H1573	-666	F	carcinoma	NCIH1573	lung	ATCC	CRL-5877	cancer cell line	Y	soft_tissue	fh_NCIH1573_LUNG-Tumor	rnaseq	6.2	28.34	59	0.3918	0.4031	0.4255	0.3902	0.3577	0.3617	0.3712	0.4115	0.4079	0.4262
SKOV3	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_A05_383732	52.7	165	SK-OV-3	-666	F	carcinoma	SKOV3	ovary	ATCC	HTB-77	cancer cell line	Y	ascites	fh_SKOV3_OVARY-Tumor	rnaseq	5.6	26.06	55	0.3963	0.3995	0.4391	0.3841	0.3407	0.3554	0.3649	0.4092	0.4177	0.4232
DMS114	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_H05_454714	38.9	143	DMS 114	-666	M	carcinoma,small cell	DMS114	lung	ATCC	CRL-2066	cancer cell line	-666	-666	fh_DMS114_LUNG-Tumor	rnaseq	6	24.01	55	0.3910	0.4021	0.4398	0.3969	0.3388	0.3502	0.3837	0.4024	0.4158	0.4250
NCIH82	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_D08_383708	37.6	150	NCI-H82|H82	-666	M	carcinoma,small cell	NCIH82	lung	ATCC	HTB-175	cancer cell line	Y	pleural_effusion	fh_NCIH82_LUNG-Tumor	rnaseq	6.3	16.89	56	0.3789	0.4071	0.4349	0.4035	0.2938	0.3485	0.3668	0.4081	0.4218	0.4402
RCM1	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_F02_454688	31.9	99	RCM-1	-666	-666	carcinoma	RCM1	large intestine	HSRRB	-666	cancer cell line	-666	-666	fh_RCM1_LARGE_INTESTINE-Tumor	rnaseq	6.7	26.09	58	0.3923	0.4079	0.4256	0.3900	0.3727	0.3609	0.3573	0.4049	0.4131	0.4351
SNU407	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_A05_587552	27.4	101	SNU-407|NCI-SNU-407	-666	M	carcinoma	SNU407	large intestine,colon	KCLB	-666	cancer cell line	N	-666	fh_SNU407_LARGE_INTESTINE-Tumor	rnaseq	15.7	19.48	57	0.3953	0.4033	0.4342	0.3886	0.3397	0.3599	0.3715	0.3986	0.4115	0.4206
PLCPRF5	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_A04_454756	39.8	139	PLC/PRF/5	Identical lines: Alexander cells and PLC/PRF/5 share high SNP identity	M	carcinoma,hepatocellular	PLCPRF5	liver,Alexander cells	ATCC	CRL-8024	cancer cell line	-666	-666	fh_PLCPRF5_LIVER-Tumor	rnaseq	7.2	26.06	56	0.3953	0.4262	0.4302	0.3823	0.3441	0.3591	0.3714	0.4044	0.4186	0.4207
HCC1428	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_A12_474732	38	121	HCC1428	-666	F	carcinoma	HCC1428	breast	ATCC	CRL-2327	cancer cell line	Y	pleural_effusion	fh_HCC1428_BREAST-Tumor	rnaseq	6.2	20.32	56	0.3906	0.4053	0.4207	0.3908	0.3368	0.3610	0.3771	0.4019	0.4250	0.4393
MCF7	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_G05_454738	48.3	138	-666	Identical lines: MCF-7 and KPL-1 share high SNP identity	F	carcinoma	MCF7	breast	ATCC	HTB-22	cancer cell line	Y	pleural_effusion	fh_MCF7_BREAST-Tumor	rnaseq	15.7	21.15	55	0.3989	0.3982	0.4226	0.3862	0.3534	0.3590	0.3715	0.4031	0.4221	0.4370
NCIH650	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_G12_569550	18.6	79	NCI-H650|H650	-666	M	carcinoma,bronchioalveolar,non-small cell lung cancer	NCIH650	lung	ATCC	CRL-5835	cancer cell line	Y	lymph_node	fh_NCIH650_LUNG-Tumor	rnaseq	6.9	21.04	59	0.3903	0.4117	0.4241	0.3756	0.3690	0.3484	0.3762	0.4137	0.4206	0.4143
SKNAS	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_G03_383634	28	127	SK-N-AS	-666	F	neuroblastoma,embryonal	SKNAS	autonomic ganglia	ATCC	CRL-2137	cancer cell line	Y	bone_marrow	fh_SKNAS_AUTONOMIC_GANGLIA-Tumor	rnaseq	5.2	27.33	58	0.3886	0.4070	0.4354	0.3862	0.3521	0.3561	0.3885	0.4089	0.4077	0.4179
OSRC2	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_C08_698810	37.1	104	OS-RC-2	-666	-666	myeloma,renal cell	OSRC2	kidney	RIKEN	-666	cancer cell line	-666	-666	fh_OSRC2_KIDNEY-Tumor	rnaseq	15.7	26.15	57	0.4050	0.4213	0.4299	0.3831	0.3469	0.3569	0.3821	0.4096	0.4074	0.4046
COLO800	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_D06_241124	38.2	128	COLO-800	Identical lines: COLO-818 and COLO-800 share high SNP identity and are likely to be COLO-800	-666	melanoma	COLO800	skin	DSMZ	-666	cancer cell line	-666	-666	fh_COLO800_SKIN-Tumor	rnaseq	7.2	19.62	56	0.4078	0.4135	0.4265	0.3853	0.3431	0.3614	0.3731	0.4062	0.4081	0.4069
JHOM2B	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_H01_698854	30	103	JHOM-2B	-666	-666	adenocarcinoma	JHOM2B	ovary	RIKEN	-666	cancer cell line	N	-666	fh_JHOM2B_OVARY-Tumor	rnaseq	5.2	41.41	58	0.3880	0.4086	0.4292	0.3772	0.3695	0.3694	0.3606	0.3963	0.4153	0.4197
JHH7	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_F06_436462	30.6	119	JHH-7	-666	M	carcinoma,hepatocellular	JHH7	liver	HSRRB	-666	cancer cell line	N	-666	fh_JHH7_LIVER-Tumor	rnaseq	15.7	17.77	56	0.3899	0.4129	0.4300	0.3969	0.3157	0.3579	0.3713	0.4079	0.4092	0.4325
HUH7	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_C11_419730	30.8	112	HUH-7	-666	M	carcinoma,hepatocellular	HUH7	liver	HSRRB	-666	cancer cell line	-666	-666	fh_HUH7_LIVER-Tumor	rnaseq	7.2	22.56	57	0.3870	0.4247	0.4337	0.3927	0.3274	0.3585	0.3861	0.4030	0.4098	0.4192
EFM19	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_A05_295998	28.4	101	EFM-19	-666	F	carcinoma,ductal	EFM19	breast	DSMZ	-666	cancer cell line	-666	-666	fh_EFM19_BREAST-Tumor	rnaseq	15.7	18.87	56	0.3916	0.4091	0.4192	0.3805	0.3502	0.3600	0.3907	0.3932	0.4095	0.4296
COLO783	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_A10_569576	32.3	102	COLO-783	-666	F	melanoma	COLO783	skin	DSMZ	-666	cancer cell line	N	-666	fh_COLO783_SKIN-Tumor	rnaseq	15.7	25.44	57	0.4057	0.4091	0.4316	0.3792	0.3479	0.3648	0.3668	0.4044	0.4044	0.4068
MELHO	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_A06_296000	41.7	126	MEL-HO	-666	F	melanoma	MELHO	skin	DSMZ	-666	cancer cell line	-666	-666	fh_MELHO_SKIN-Tumor	rnaseq	15.7	17.25	55	0.4000	0.4154	0.4263	0.3808	0.3296	0.3712	0.3737	0.4093	0.3966	0.4039
WM2664	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_C12_257668	29	102	WM-266-4	Metastatic pair: WM-115 and WM-266-4 are from the same patient	F	melanoma	WM2664	skin	ATCC	CRL-1676	cancer cell line	Y	skin	fh_WM2664_SKIN-Tumor	rnaseq	7.2	21.59	56	0.4056	0.4120	0.4282	0.3819	0.3587	0.3623	0.3655	0.3985	0.4098	0.4011
SNGM	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_C10_436514	43.8	138	SNG-M	-666	F	carcinoma	SNGM	endometrium,uterus	HSRRB	-666	cancer cell line	-666	-666	fh_SNGM_ENDOMETRIUM-Tumor	rnaseq	7.2	23.86	55	0.3983	0.4006	0.4151	0.3737	0.3676	0.3598	0.3719	0.4132	0.4101	0.4066
GMS10	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_A11_296010	26.8	93	GMS-10	-666	M	glioma,astrocytoma,grade IV	GMS10	CNS	DSMZ	-666	cancer cell line	-666	-666	fh_GMS10_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.3	26	59	0.3834	0.4190	0.4274	0.3823	0.3460	0.3674	0.3681	0.4057	0.4077	0.4199
NCIH1623	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_E02_454662	32.7	100	NCI-H1623|H1623	-666	M	adenocarcinoma,NSCLC	NCIH1623	lung	ATCC	CRL-5881	cancer cell line	Y	lymph_node	fh_NCIH1623_LUNG-Tumor	rnaseq	6.9	21.02	57	0.3956	0.3993	0.4239	0.3876	0.3395	0.3486	0.3666	0.4068	0.4151	0.4227
SJSA1	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_C09_241106	36.2	136	SJSA-1	-666	M	osteosarcoma	SJSA1	bone	ATCC	CRL-2098	cancer cell line	-666	-666	fh_SJSA1_BONE-Tumor	rnaseq	6.9	25.34	56	0.3781	0.4089	0.4381	0.3854	0.3386	0.3551	0.3680	0.4013	0.4155	0.4190
2313287	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_E11_474718	34	126	23132-87	-666	M	carcinoma	2313287	stomach	DSMZ	-666	cancer cell line	-666	-666	fh_2313287_STOMACH-Tumor	rnaseq	5.6	24.05	57	0.3889	0.3963	0.4398	0.3848	0.3517	0.3523	0.3619	0.4033	0.4134	0.4358
LN229	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_C01_436536	29.3	111	LN-229	-666	F	glioma,astrocytoma,grade IV	LN229	CNS	ATCC	CRL-2611	cancer cell line	-666	-666	fh_LN229_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.7	23.75	58	0.3967	0.4029	0.4305	0.3849	0.3301	0.3609	0.3758	0.4004	0.4055	0.4150
LS1034	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_G05_296142	38.7	126	-666	-666	M	carcinoma,colorectal	LS1034	large intestine,cecum	ATCC	CRL-2158	cancer cell line	-666	-666	fh_LS1034_LARGE_INTESTINE-Tumor	rnaseq	7.2	26.25	56	0.3935	0.4006	0.4262	0.3815	0.3469	0.3572	0.3618	0.4044	0.4235	0.4388
ABC1	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_D12_296084	27.1	103	ABC-1	-666	M	carcinoma,non-small cell	ABC1	lung	HSRRB	-666	cancer cell line	-666	-666	fh_ABC1_LUNG-Tumor	rnaseq	15.7	20.88	57	0.3933	0.4133	0.4299	0.3940	0.3326	0.3515	0.3648	0.3935	0.4072	0.4240
COV644	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_E08_569464	38.6	129	-666	-666	F	carcinoma	COV644	ovary	ECACC	-666	cancer cell line	N	-666	fh_COV644_OVARY-Tumor	rnaseq	5.8	31.15	57	0.3886	0.3972	0.4512	0.3801	0.3557	0.3533	0.3612	0.4061	0.4239	0.4290
SNU81	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_C10_779682	28.1	103	SNU-81|NCI-SNU-81	-666	M	carcinoma	SNU81	large intestine,colon	KCLB	-666	cancer cell line	N	-666	fh_SNU81_LARGE_INTESTINE-Tumor	rnaseq	6.9	15.94	57	0.3831	0.4058	0.4356	0.3819	0.3616	0.3495	0.3594	0.3966	0.4193	0.4254
NHA	-666	26.8	85	-666	-666	-666	-666	NHA	-666	-666	-666	cancer cell line	-666	-666	fh_NHA_hT_DD-Tumor	rnaseq	7.2	26.62	59	0.3927	0.4086	0.4221	0.3765	0.3704	0.3536	0.3878	0.4093	0.4031	0.4072
SKMEL5	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_B06_257632	34.4	102	SK-MEL-5	-666	F	melanoma	SKMEL5	skin	ATCC	HTB-70	cancer cell line	-666	-666	fh_SKMEL5_SKIN-Tumor	rnaseq	15.7	16.5	55	0.4019	0.4046	0.4334	0.3827	0.3366	0.3574	0.3618	0.4038	0.3980	0.4070
MESSA	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_D02_383624	33.3	138	MES-SA	-666	F	sarcoma	MESSA	uterus,sofT tissue	ATCC	CRL-1976	cancer cell line	-666	-666	fh_MESSA_SOFT_TISSUE-Tumor	rnaseq	5.6	25.81	57	0.3980	0.3987	0.4132	0.3799	0.3247	0.3482	0.3793	0.4069	0.4117	0.4246
SNU216	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_A08_587590	41.1	158	SNU-216|NCI-SNU-216	-666	F	carcinoma	SNU216	stomach	KCLB	-666	cancer cell line	Y	stomach	fh_SNU216_STOMACH-Tumor	rnaseq	6.3	27.48	56	0.3888	0.3914	0.4266	0.3736	0.3742	0.3609	0.3524	0.4043	0.4089	0.4151
AGS	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_E04_296092	24.3	89	-666	-666	F	adenocarcinoma,gastric	AGS	stomach	ATCC	CRL-1739	cancer cell line	-666	-666	fh_AGS_STOMACH-Tumor	rnaseq	15.7	20.69	58	0.3892	0.4050	0.4363	0.3863	0.3330	0.3532	0.3663	0.3988	0.4166	0.4211
PK59	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_B10_296032	30.6	92	PK-59	-666	-666	carcinoma	PK59	pancreas	RIKEN	-666	cancer cell line	N	-666	fh_PK59_PANCREAS-Tumor	rnaseq	15.7	22.35	58	0.3919	0.4073	0.4206	0.3818	0.3676	0.3694	0.3636	0.4019	0.4092	0.4077
SW403	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_G12_296156	34.1	128	-666	-666	F	adenocarcinoma,colorectal	SW403	large intestine,colon	ATCC	CCL-230	cancer cell line	-666	-666	fh_SW403_LARGE_INTESTINE-Tumor	rnaseq	15.7	21.02	56	0.3886	0.4011	0.4265	0.3855	0.3369	0.3618	0.3578	0.3966	0.4152	0.4287
BHT101	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_E12_474674	36.9	118	BHT-101	-666	F	carcinoma,anaplastic	BHT101	thyroid	DSMZ	-666	cancer cell line	-666	-666	fh_BHT101_THYROID-Tumor	rnaseq	6.6	22.76	57	0.3835	0.4123	0.4188	0.3699	0.3582	0.3587	0.3711	0.4060	0.4083	0.4124
SCC15	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_A12_523608	29.5	77	SCC-15	-666	M	carcinoma,squamous cell	SCC15	upper aerodigestive tract,tongue	ATCC	CRL-1623	cancer cell line	-666	-666	fh_SCC15_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	18.08	57	0.3857	0.4061	0.4209	0.3781	0.3635	0.3614	0.3623	0.4027	0.4102	0.4156
NCIH526	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_A05_257606	30.3	137	NCI-H526|H526	-666	M	carcinoma,small cell	NCIH526	lung	ATCC	CRL-5811	cancer cell line	Y	bone_marrow	fh_NCIH526_LUNG-Tumor	rnaseq	4.9	20.33	56	0.3881	0.4005	0.4337	0.3831	0.3054	0.3514	0.3677	0.4099	0.4200	0.4405
MDAMB415	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_H09_296174	44.5	157	MDA-MB-415	-666	F	carcinoma	MDAMB415	breast	ATCC	HTB-128	cancer cell line	Y	pleural_effusion	fh_MDAMB415_BREAST-Tumor	rnaseq	6.4	26.21	56	0.3971	0.3870	0.4184	0.3816	0.3648	0.3783	0.3705	0.4012	0.4003	0.4262
LN319	-666	21.4	90	-666	-666	-666	glioma	LN319	CNS	-666	-666	cancer cell line	-666	-666	fh_LN319_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	22.46	59	0.3897	0.3985	0.4237	0.3829	0.3297	0.3466	0.3742	0.4091	0.4021	0.4174
SKPNDW	-666	24.5	100	SK-PN-DW	-666	-666	PNET	SKPNDW	retroperitoneal	ATCC	CRL-2139	cancer cell line	-666	-666	fh_SKPNDW-Tumor	rnaseq	6.3	21.58	58	0.3701	0.4081	0.4365	0.3979	0.2911	0.3334	0.3694	0.4033	0.4138	0.4134
CHAGOK1	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_C06_569486	26.5	92	CHAGO-K-1	-666	M	carcinoma,bronchogenic	CHAGOK1	lung,bronchus	ATCC	HTB-168	cancer cell line	Y	subcutaneous	fh_CHAGOK1_LUNG-Tumor	rnaseq	15.7	15.69	57	0.3860	0.3950	0.4230	0.3822	0.3465	0.3495	0.3795	0.4030	0.4076	0.4182
JHH2	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_C08_257660	28.1	85	JHH-2	-666	M	carcinoma,hepatocellular	JHH2	liver	HSRRB	-666	cancer cell line	Y	ascites	fh_JHH2_LIVER-Tumor	rnaseq	15.7	22.09	58	0.3903	0.4026	0.4155	0.3634	0.3587	0.3583	0.3704	0.4072	0.3987	0.4012
WM1799	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_D06_569514	40.9	120	WM1799	-666	-666	melanoma	WM1799	skin	-666	-666	cancer cell line	N	-666	fh_WM1799_SKIN-Tumor	rnaseq	7.2	23.73	56	0.3998	0.4104	0.4310	0.3751	0.3475	0.3516	0.3716	0.3979	0.4043	0.4038
U2OS	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_D10_383716	31.6	109	U-2 OS	osteosarcoma cancer (epithelial) osteosarcoma,15 yo caucasian female tibia	F	osteosarcoma	U2OS	bone	ATCC	HTB-96	cancer cell line	-666	-666	fh_U2OS_BONE-Tumor	rnaseq	15.7	15.05	56	0.3836	0.4010	0.4242	0.3810	0.3193	0.3469	0.3850	0.4120	0.4135	0.4305
KMRC20	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_D01_419718	39.1	113	KMRC-20	-666	-666	carcinoma,renal	KMRC20	kidney	JCRB	JCRB1071	cancer cell line	-666	-666	fh_KMRC20_KIDNEY-Tumor	rnaseq	15.7	21	56	0.3904	0.4114	0.4224	0.3818	0.3367	0.3492	0.3752	0.4007	0.4088	0.4099
NUGC2	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_A03_454754	32.1	93	NUGC-2	-666	F	carcinoma	NUGC2	stomach	HSRRB	-666	cancer cell line	N	-666	fh_NUGC2_STOMACH-Tumor	rnaseq	15.7	18.9	56	0.4007	0.3916	0.4086	0.3715	0.3457	0.3711	0.3671	0.4054	0.4100	0.4082
TM31	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_D02_698892	27.1	88	TM-31	-666	-666	glioma,astrocytoma	TM31	CNS	RIKEN	-666	cancer cell line	N	-666	fh_TM31_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	7.2	22.72	58	0.3850	0.4077	0.4358	0.3842	0.3432	0.3494	0.3728	0.4019	0.4068	0.4148
TTC549	-666	21.1	90	-666	-666	-666	-666	TTC549	-666	-666	-666	cancer cell line	-666	-666	fh_TTC549-Tumor	rnaseq	15.7	24.58	58	0.3797	0.4094	0.4296	0.3882	0.3415	0.3449	0.3674	0.3923	0.4090	0.4226
BEN	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_C02_474694	24.1	67	-666	-666	M	carcinoma	BEN	lung	DSMZ	-666	cancer cell line	-666	-666	fh_BEN_LUNG-Tumor	rnaseq	15.7	20.03	58	0.4107	0.4022	0.4118	0.3821	0.3440	0.3530	0.3650	0.4075	0.3954	0.4139
HCC1419	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_A07_474600	27.7	93	-666	-666	F	carcinoma,ductal,primary	HCC1419	breast	ATCC	CRL-2326	cancer cell line	-666	-666	fh_HCC1419_BREAST-Tumor	rnaseq	6.6	19.88	58	0.3883	0.3879	0.4117	0.3923	0.3508	0.3633	0.3695	0.3959	0.4045	0.4358
MDST8	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_F09_569594	33.6	97	MDST8	-666	-666	adenocarcinoma	MDST8	large intestine,colon	ECACC	-666	cancer cell line	N	-666	fh_MDST8_LARGE_INTESTINE-Tumor	rnaseq	15.7	21.97	57	0.4073	0.4015	0.4061	0.3657	0.3214	0.3596	0.3801	0.4150	0.4080	0.4110
TGBC11TKB	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_E12_698778	28.9	116	TGBC11TKB	-666	-666	carcinoma	TGBC11TKB	stomach	RIKEN	-666	cancer cell line	-666	-666	fh_TGBC11TKB_STOMACH-Tumor	rnaseq	7.2	25.85	57	0.3849	0.4002	0.4288	0.3851	0.3551	0.3601	0.3622	0.3942	0.4001	0.4167
G402	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_G06_296144	25.7	112	G-402	-666	F	rhabdoid	G402	sofT tissue,kidney	ATCC	CRL-1440	cancer cell line	-666	-666	fh_G402_SOFT_TISSUE-Tumor	rnaseq	7.2	26.96	57	0.3820	0.4041	0.4190	0.3863	0.3263	0.3402	0.3681	0.4027	0.4198	0.4165
HS695T	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_D06_240932	28.5	86	HS 695T	-666	M	melanoma,amelanotic	HS695T	skin	ATCC	HTB-137	cancer cell line	Y	lymph_node	fh_HS695T_SKIN-Tumor	rnaseq	6.6	18.66	58	0.3897	0.3981	0.4187	0.3802	0.3505	0.3634	0.3695	0.4106	0.4001	0.4065
NCIH810	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_G07_241198	23.8	97	NCI-H810|H810	-666	M	carcinoma,large cell	NCIH810	lung	ATCC	CRL-5816	cancer cell line	-666	-666	fh_NCIH810_LUNG-Tumor	rnaseq	15.7	19.25	58	0.3824	0.4117	0.4312	0.4009	0.3317	0.3471	0.3572	0.4037	0.4042	0.4266
PECAPJ15	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_E10_569416	23.5	67	PE/CA-PJ15	-666	M	carcinoma,squamous cell	PECAPJ15	upper aerodigestive tract,mouth	ECACC	-666	cancer cell line	N	-666	fh_PECAPJ15_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	21.86	58	0.3790	0.4067	0.4153	0.3768	0.3518	0.3535	0.3689	0.4060	0.4097	0.4045
T47D	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_H12_436432	27.9	106	T-47D	-666	F	carcinoma,ductal	T47D	breast	ATCC	HTB-133	cancer cell line	Y	pleural_effusion	fh_T47D_BREAST-Tumor	rnaseq	15.7	22.79	57	0.3869	0.3994	0.4097	0.3818	0.3246	0.3619	0.3731	0.4009	0.4104	0.4268
TF1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_B08_523640	44.6	187	TF-1	-666	M	AML,erytholeukemia	TF1	haematopoietic,lymphoid,erythroblast	ATCC	CRL-2003	cancer cell line	-666	-666	fh_TF1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	19.02	54	0.3939	0.3968	0.4132	0.3846	0.2993	0.3540	0.3702	0.4014	0.4088	0.4096
VMCUB1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_F12_523606	17.5	54	VM-CUB-1	-666	M	carcinoma,transitional cell	VMCUB1	urinary tract,bladder	DSMZ	-666	cancer cell line	-666	-666	fh_VMCUB1_URINARY_TRACT-Tumor	rnaseq	6.7	22.71	60	0.3954	0.4057	0.4224	0.3813	0.3453	0.3489	0.3611	0.4001	0.4094	0.3985
TE6	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_B11_698790	38.6	140	TE-6	-666	-666	carcinoma,squamous cell	TE6	oesophagus	RIKEN	-666	cancer cell line	-666	-666	fh_TE6_OESOPHAGUS-Tumor	rnaseq	6	27.48	56	0.3920	0.3980	0.4280	0.3881	0.3192	0.3518	0.3700	0.3903	0.4109	0.4129
HS888T	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_D03_474638	22.6	74	HS 888.T	-666	M	osteosarcoma	HS888T	bone	ATCC	CRL-7622	cancer cell line	Y	lung	fh_HS888T_BONE-Tumor	rnaseq	15.7	25.95	59	0.3858	0.4084	0.4245	0.3742	0.3702	0.3497	0.3759	0.4049	0.4024	0.4042
SKMEL28	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_A06_698750	29.7	100	SK-MEL-28	-666	M	melanoma	SKMEL28	skin	ATCC	HTB-72	cancer cell line	-666	-666	fh_SKMEL28_SKIN-Tumor	rnaseq	15.7	19.61	57	0.3950	0.4096	0.4228	0.3851	0.3560	0.3518	0.3566	0.4014	0.3957	0.3963
OVMANA	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_H02_569500	31.8	82	-666	-666	F	carcinoma,clearcell	OVMANA	ovary	HSRRB	-666	cancer cell line	N	-666	fh_OVMANA_OVARY-Tumor	rnaseq	15.7	17.38	57	0.3876	0.4007	0.4168	0.3805	0.3513	0.3606	0.3568	0.4089	0.4100	0.4121
LN215	-666	27.8	102	-666	-666	-666	glioma	LN215	CNS	-666	-666	cancer cell line	-666	-666	fh_LN215_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.7	22.01	58	0.3833	0.4123	0.4229	0.3776	0.3402	0.3555	0.3775	0.4092	0.4043	0.4113
GSU	BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_G11_698762	33.2	97	-666	-666	-666	adenocarcinoma	GSU	stomach	RIKEN	-666	cancer cell line	-666	-666	fh_GSU_STOMACH-Tumor	rnaseq	15.7	20.6	57	0.3823	0.4094	0.4212	0.3805	0.3504	0.3537	0.3578	0.3838	0.4070	0.4118
NCIH1563	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_B05_383744	28	109	NCI-H1563|H1563	-666	M	adenocarcinoma,NSCLC	NCIH1563	lung	ATCC	CRL-5875	cancer cell line	-666	-666	fh_NCIH1563_LUNG-Tumor	rnaseq	7.2	24.38	57	0.3787	0.3972	0.4224	0.3744	0.3509	0.3520	0.3725	0.3949	0.4110	0.4146
SNU1105	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_B07_587548	28.5	80	SNU-1105|NCI-SNU-1105	-666	M	glioma,astrocytoma,grade IV	SNU1105	CNS	KCLB	-666	cancer cell line	N	-666	fh_SNU1105_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	18.07	57	0.3961	0.4010	0.4271	0.3773	0.3419	0.3488	0.3811	0.4030	0.4010	0.4125
DMS454	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_C07_569558	27.2	89	DMS 454	-666	M	carcinoma,small cell	DMS454	lung	ECACC	-666	cancer cell line	N	-666	fh_DMS454_LUNG-Tumor	rnaseq	15.7	15.02	57	0.3912	0.4001	0.4162	0.3853	0.3166	0.3518	0.3722	0.4007	0.4011	0.4182
RDES	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_C12_383616	37.9	148	RD-ES	-666	M	sarcoma,Ewings,PNET	RDES	bone	ATCC	HTB-166	cancer cell line	-666	-666	fh_RDES_BONE-Tumor	rnaseq	4.7	21.96	56	0.3832	0.3986	0.4179	0.3814	0.3076	0.3383	0.3738	0.4106	0.4104	0.4131
YH13	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_F10_383682	30.1	101	YH-13	-666	M	glioma,astrocytoma,grade IV	YH13	CNS	HSRRB	-666	cancer cell line	-666	-666	fh_YH13_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	7.2	28.83	58	0.3748	0.4049	0.4280	0.3781	0.3565	0.3478	0.3721	0.3960	0.3971	0.4115
NCIH520	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_D02_241116	38.8	128	NCI-H520|H520	-666	M	carcinoma,squamous cell	NCIH520	lung	ATCC	HTB-182	cancer cell line	-666	-666	fh_NCIH520_LUNG-Tumor	rnaseq	6.9	18.06	56	0.3865	0.4010	0.4249	0.3977	0.3238	0.3461	0.3663	0.4009	0.3987	0.4088
FU97	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_D05_241122	28.9	103	-666	-666	F	adenocarcinoma,diffuse	FU97	stomach	HSRRB	-666	cancer cell line	N	-666	fh_FU97_STOMACH-Tumor	rnaseq	6.3	22.84	58	0.3780	0.4085	0.4172	0.3795	0.3147	0.3361	0.3736	0.3909	0.4072	0.4178
TUHR10TKB	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_E09_698764	62.3	152	TUHR10TKB	-666	-666	carcinoma	TUHR10TKB	kidney	RIKEN	-666	cancer cell line	N	-666	fh_TUHR10TKB_KIDNEY-Tumor	rnaseq	6.1	23.67	54	0.3929	0.4032	0.4149	0.3588	0.3275	0.3552	0.3598	0.4027	0.4084	0.3940
HS852T	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_A06_474676	38.8	128	Hs 852.T	-666	M	melanoma	HS852T	skin	ATCC	CRL-7585	cancer cell line	-666	-666	fh_HS852T_SKIN-Tumor	rnaseq	7.2	22.73	56	0.3950	0.4007	0.4203	0.3721	0.3267	0.3626	0.3564	0.4113	0.3953	0.4092
BFTC909	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_C08_474696	39.3	112	BFTC-909	-666	M	carcinoma	BFTC909	kidney	DSMZ	-666	cancer cell line	N	-666	fh_BFTC909_KIDNEY-Tumor	rnaseq	6.4	25.18	57	0.3835	0.4108	0.4106	0.3733	0.3416	0.3506	0.3730	0.4002	0.4049	0.4036
SKNSH	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_F07_419790	26.6	99	SK-N-SH	Identical lines: SH-SY5Y is a subclone derived from SK-N-SH and is identical to LAN-5	F	neuroblastoma	SKNSH	autonomic ganglia	ATCC	HTB-11	cancer cell line	Y	bone_marrow	fh_SKNSH_AUTONOMIC_GANGLIA-Tumor	rnaseq	15.7	19.4	57	0.3803	0.4022	0.4182	0.3628	0.3454	0.3359	0.3790	0.4021	0.4038	0.4037
SKMEL3	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_E01_240946	30.4	106	SK-MEL-3	-666	F	melanoma	SKMEL3	skin	ATCC	HTB-69	cancer cell line	Y	lymph_node	fh_SKMEL3_SKIN-Tumor	rnaseq	15.7	20.39	56	0.3847	0.4006	0.4185	0.3770	0.3235	0.3568	0.3642	0.4034	0.3930	0.3977
JHH1	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_C07_241102	35.9	111	JHH-1	-666	M	carcinoma,hepatocellular	JHH1	liver	HSRRB	-666	cancer cell line	N	-666	fh_JHH1_LIVER-Tumor	rnaseq	15.7	27.5	56	0.3842	0.4120	0.4228	0.3796	0.3504	0.3503	0.3571	0.3947	0.4021	0.4089
KYO1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_C11_523564	55.4	196	KYO-1	blast phase	M	CML,blast phase	KYO1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_KYO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	15.2	53	0.3778	0.3916	0.4012	0.3766	0.3181	0.3598	0.3734	0.4026	0.4032	0.4138
OAW28	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_F10_569482	24.7	88	OAW28	-666	F	carcinoma	OAW28	ovary	ECACC	-666	cancer cell line	-666	-666	fh_OAW28_OVARY-Tumor	rnaseq	6.5	24.25	59	0.3918	0.4060	0.4216	0.3729	0.3397	0.3478	0.3569	0.3916	0.4036	0.4198
SNU761	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_E02_698862	42.8	116	SNU-761|NCI-SNU-761	-666	M	hepatocellular carcinoma	SNU761	liver	KCLB	-666	cancer cell line	N	-666	fh_SNU761_LIVER-Tumor	rnaseq	6.9	20.51	56	0.3929	0.4005	0.4011	0.3655	0.3620	0.3623	0.3666	0.3961	0.3873	0.3929
HCC1588	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_F03_698802	40.5	108	HCC-1588	Identical lines: HCC-1588 and LS513 share high SNP identity. Really is LS513	F	carcinoma,squamous cell	HCC1588	lung	KCLB	-666	cancer cell line	N	-666	fh_HCC1588_LUNG-Tumor	rnaseq	6.9	16.97	55	0.3836	0.3939	0.4207	0.3728	0.3738	0.3533	0.3516	0.3924	0.4034	0.4082
HS839T	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_B10_454602	19.9	66	HS 839.T	-666	F	melanoma	HS839T	skin	ATCC	CRL-7572	cancer cell line	-666	-666	fh_HS839T_SKIN-Tumor	rnaseq	6.7	30.45	61	0.3749	0.3986	0.4172	0.3717	0.3539	0.3455	0.3723	0.3984	0.4005	0.4122
NCIH524	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_A11_240870	31.6	127	NCI-H524|H524	-666	M	carcinoma,small cell	NCIH524	lung	ATCC	CRL-5831	cancer cell line	Y	lymph_node	fh_NCIH524_LUNG-Tumor	rnaseq	7.2	19.48	57	0.3650	0.3997	0.4190	0.3870	0.2949	0.3407	0.3633	0.4004	0.3985	0.4242
HCC2935	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_D02_474658	25.5	82	HCC2935	-666	M	carcinoma,non-small cell	HCC2935	lung	ATCC	CRL-2869	cancer cell line	-666	-666	fh_HCC2935_LUNG-Tumor	rnaseq	15.7	18.19	58	0.3899	0.3892	0.4172	0.3704	0.3565	0.3665	0.3639	0.4021	0.4013	0.4020
TUHR14TKB	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_D09_698792	32.6	98	TUHR14TKB	-666	-666	carcinoma	TUHR14TKB	kidney	RIKEN	-666	cancer cell line	N	-666	fh_TUHR14TKB_KIDNEY-Tumor	rnaseq	6.5	30.61	58	0.3868	0.4025	0.4138	0.3650	0.3738	0.3463	0.3712	0.3880	0.4088	0.3871
JHUEM2	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_D05_296070	38.1	121	JHUEM-2	-666	F	carcinoma	JHUEM2	endometrium	RIKEN	-666	cancer cell line	N	-666	fh_JHUEM2_ENDOMETRIUM-Tumor	rnaseq	6.9	20.58	56	0.3753	0.3919	0.4174	0.3737	0.3160	0.3390	0.3762	0.4001	0.4040	0.4157
A704	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_D04_569578	55.3	221	-666	-666	M	carcinoma,renal	A704	kidney	ATCC	CRL-7911	cancer cell line	-666	-666	fh_A704_KIDNEY-Tumor	rnaseq	7.2	21.2	52	0.3818	0.3983	0.4265	0.3744	0.3450	0.3516	0.3578	0.3897	0.4042	0.4063
HCC1500	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_D09_523496	43.3	169	-666	-666	F	carcinoma,ductal,primary	HCC1500	breast	ATCC	CRL-2329	cancer cell line	-666	-666	fh_HCC1500_BREAST-Tumor	rnaseq	15.7	19.25	54	0.3739	0.3905	0.4091	0.3658	0.3417	0.3574	0.3672	0.3930	0.4053	0.4231
NCIH596	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_G11_569590	29.3	100	NCI-H596|H596	-666	M	carcinoma,mixed adenosquamous	NCIH596	lung	ATCC	HTB-178	cancer cell line	-666	-666	fh_NCIH596_LUNG-Tumor	rnaseq	7.2	21.34	57	0.3839	0.3937	0.4150	0.3774	0.3550	0.3663	0.3564	0.3981	0.3946	0.4020
KURAMOCHI	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_B09_779666	26.2	95	-666	-666	F	carcinoma,undifferentiated	KURAMOCHI	ovary	HSRRB	-666	cancer cell line	-666	-666	fh_KURAMOCHI_OVARY-Tumor	rnaseq	5.7	28.9	58	0.3814	0.3988	0.4103	0.3673	0.3692	0.3377	0.3654	0.3979	0.3796	0.4092
KPNSI9S	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_B11_419860	35.3	121	KP-N-SI9S|KP-N-S19s	neuroblastoma, from lymph node, smooth muscle marker-expressing	M	neuroblastoma	KPNSI9S	autonomic ganglia	HSRRB	IFO50433	cancer cell line	-666	-666	fh_KPNSI9S_AUTONOMIC_GANGLIA-Tumor	rnaseq	7.2	22.33	56	0.3880	0.4009	0.4140	0.3630	0.3297	0.3474	0.3667	0.3948	0.4036	0.4080
NCIH510	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_D12_436552	33.3	116	NCI-H510|NCI-H510A|H510|H510A	-666	M	carcinoma,small cell	NCIH510	lung	ATCC	-666	cancer cell line	N	-666	fh_NCIH510_LUNG-Tumor	rnaseq	5.5	25.61	58	0.3812	0.3903	0.4160	0.3809	0.3257	0.3381	0.3609	0.4012	0.4130	0.4107
H4	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_D12_383660	29.3	111	-666	-666	M	neuroglioma	H4	CNS	ATCC	HTB-148	cancer cell line	-666	-666	fh_H4_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.4	28.73	58	0.3945	0.3970	0.4150	0.3689	0.3368	0.3551	0.3796	0.4055	0.3963	0.3995
HS934T	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_A10_474662	19.8	67	HS 934.T	-666	F	melanoma	HS934T	skin,connective tissue	ATCC	CRL-7684	cancer cell line	-666	-666	fh_HS934T_SKIN-Tumor	rnaseq	7.2	26.98	60	0.3714	0.3987	0.4170	0.3685	0.3526	0.3393	0.3714	0.3934	0.3979	0.4103
HCC1599	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_D10_523634	51.4	147	-666	-666	F	carcinoma,ductal,primary	HCC1599	breast	ATCC	CRL-2331	cancer cell line	-666	-666	fh_HCC1599_BREAST-Tumor	rnaseq	15.7	18.61	54	0.3706	0.3914	0.4269	0.3780	0.3072	0.3536	0.3563	0.3909	0.4042	0.4316
HPAC	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_B05_698754	33.7	93	HPAC	Identical lines: KCI-MOH1 is a derivative of HPAC	F	carcinoma,ductal	HPAC	pancreas	ATCC	CRL-2119	cancer cell line	-666	-666	fh_HPAC_PANCREAS-Tumor	rnaseq	7.2	22.1	58	0.3738	0.3956	0.4232	0.3732	0.3572	0.3524	0.3551	0.3918	0.3995	0.4185
MEG01	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_G11_454734	54.2	187	MEG-01	-666	M	CML,blast phase	MEG01	haematopoietic,lymphoid,megakaryoblast	ATCC	CRL-2021	cancer cell line	-666	-666	fh_MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.7	21.68	54	0.3795	0.3954	0.4118	0.3772	0.3130	0.3510	0.3754	0.3951	0.4009	0.4036
CHP212	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_G10_296152	27.9	110	CHP-212	-666	-666	neuroblastoma	CHP212	autonomic ganglia	ATCC	CRL-2273	cancer cell line	-666	-666	fh_CHP212_AUTONOMIC_GANGLIA-Tumor	rnaseq	5.9	28.7	58	0.3735	0.4001	0.4341	0.3833	0.3274	0.3425	0.3792	0.3918	0.4029	0.4018
HDQP1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_H05_523478	28.9	85	HDQ-P1	-666	F	carcinoma,ductal	HDQP1	breast	DSMZ	-666	cancer cell line	N	-666	fh_HDQP1_BREAST-Tumor	rnaseq	15.7	21.28	57	0.3798	0.4040	0.4136	0.3661	0.3705	0.3628	0.3547	0.3944	0.4028	0.3975
HS281T	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_A09_474590	27.1	74	HS 281.T	-666	F	carcinoma	HS281T	breast	ATCC	CRL-7227	cancer cell line	-666	-666	fh_HS281T_BREAST-Tumor	rnaseq	15.7	23.04	59	0.3827	0.3970	0.4142	0.3642	0.3559	0.3384	0.3643	0.3889	0.4011	0.4049
COLO668	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_C07_698840	27.4	124	COLO-668	-666	F	carcinoma,small cell lung	COLO668	lung	ECACC	-666	cancer cell line	-666	-666	fh_COLO668_LUNG-Tumor	rnaseq	5.6	23.83	58	0.3771	0.3897	0.4304	0.3815	0.3225	0.3408	0.3533	0.3971	0.4029	0.4281
RL952	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_D11_241134	31.9	105	RL95-2	-666	F	carcinoma,mixed adenosquamous	RL952	endometrium,uterus	ATCC	CRL-1671	cancer cell line	-666	-666	fh_RL952_ENDOMETRIUM-Tumor	rnaseq	15.7	23.02	57	0.3751	0.3973	0.4116	0.3729	0.3245	0.3525	0.3560	0.3936	0.4043	0.4054
MALME3M	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_F02_240972	23.8	84	MALME-3M	-666	M	melanoma	MALME3M	skin	ATCC	HTB-64	cancer cell line	-666	-666	fh_MALME3M_SKIN-Tumor	rnaseq	15.7	19.47	58	0.3924	0.3936	0.4119	0.3596	0.3450	0.3487	0.3675	0.3956	0.3864	0.3793
SKMEL1	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_F04_436458	43	144	SK-MEL-1	-666	M	melanoma	SKMEL1	skin	ATCC	HTB-67	cancer cell line	Y	thoracic_duct	fh_SKMEL1_SKIN-Tumor	rnaseq	6.4	29.81	56	0.3932	0.4144	0.4062	0.3710	0.3353	0.3662	0.3706	0.3948	0.3921	0.3928
HS294T	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_B05_257630	26.6	99	HS 294T	Isolated from the same donor tissue as A101D	M	melanoma,amelanotic	HS294T	skin	ATCC	HTB-140	cancer cell line	Y	lymph_node	fh_HS294T_SKIN-Tumor	rnaseq	6.5	24.34	58	0.3962	0.4004	0.4051	0.3592	0.3413	0.3434	0.3637	0.3989	0.3898	0.3968
CL14	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_C10_523636	25.9	76	CL-14	-666	M	carcinoma	CL14	large intestine,colon	DSMZ	-666	cancer cell line	N	-666	fh_CL14_LARGE_INTESTINE-Tumor	rnaseq	15.7	25.35	58	0.3784	0.3932	0.4145	0.3673	0.3478	0.3472	0.3519	0.3832	0.4088	0.4222
TTC709	-666	30.7	119	-666	-666	-666	-666	TTC709	-666	-666	-666	cancer cell line	-666	-666	fh_TTC-709-Tumor	rnaseq	15.7	17.4	55	0.3805	0.3935	0.4183	0.3858	0.3236	0.3391	0.3629	0.3928	0.3932	0.4256
RERFLCSQ1	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_E07_240958	33.5	95	RERF-LC-SQ1	-666	F	carcinoma,squamous cell	RERFLCSQ1	lung	HSRRB	-666	cancer cell line	N	-666	fh_RERFLCSQ1_LUNG-Tumor	rnaseq	15.7	24.33	57	0.3810	0.3876	0.4145	0.3684	0.3290	0.3354	0.3684	0.3952	0.3969	0.4072
NCIH146	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_G08_296148	25.6	99	NCI-H146|H146	-666	M	carcinoma,small cell	NCIH146	lung	ATCC	HTB-173	cancer cell line	Y	bone_marrow	fh_NCIH146_LUNG-Tumor	rnaseq	6.6	18.61	57	0.3762	0.3917	0.4144	0.3704	0.3058	0.3350	0.3640	0.4033	0.4055	0.4137
NCIH1930	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_E01_454664	13	80	NCI-H1930|H1930	-666	M	carcinoma,small cell	NCIH1930	lung	ATCC	CRL-5906	cancer cell line	Y	lymph_node	fh_NCIH1930_LUNG-Tumor	rnaseq	4.3	21.4	60	0.3702	0.3779	0.4172	0.3701	0.2916	0.3326	0.3728	0.4006	0.3986	0.4067
MHHES1	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_C09_474764	37.8	125	MHH-ES-1	-666	M	sarcoma,Ewings,PNET	MHHES1	bone	DSMZ	-666	cancer cell line	-666	-666	fh_MHHES1_BONE-Tumor	rnaseq	7.2	18.11	55	0.3727	0.3944	0.4107	0.3782	0.3104	0.3309	0.3633	0.4028	0.3975	0.4139
SKNEP1	-666	39.6	136	SK-NEP-1	-666	-666	Wilms Tumor	SKNEP1	kidney	ATCC	HTB-48	cancer cell line	Y	pleural_effusion	fh_SKNEP1-Tumor	rnaseq	5.7	20.17	56	0.3696	0.3941	0.4103	0.3756	0.2777	0.3284	0.3641	0.4023	0.4012	0.4043
YD8	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_C04_587610	28.1	90	-666	-666	F	carcinoma,squamous cell	YD8	upper aerodigestive tract	KCLB	-666	cancer cell line	-666	-666	fh_YD8_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	6.7	30.75	59	0.3715	0.3897	0.4258	0.3750	0.3742	0.3405	0.3508	0.3844	0.4014	0.4151
CAS1	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_H09_419838	30.1	91	CAS-1	-666	M	glioma,astrocytoma,grade IV	CAS1	CNS	ICLC	-666	cancer cell line	-666	-666	fh_CAS1_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	21.61	57	0.3789	0.4062	0.4138	0.3634	0.3432	0.3385	0.3777	0.3923	0.3883	0.3976
COV434	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_B08_569552	37.7	150	-666	-666	F	granulosa cell tumour	COV434	ovary	ECACC	-666	cancer cell line	N	-666	fh_COV434_OVARY-Tumor	rnaseq	7.2	22.13	55	0.3737	0.3954	0.4093	0.3784	0.3024	0.3464	0.3630	0.3926	0.3972	0.3981
KG1C	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_C10_419732	46.4	139	KG-1-C	-666	M	glioma,astrocytoma,grade IV	KG1C	CNS	HSRRB	-666	cancer cell line	N	-666	fh_KG1C_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.1	30.99	56	0.3833	0.4017	0.4033	0.3667	0.3454	0.3488	0.3563	0.3954	0.3929	0.3899
TE8	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_F07_698902	27.1	85	TE-8	-666	-666	carcinoma,squamous cell	TE8	oesophagus	RIKEN	-666	cancer cell line	-666	-666	fh_TE8_OESOPHAGUS-Tumor	rnaseq	15.7	27.67	58	0.3769	0.4021	0.4201	0.3711	0.3440	0.3334	0.3541	0.3764	0.3982	0.3945
TUHR4TKB	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_B02_698922	32.5	98	TUHR4TKB	-666	-666	carcinoma	TUHR4TKB	kidney	RIKEN	-666	cancer cell line	N	-666	fh_TUHR4TKB_KIDNEY-Tumor	rnaseq	15.7	19.41	57	0.3858	0.4033	0.4128	0.3678	0.3451	0.3442	0.3583	0.3904	0.4039	0.3989
RH41	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_E05_523510	28.4	98	RH-41	-666	F	rhabdomyosarcoma,alveolar	RH41	sofT tissue,striated muscle	DSMZ	-666	cancer cell line	N	-666	fh_RH41_SOFT_TISSUE-Tumor	rnaseq	7.2	18.79	57	0.3698	0.3932	0.4187	0.3895	0.3133	0.3283	0.3627	0.3843	0.3969	0.4133
NCIH2342	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_G11_436494	45.3	128	NCI-H2342|H2342	-666	M	adenocarcinoma,NSCLC	NCIH2342	lung	ATCC	CRL-5941	cancer cell line	-666	-666	fh_NCIH2342_LUNG-Tumor	rnaseq	15.7	15.42	54	0.3731	0.4019	0.4163	0.3718	0.3306	0.3445	0.3446	0.3819	0.3955	0.4213
OVK18	BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_F01_698864	31.1	146	-666	-666	-666	endometrioid carcinoma	OVK18	ovary	RIKEN	-666	cancer cell line	-666	-666	fh_OVK18_OVARY-Tumor	rnaseq	6.7	19.89	55	0.4004	0.3867	0.3946	0.3663	0.3262	0.3481	0.3695	0.4080	0.3993	0.3974
SNU626	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_D09_587598	48.8	181	SNU-626|NCI-SNU-626	-666	M	glioma,astrocytoma,grade IV	SNU626	CNS	KCLB	-666	cancer cell line	N	-666	fh_SNU626_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.3	21.94	55	0.3677	0.3933	0.4145	0.3690	0.3414	0.3472	0.3574	0.3897	0.3893	0.4045
CAMA1	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_F09_419786	37.3	144	CAMA-1	-666	F	carcinoma	CAMA1	breast	ATCC	HTB-21	cancer cell line	Y	pleural_effusion	fh_CAMA1_BREAST-Tumor	rnaseq	5.3	20.55	56	0.3764	0.3891	0.4088	0.3700	0.3331	0.3497	0.3712	0.3865	0.3963	0.4225
KMS12BM	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_F04_240976	38.3	144	KMS-12-BM	established from the bone marrow of a 64-year-old woman with multiple myeloma in 1988; sister cell line of KMS-12-PE (DSM ACC 606)	F	myeloma,plasma cell	KMS12BM	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_KMS12BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.6	18.3	55	0.3882	0.3823	0.4017	0.3616	0.2952	0.3689	0.3651	0.4014	0.4119	0.3903
HEPG2	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_A09_240866	19.1	83	-666	Identical lines: Hep G2 and C3A share high SNP identity	M	carcinoma,hepatocellular	HEPG2	liver	ATCC	HB-8065	cancer cell line	-666	-666	fh_HEPG2_LIVER-Tumor	rnaseq	7.2	22.29	59	0.3820	0.3943	0.4030	0.3743	0.3063	0.3382	0.3580	0.3819	0.3948	0.4142
COLO680N	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_F02_523546	29.1	85	COLO-680N	-666	F	carcinoma,squamous cell	COLO680N	oesophagus	DSMZ	-666	cancer cell line	-666	-666	fh_COLO680N_OESOPHAGUS-Tumor	rnaseq	15.7	23.63	57	0.3774	0.3913	0.4060	0.3693	0.3526	0.3435	0.3644	0.3851	0.3886	0.3962
HS863T	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_B08_474720	27.5	96	HS 863.T	-666	F	sarcoma,Ewings,PNET	HS863T	bone	ATCC	CRL-7598	cancer cell line	-666	-666	fh_HS863T_BONE-Tumor	rnaseq	6.3	26.84	58	0.3671	0.3893	0.4145	0.3631	0.3476	0.3348	0.3630	0.3804	0.3977	0.4074
HLFA	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_B01_296014	35.4	99	HLF-A	-666	F	carcinoma,epidermoid	HLFA	lung	ATCC	CCL-199	cancer cell line	-666	-666	fh_HLFA_LUNG-Tumor	rnaseq	15.7	27.13	57	0.3717	0.3923	0.4120	0.3696	0.3606	0.3369	0.3583	0.3893	0.3903	0.4008
TTC1240	-666	30.1	121	-666	-666	-666	-666	TTC1240	-666	-666	-666	cancer cell line	-666	-666	fh_TTC1240-Tumor	rnaseq	6.7	23.66	57	0.3760	0.3946	0.4104	0.3794	0.3139	0.3269	0.3565	0.3883	0.4041	0.4098
NCIH854	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_A12_587660	24.7	68	NCI-H854	-666	-666	adenocarcinoma	NCIH854	lung	KCLB	-666	cancer cell line	N	-666	fh_NCIH854_LUNG-Tumor	rnaseq	6	20.76	57	0.3856	0.3828	0.4080	0.3662	0.3674	0.3555	0.3551	0.3909	0.3971	0.4004
SF539	-666	35.6	123	-666	-666	-666	glioma	SF539	brain	NCI	-666	cancer cell line	-666	-666	fh_SF539_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.2	33.55	57	0.3689	0.3930	0.4162	0.3680	0.3343	0.3394	0.3506	0.3861	0.3935	0.4109
HEP3B217	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_E10_587624	39.1	133	HEP3B2.1-7|HEP-3B|HEP3B	-666	M	carcinoma,hepatocellular	HEP3B217	liver	ATCC	HB-8064	cancer cell line	-666	-666	fh_HEP3B217_LIVER-Tumor	rnaseq	5.7	24.04	57	0.3730	0.4145	0.4117	0.3729	0.3195	0.3465	0.3632	0.3840	0.3911	0.3973
NCIH209	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_A12_240872	29.1	126	NCI-H209|H209|H-209	-666	M	carcinoma,small cell	NCIH209	lung	ATCC	HTB-172	cancer cell line	Y	bone_marrow	fh_NCIH209_LUNG-Tumor	rnaseq	5.3	22.62	57	0.3752	0.3803	0.4102	0.3753	0.3092	0.3278	0.3527	0.3984	0.3956	0.4152
NCIH522	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_B08_296028	27.4	108	NCI-H522|H522	-666	M	carcinoma,non-small cell	NCIH522	lung	ATCC	CRL-5810	cancer cell line	-666	-666	fh_NCIH522_LUNG-Tumor	rnaseq	6.4	23.29	58	0.3773	0.3876	0.4077	0.3820	0.3315	0.3368	0.3578	0.3943	0.3896	0.4177
QGP1	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_E05_296094	33.7	113	QGP-1	-666	-666	carcinoma	QGP1	pancreas	HSRRB	-666	cancer cell line	N	-666	fh_QGP1_PANCREAS-Tumor	rnaseq	6.2	14.58	55	0.3781	0.3961	0.4093	0.3677	0.3403	0.3268	0.3530	0.3891	0.3878	0.4027
RERFGC1B	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_D07_436562	23.7	84	RERF-GC-1B	-666	M	carcinoma	RERFGC1B	stomach	HSRRB	-666	cancer cell line	Y	lymph_node	fh_RERFGC1B_STOMACH-Tumor	rnaseq	6.5	21.8	59	0.3769	0.4008	0.4053	0.3732	0.3327	0.3432	0.3504	0.3816	0.3919	0.3964
JL1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_C12_523572	47.4	124	JL-1	-666	M	mesothelioma	JL1	pleura	DSMZ	-666	cancer cell line	Y	pleural_effusion	fh_JL1_PLEURA-Tumor	rnaseq	5.5	26.77	56	0.3777	0.3895	0.3915	0.3584	0.3422	0.3399	0.3638	0.3928	0.3797	0.3842
SNB75	-666	38.5	117	SNB_75	-666	-666	glioma	SNB75	CNS	-666	-666	cancer cell line	-666	-666	fh_SNB75_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	7.2	24.18	56	0.3739	0.3881	0.4147	0.3599	0.3300	0.3473	0.3541	0.3901	0.3897	0.4065
NB1	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_B04_474582	42.7	177	-666	-666	M	neuroblastoma	NB1	autonomic ganglia	HSRRB	-666	cancer cell line	-666	-666	fh_NB1_AUTONOMIC_GANGLIA-Tumor	rnaseq	6.5	21.76	55	0.3624	0.3814	0.4104	0.3581	0.2921	0.3421	0.3625	0.3988	0.3876	0.4014
SNU520	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_F08_698928	31.1	116	SNU-520|NCI-SNU-520	-666	F	carcinoma	SNU520	stomach	KCLB	-666	cancer cell line	N	-666	fh_SNU520_STOMACH-Tumor	rnaseq	15.7	22.26	57	0.3790	0.3778	0.4162	0.3587	0.3134	0.3456	0.3494	0.3827	0.3931	0.4050
KYM1	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_E11_587582	22	88	KYM-1	-666	-666	rhabdomyosarcoma	KYM1	sofT tissue,striated muscle	HSRRB	-666	cancer cell line	N	-666	fh_KYM1_SOFT_TISSUE-Tumor	rnaseq	15.7	23.31	59	0.3736	0.3911	0.3973	0.3735	0.3223	0.3403	0.3547	0.3815	0.3879	0.3990
BICR31	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_B03_569512	29.4	87	BICR 31	-666	M	carcinoma,squamous cell	BICR31	upper aerodigestive tract,mouth	ECACC	-666	cancer cell line	N	-666	fh_BICR31_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	22.78	58	0.3786	0.3893	0.3962	0.3620	0.3572	0.3541	0.3554	0.3851	0.3825	0.3930
KYSE70	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_B05_296022	45.7	142	KYSE-70	-666	M	carcinoma,squamous cell	KYSE70	oesophagus	DSMZ	-666	cancer cell line	-666	-666	fh_KYSE70_OESOPHAGUS-Tumor	rnaseq	6.9	26.18	55	0.3776	0.3874	0.3948	0.3702	0.3414	0.3369	0.3657	0.3857	0.3879	0.3797
NCIH2081	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_D09_569554	23.6	82	NCI-H2081|H2081	-666	F	carcinoma,small cell	NCIH2081	lung	ATCC	CRL-5920	cancer cell line	Y	pleural_effusion	fh_NCIH2081_LUNG-Tumor	rnaseq	6.3	16.31	57	0.3657	0.3799	0.4044	0.3665	0.3012	0.3255	0.3557	0.3972	0.3967	0.4091
SW1353	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_H11_454752	27.5	87	SW 1353	-666	F	chondrosarcoma	SW1353	bone	ATCC	HTB-94	cancer cell line	-666	-666	fh_SW1353_BONE-Tumor	rnaseq	5.8	29.32	59	0.3589	0.3862	0.4142	0.3676	0.3349	0.3316	0.3602	0.3777	0.3894	0.3962
SNU719	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_C08_779780	31.7	99	SNU-719|NCI-SNU-719	-666	M	carcinoma	SNU719	stomach	KCLB	-666	cancer cell line	N	-666	fh_SNU719_STOMACH-Tumor	rnaseq	6.7	19.95	57	0.3714	0.3808	0.4047	0.3699	0.3482	0.3400	0.3472	0.3741	0.3936	0.3905
NUGC4	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_H06_419836	41.6	141	NUGC-4	-666	-666	adenocarcinoma,signet ring	NUGC4	stomach	RIKEN	-666	cancer cell line	Y	lymph_node	fh_NUGC4_STOMACH-Tumor	rnaseq	6.6	23.68	56	0.3788	0.3795	0.3999	0.3642	0.3358	0.3439	0.3510	0.3932	0.3874	0.3890
VMRCRCW	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_G12_419818	40.1	123	VMRC-RCW	-666	M	carcinoma	VMRCRCW	kidney	RIKEN	-666	cancer cell line	N	-666	fh_VMRCRCW_KIDNEY-Tumor	rnaseq	7.2	22.15	56	0.3688	0.3960	0.4053	0.3646	0.3578	0.3370	0.3515	0.3775	0.3933	0.3920
EFO21	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_A12_257620	33.3	94	EFO-21	-666	F	serous carcinoma	EFO21	ovary	DSMZ	-666	cancer cell line	-666	-666	fh_EFO21_OVARY-Tumor	rnaseq	5.9	25.2	58	0.3627	0.3909	0.4112	0.3570	0.3374	0.3199	0.3437	0.3805	0.3921	0.4011
SKMEL31	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_B09_454604	45.8	146	SK-MEL-31	-666	F	melanoma	SKMEL31	skin	ATCC	HTB-73	cancer cell line	-666	-666	fh_SKMEL31_SKIN-Tumor	rnaseq	6.6	25.21	55	0.3857	0.3867	0.4066	0.3632	0.3383	0.3509	0.3472	0.3811	0.3861	0.3772
HS675T	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_B04_454590	37.4	114	HS 675.T	-666	M	carcinoma,colorectal	HS675T	large intestine,colon	ATCC	CRL-7400	cancer cell line	-666	-666	fh_HS675T_LARGE_INTESTINE-Tumor	rnaseq	7.2	33.55	57	0.3659	0.3837	0.4034	0.3674	0.3604	0.3379	0.3545	0.3816	0.3869	0.3899
A172	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_H02_241020	47.4	152	-666	-666	M	glioma,astrocytoma,grade IV	A172	CNS	ATCC	CRL-1620	cancer cell line	-666	-666	fh_A172_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	4.9	28.01	56	0.3653	0.3885	0.4047	0.3571	0.3265	0.3321	0.3595	0.3811	0.3932	0.3956
NCIH446	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_B03_257626	33.7	125	NCI-H446|H446	-666	M	carcinoma,small cell	NCIH446	lung	ATCC	HTB-171	cancer cell line	Y	pleural_effusion	fh_NCIH446_LUNG-Tumor	rnaseq	6.4	24.37	56	0.3624	0.3949	0.4137	0.3630	0.2975	0.3231	0.3537	0.3840	0.3865	0.3932
CAL54	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_F07_523500	23.1	78	CAL-54	-666	M	carcinoma,renal	CAL54	kidney	DSMZ	-666	cancer cell line	-666	-666	fh_CAL54_KIDNEY-Tumor	rnaseq	15.7	23.8	59	0.3764	0.3893	0.3871	0.3499	0.3547	0.3203	0.3627	0.3837	0.3856	0.3738
CCFSTTG1	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_A06_454776	32.8	106	CCF-STTG1	-666	F	glioma,astrocytoma	CCFSTTG1	CNS	ATCC	CRL-1718	cancer cell line	-666	-666	fh_CCFSTTG1_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	24.38	57	0.3687	0.3711	0.4148	0.3643	0.3222	0.3361	0.3523	0.3849	0.3866	0.4037
OE19	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_C06_257656	41.1	107	-666	-666	M	carcinoma	OE19	oesophagus	ECACC	-666	cancer cell line	-666	-666	fh_OE19_OESOPHAGUS-Tumor	rnaseq	6.7	21.99	55	0.3690	0.3818	0.4019	0.3649	0.3342	0.3350	0.3423	0.3840	0.3831	0.4069
HS751T	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_B12_569522	22.7	68	HS 751.T	-666	-666	lymphoma,Hodgkins	HS751T	haematopoietic,lymphoid	ATCC	CRL-7488	cancer cell line	-666	-666	fh_HS751T_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.9	28.36	60	0.3590	0.3883	0.4067	0.3609	0.3418	0.3282	0.3574	0.3757	0.3864	0.3952
MON	-666	18.4	78	-666	-666	-666	-666	MON	-666	-666	-666	cancer cell line	-666	-666	fh_MON-Tumor	rnaseq	15.7	18.36	59	0.3629	0.3875	0.4102	0.3648	0.3200	0.3227	0.3510	0.3784	0.3892	0.3999
SNU1079	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_A10_587668	28.5	82	NCI-SNU-1079	-666	-666	carcinoma	SNU1079	biliary tract	KCLB	-666	cancer cell line	-666	-666	fh_SNU1079_BILIARY_TRACT-Tumor	rnaseq	15.7	28.39	58	0.3848	0.3798	0.3932	0.3574	0.3538	0.3305	0.3620	0.3855	0.3925	0.3834
NCIH2196	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_A10_257616	22.2	87	NCI-H2196|H2196	-666	M	carcinoma,small cell	NCIH2196	lung	ATCC	CRL-5932	cancer cell line	Y	bone_marrow	fh_NCIH2196_LUNG-Tumor	rnaseq	5.3	26.59	59	0.3644	0.3783	0.4062	0.3664	0.3224	0.3299	0.3594	0.3845	0.3826	0.4027
T173	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_H04_436446	21.2	69	T1-73	-666	-666	osteosarcoma	T173	bone	ATCC	CRL-7943	cancer cell line	-666	-666	fh_T173_BONE-Tumor	rnaseq	6.1	39.05	61	0.3566	0.3889	0.4067	0.3604	0.3517	0.3212	0.3535	0.3751	0.3827	0.3977
TE5	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_D08_296076	20.4	65	TE-5	-666	-666	carcinoma,squamous cell	TE5	oesophagus	RIKEN	-666	cancer cell line	-666	-666	fh_TE5_OESOPHAGUS-Tumor	rnaseq	15.7	25.81	58	0.3652	0.3900	0.3960	0.3680	0.3401	0.3414	0.3516	0.3777	0.3874	0.3890
DU4475	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_F10_436454	28.9	99	-666	-666	F	carcinoma,ductal	DU4475	breast	ATCC	HTB-123	cancer cell line	-666	-666	fh_DU4475_BREAST-Tumor	rnaseq	7.2	18.9	56	0.3609	0.3787	0.3971	0.3665	0.3017	0.3438	0.3794	0.3935	0.3814	0.3976
NCIH2228	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_C10_241108	28.1	91	NCI-H2228|H2228	-666	F	adenocarcinoma,NSCLC	NCIH2228	lung	ATCC	CRL-5935	cancer cell line	-666	-666	fh_NCIH2228_LUNG-Tumor	rnaseq	5.7	21.95	58	0.3789	0.3886	0.4076	0.3591	0.3403	0.3367	0.3521	0.3793	0.3816	0.3925
SNU1076	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_A02_587604	29.3	81	NCI-SNU-1076	-666	M	carcinoma,squamous cell	SNU1076	upper aerodigestive tract	KCLB	-666	cancer cell line	-666	-666	fh_SNU1076_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	7.2	22.46	57	0.3697	0.3746	0.3927	0.3493	0.3444	0.3515	0.3263	0.3854	0.3893	0.3927
D283MED	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_E10_383698	39.8	156	D283 MED	-666	M	PNET,medulloblastoma	D283MED	CNS,cerebellum	ATCC	HTB-185	cancer cell line	Y	ascites,peritoneum	fh_D283MED_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	5.9	21.8	56	0.3597	0.3772	0.4021	0.3787	0.2943	0.3288	0.3572	0.3813	0.3889	0.3997
HUTU80	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_G09_454730	32.5	138	HUTU 80	Identical lines: HuTu 80 and AZ-521 share high SNP identity. Really is HuTu 82	-666	carcinoma	HUTU80	small intestine,duodenum	ATCC	HTB-40	cancer cell line	-666	-666	fh_HUTU80_SMALL_INTESTINE-Tumor	rnaseq	7.2	22.83	56	0.3707	0.3851	0.4003	0.3632	0.3142	0.3314	0.3643	0.3789	0.3790	0.3949
RH18	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_H03_474762	25	90	RH-18	-666	-666	rhabdomyosarcoma,alveolar	RH18	sofT tissue	DSMZ	-666	cancer cell line	-666	-666	fh_RH18_SOFT_TISSUE-Tumor	rnaseq	6.9	33.33	59	0.3662	0.3939	0.4025	0.3626	0.3569	0.3343	0.3442	0.3764	0.3805	0.3957
SKMEL24	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_C11_240918	32.8	95	SK-MEL-24	-666	M	melanoma	SKMEL24	skin	ATCC	HTB-71	cancer cell line	-666	-666	fh_SKMEL24_SKIN-Tumor	rnaseq	6.9	26.86	57	0.3842	0.3838	0.4046	0.3523	0.3384	0.3385	0.3394	0.3805	0.3771	0.3805
SNU387	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_G10_383606	31.5	87	SNU-387|NCI-SNU-387	-666	F	carcinoma,hepatocellular	SNU387	liver	ATCC	CRL-2237	cancer cell line	-666	-666	fh_SNU387_LIVER-Tumor	rnaseq	15.7	21.12	58	0.3610	0.3824	0.4044	0.3530	0.3125	0.3226	0.3525	0.3823	0.3884	0.3979
BT483	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_A08_474686	23.4	75	BT-483	-666	F	carcinoma,ductal	BT483	breast	ATCC	HTB-121	cancer cell line	-666	-666	fh_BT483_BREAST-Tumor	rnaseq	6.3	23.62	58	0.3727	0.3726	0.3839	0.3465	0.3383	0.3408	0.3559	0.3760	0.3796	0.4035
KCL22	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_D07_474672	52.4	192	KCL-22	blast phase	F	CML,blast phase	KCL22	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_KCL22_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.9	22.23	54	0.3725	0.3658	0.3982	0.3521	0.2998	0.3403	0.3586	0.3864	0.3856	0.3923
NCIH2066	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_E03_436546	28.8	97	NCI-H2066|H2066	-666	F	carcinoma,small cell	NCIH2066	lung	ATCC	CRL-5917	cancer cell line	-666	-666	fh_NCIH2066_LUNG-Tumor	rnaseq	7.2	15.52	57	0.3619	0.3863	0.4167	0.3741	0.2961	0.3294	0.3436	0.3819	0.3839	0.4028
HS940T	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_D03_436524	27.8	77	HS 940.T	-666	M	melanoma	HS940T	skin	ATCC	CRL-7691	cancer cell line	-666	-666	fh_HS940T_SKIN-Tumor	rnaseq	6.9	27.64	59	0.3602	0.3893	0.4022	0.3602	0.3551	0.3313	0.3601	0.3765	0.3848	0.3922
GSS	BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_G03_698786	33.2	118	-666	-666	-666	adenocarcinoma	GSS	stomach	RIKEN	-666	cancer cell line	-666	-666	fh_GSS_STOMACH-Tumor	rnaseq	5.6	19.84	57	0.3643	0.3848	0.4076	0.3747	0.3198	0.3212	0.3458	0.3771	0.3907	0.4131
HCC1143	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_E02_383668	20.3	69	-666	-666	F	carcinoma,ductal,primary	HCC1143	breast	ATCC	CRL-2321	cancer cell line	-666	-666	fh_HCC1143_BREAST-Tumor	rnaseq	15.7	22.75	59	0.3600	0.3838	0.4046	0.3599	0.3153	0.3343	0.3592	0.3779	0.3983	0.3893
BCPAP	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_G05_474666	36.8	113	-666	-666	F	carcinoma,papillary	BCPAP	thyroid	DSMZ	-666	cancer cell line	-666	-666	fh_BCPAP_THYROID-Tumor	rnaseq	5.9	29.58	57	0.3721	0.3929	0.3820	0.3439	0.3696	0.3384	0.3423	0.3886	0.3795	0.3688
KMBC2	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_C12_419720	30	110	KMBC-2	-666	-666	carcinoma	KMBC2	urinary tract,bladder	HSRRB	-666	cancer cell line	N	-666	fh_KMBC2_URINARY_TRACT-Tumor	rnaseq	4.6	27.06	58	0.3651	0.3865	0.3981	0.3590	0.3405	0.3534	0.3387	0.3746	0.3860	0.3902
NCIH2029	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_E05_436558	32.4	118	NCI-H2029|H2029	-666	F	carcinoma,small cell	NCIH2029	lung	ATCC	CRL-5913	cancer cell line	Y	lymph_node	fh_NCIH2029_LUNG-Tumor	rnaseq	7.2	21.73	57	0.3641	0.3759	0.3992	0.3589	0.3098	0.3380	0.3479	0.3849	0.3863	0.4018
SBC5	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_B03_240878	27.8	107	SBC-5	-666	-666	carcinoma,small cell	SBC5	lung	HSRRB	-666	cancer cell line	-666	-666	fh_SBC5_LUNG-Tumor	rnaseq	6.7	19.37	56	0.3689	0.3829	0.3952	0.3659	0.3360	0.3235	0.3498	0.3932	0.3809	0.3891
ASPC1	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_E02_240948	47.1	132	ASPC-1	-666	F	carcinoma,ductal	ASPC1	pancreas	ATCC	CRL-1682	cancer cell line	Y	ascites	fh_ASPC1_PANCREAS-Tumor	rnaseq	5.4	33.54	56	0.3673	0.3766	0.4102	0.3570	0.3701	0.3386	0.3338	0.3753	0.3866	0.3827
MDAMB175VII	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_G03_436510	32.2	101	MDA-MB-175-VII	-666	F	carcinoma,ductal	MDAMB175VII	breast	ATCC	HTB-25	cancer cell line	Y	pleural_effusion	fh_MDAMB175VII_BREAST-Tumor	rnaseq	7.2	30.1	58	0.3699	0.3723	0.3890	0.3532	0.3505	0.3511	0.3551	0.3780	0.3777	0.3916
HS600T	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_F05_454694	26.7	76	HS 600.T	-666	-666	melanoma	HS600T	skin	ATCC	CRL-7360	cancer cell line	-666	-666	fh_HS600T_SKIN-Tumor	rnaseq	7.2	28.31	59	0.3622	0.3882	0.3968	0.3584	0.3534	0.3269	0.3538	0.3777	0.3833	0.3906
UACC812	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_C01_523502	50.3	160	UACC-812	-666	F	carcinoma,ductal	UACC812	breast	ATCC	CRL-1897	cancer cell line	-666	-666	fh_UACC812_BREAST-Tumor	rnaseq	7.2	34.02	55	0.3701	0.3731	0.3805	0.3524	0.3321	0.3340	0.3509	0.3690	0.3818	0.3943
TE617T	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_D09_454656	23.9	101	TE 617.T	-666	F	rhabdomyosarcoma	TE617T	sofT tissue	ATCC	CRL-7774	cancer cell line	-666	-666	fh_TE617T_SOFT_TISSUE-Tumor	rnaseq	15.7	23.28	58	0.3620	0.3799	0.3981	0.3659	0.3161	0.3215	0.3492	0.3774	0.3765	0.3975
HS834T	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_B10_523628	23.4	68	Hs 834.T	-666	F	melanoma	HS834T	skin	ATCC	CRL-7568	cancer cell line	Y	lymph_node,neck	fh_HS834T_SKIN-Tumor	rnaseq	7.2	32.61	60	0.3596	0.3826	0.3967	0.3632	0.3502	0.3285	0.3577	0.3772	0.3788	0.3890
U343	-666	46.6	147	-666	-666	-666	glioblastoma	U343	CNS	-666	-666	cancer cell line	-666	-666	fh_U343_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	5.7	29.07	56	0.3726	0.3868	0.3948	0.3475	0.3532	0.3309	0.3537	0.3769	0.3816	0.3898
DM3	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_C06_523488	32.5	97	DM-3	-666	M	mesothelioma	DM3	pleura	DSMZ	-666	cancer cell line	Y	pleural_effusion	fh_DM3_PLEURA-Tumor	rnaseq	15.7	31.26	57	0.3621	0.3816	0.4001	0.3486	0.3635	0.3251	0.3479	0.3740	0.3828	0.3896
LXF289	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_G02_523642	29.5	82	LXF-289	-666	M	carcinoma	LXF289	lung	DSMZ	-666	cancer cell line	-666	-666	fh_LXF289_LUNG-Tumor	rnaseq	6.7	23.52	58	0.3641	0.3793	0.3935	0.3566	0.3422	0.3309	0.3516	0.3723	0.3754	0.3804
NCIH508	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_F12_436508	33.2	108	NCI-H508|H508	-666	M	adenocarcinoma,colorectal	NCIH508	large intestine,cecum	ATCC	CCL-253	cancer cell line	-666	-666	fh_NCIH508_LARGE_INTESTINE-Tumor	rnaseq	7.2	20.04	56	0.3630	0.3746	0.3898	0.3572	0.3493	0.3295	0.3384	0.3630	0.3853	0.3899
NCIH660	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_B02_454586	22	85	NCI-H660|H660	-666	M	carcinoma,extrapulmonarysmallcell,neuroendocrine	NCIH660	prostate	ATCC	CRL-5813	cancer cell line	Y	lymph_node	fh_NCIH660_PROSTATE-Tumor	rnaseq	4.7	22.81	59	0.3571	0.3575	0.3996	0.3467	0.3008	0.3304	0.3468	0.3805	0.3900	0.3995
HUH28	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_F01_419770	43.9	122	HUH-28	-666	-666	carcinoma	HUH28	biliary tract	HSRRB	-666	cancer cell line	-666	-666	fh_HUH28_BILIARY_TRACT-Tumor	rnaseq	7.2	27.53	56	0.3642	0.3811	0.3915	0.3470	0.3371	0.3355	0.3445	0.3769	0.3754	0.3879
CAOV4	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_B02_419878	30.5	96	CAOV-4	-666	F	carcinoma	CAOV4	ovary	ATCC	HTB-76	cancer cell line	Y	fallopian_tube	fh_CAOV4_OVARY-Tumor	rnaseq	7.2	20.94	57	0.3768	0.3792	0.3957	0.3511	0.3554	0.3204	0.3276	0.3741	0.3710	0.3915
KPMRTRY	-666	23	85	-666	-666	-666	-666	KPMRTRY	-666	-666	-666	cancer cell line	-666	-666	fh_KPMRTRY-Tumor	rnaseq	15.7	26.42	58	0.3634	0.3771	0.3903	0.3615	0.3110	0.3124	0.3516	0.3650	0.3848	0.3887
ZR751	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_C04_454614	50.1	195	ZR-75-1	Identical lines: ZR-75-1 and YMB-1 share high SNP identity	F	carcinoma,ductal	ZR751	breast	ATCC	CRL-1500	cancer cell line	Y	ascites	fh_ZR751_BREAST-Tumor	rnaseq	7.2	19.97	54	0.3575	0.3731	0.3963	0.3558	0.3170	0.3247	0.3491	0.3653	0.3923	0.4151
HS274T	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_B05_474706	20.7	63	HS 274.T	-666	F	carcinoma	HS274T	breast	ATCC	CRL-7222	cancer cell line	-666	-666	fh_HS274T_BREAST-Tumor	rnaseq	7.2	28.82	60	0.3508	0.3791	0.3952	0.3578	0.3423	0.3222	0.3552	0.3686	0.3736	0.3859
COLO684	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_B11_779720	34	122	COLO-684	Identical lines: COLO-704 and COLO 684 are identical lines. The definitive tissue of origin cannot be ascertained	F	carcinoma	COLO684	uterus,endometrium	ECACC	-666	cancer cell line	-666	-666	fh_COLO684_ENDOMETRIUM-Tumor	rnaseq	6.3	16.72	57	0.3545	0.3645	0.3914	0.3577	0.2923	0.3251	0.3487	0.3830	0.3845	0.4032
MOLM16	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_H04_474738	32.2	134	MOLM-16	-666	F	leukemia,AML	MOLM16	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_MOLM16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.6	17.77	57	0.3701	0.3760	0.3913	0.3581	0.2941	0.3283	0.3477	0.3753	0.3850	0.3829
SCC9	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_E11_383702	16.2	49	SCC-9	-666	M	carcinoma,squamous cell	SCC9	upper aerodigestive tract,tongue	ATCC	CRL-1629	cancer cell line	-666	-666	fh_SCC9_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	33.4	62	0.3599	0.3758	0.3947	0.3496	0.3315	0.3348	0.3464	0.3796	0.3772	0.3760
U251MG	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_C08_296052	34	110	U-251MG|U251	Identical lines: SNB-19 and U-251 MG share high SNP identity	M	glioma,astrocytoma	U251MG	CNS	HSRRB	-666	cancer cell line	N	-666	fh_U251MG_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	7.2	21.9	57	0.3615	0.3743	0.3978	0.3568	0.3408	0.3096	0.3487	0.3659	0.3727	0.3854
SKNMC	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_C04_383648	57.9	189	SK-N-MC	-666	F	sarcoma,Ewings,PNET,neuroepithelioma	SKNMC	bone,brain	ATCC	HTB-10	cancer cell line	Y	supraorbital_area	fh_SKNMC_BONE-Tumor	rnaseq	5.9	22.37	54	0.3494	0.3803	0.3978	0.3683	0.2600	0.3158	0.3355	0.3716	0.3819	0.3939
A4FUK	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_E09_419778	23	105	A4-FUK	-666	F	lymphoma,diffuse large B cell	A4FUK	haematopoietic,lymphoid,skin	HSRRB	-666	cancer cell line	-666	-666	fh_A4FUK_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	17.07	58	0.3586	0.3558	0.3829	0.3609	0.2973	0.3351	0.3420	0.3760	0.3805	0.3917
COLO792	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_B07_569472	42.9	118	COLO-792	-666	M	melanoma	COLO792	skin	ECACC	-666	cancer cell line	-666	-666	fh_COLO792_SKIN-Tumor	rnaseq	6.3	19.23	56	0.3690	0.3842	0.3821	0.3455	0.3198	0.3481	0.3405	0.3803	0.3770	0.3615
L428	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_E07_474598	46.1	163	L-428	-666	F	lymphoma,Hodgkins	L428	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_L428_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.9	20.98	55	0.3650	0.3690	0.3925	0.3508	0.2753	0.3552	0.3386	0.3891	0.3789	0.3802
SNU489	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_C09_779744	32.3	98	SNU-489|NCI-SNU-489	-666	M	glioma,astrocytoma,grade IV	SNU489	CNS	KCLB	-666	cancer cell line	N	-666	fh_SNU489_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	7.2	23.69	58	0.3668	0.3698	0.3906	0.3556	0.3485	0.3282	0.3494	0.3737	0.3722	0.3839
DKMG	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_H11_569412	19	71	DK-MG	-666	F	glioma,astrocytoma,grade IV	DKMG	CNS	DSMZ	-666	cancer cell line	-666	-666	fh_DKMG_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.6	25.29	60	0.3553	0.3857	0.3996	0.3544	0.3291	0.3169	0.3588	0.3645	0.3694	0.3820
NCIH1436	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_E04_569528	36.4	122	NCI-H1436	-666	M	carcinoma,classic small cell lung cancer	NCIH1436	lung	ATCC	CRL-5871	cancer cell line	Y	lymph_node	fh_NCIH1436_LUNG-Tumor	rnaseq	6.5	20.74	56	0.3541	0.3643	0.3979	0.3586	0.2785	0.3175	0.3413	0.3820	0.3805	0.3998
TTOESOPHAGUS	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_H06_454716	40.1	131	T.T	-666	M	squamous_cell_carcinoma	TTOESOPHAGUS	oesophagus	HSRBB	JCRB0262	cancer cell line	Y	mandible	fh_TT_OESOPHAGUS-Tumor	rnaseq	6.7	20.67	56	0.3546	0.3869	0.3907	0.3691	0.3479	0.3270	0.3398	0.3702	0.3855	0.3737
RVH421	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_A11_436612	34.8	102	RVH-421	-666	M	melanoma	RVH421	skin	DSMZ	-666	cancer cell line	-666	-666	fh_RVH421_SKIN-Tumor	rnaseq	6	18.12	56	0.3745	0.3769	0.3934	0.3431	0.3477	0.3331	0.3411	0.3696	0.3669	0.3666
BCP1	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_A12_383780	30.4	137	BCP-1	B_cell_lymphoma_unspecified, body_cavity_based	M	lymphoma,B cell	BCP1	haematopoietic,B lymphoblast	ATCC	CRL-2294	cancer cell line	-666	-666	fh_BCP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	16.2	56	0.3574	0.3598	0.3921	0.3678	0.2934	0.3324	0.3355	0.3689	0.3810	0.3907
DEL	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_C01_474756	29.1	124	-666	-666	M	lymphoid neoplasm	DEL	haematopoietic,lymphoid,skin	DSMZ	-666	cancer cell line	-666	-666	fh_DEL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.9	17.13	57	0.3601	0.3749	0.4062	0.3551	0.3068	0.3408	0.3428	0.3730	0.3772	0.3815
RCC10RGB	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_B06_698756	38.9	92	RCC10RGB	-666	-666	myeloma,renal cell	RCC10RGB	kidney	RIKEN	-666	cancer cell line	-666	-666	fh_RCC10RGB_KIDNEY-Tumor	rnaseq	6.4	22.97	57	0.3571	0.3758	0.3764	0.3397	0.3408	0.3287	0.3450	0.3750	0.3672	0.3560
KU812	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_B01_474602	61.4	220	-666	-666	M	CML	KU812	haematopoietic,lymphoid,basophil	ATCC	CRL-2099	cancer cell line	-666	-666	fh_KU812_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.8	24.6	54	0.3633	0.3734	0.3890	0.3572	0.3020	0.3304	0.3550	0.3736	0.3759	0.3802
OVKATE	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_F05_296118	39.5	96	-666	-666	F	carcinoma	OVKATE	ovary	HSRRB	-666	cancer cell line	N	-666	fh_OVKATE_OVARY-Tumor	rnaseq	6.9	24.9	56	0.3607	0.3721	0.3908	0.3455	0.3497	0.3346	0.3380	0.3689	0.3773	0.3937
HMEL	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_A04_767910	16.3	46	-666	-666	-666	immortalized_epithelial	HMEL	breast	-666	-666	immortalized_epithelial	-666	-666	fh_HMEL_BREAST-Tumor	rnaseq	15.7	30.3	62	0.3627	0.3741	0.3903	0.3537	0.3327	0.3220	0.3399	0.3734	0.3769	0.3574
MFE280	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_E10_241156	34.5	114	MFE-280	-666	F	carcinoma	MFE280	endometrium,uterus	DSMZ	-666	cancer cell line	-666	-666	fh_MFE280_ENDOMETRIUM-Tumor	rnaseq	6.3	19.44	57	0.3562	0.3796	0.3945	0.3517	0.2969	0.3169	0.3386	0.3818	0.3713	0.4089
TO175T	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_D01_454634	20.2	65	TO 175.T	-666	M	lymphoma,Hodgkins	TO175T	haematopoietic,lymphoid	ATCC	CRL-7779	cancer cell line	Y	skin	fh_TO175T_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.3	32.83	61	0.3479	0.3740	0.4017	0.3499	0.3371	0.3208	0.3468	0.3662	0.3764	0.3837
OVISE	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_A03_295994	29.9	96	-666	-666	F	carcinoma,clearcell	OVISE	ovary	HSRRB	-666	cancer cell line	N	-666	fh_OVISE_OVARY-Tumor	rnaseq	6.3	25.6	58	0.3630	0.3717	0.3888	0.3570	0.3367	0.3209	0.3305	0.3630	0.3855	0.3850
PANC0213	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_C10_383608	24.7	64	PANC 02.13	-666	F	carcinoma	PANC0213	pancreas	ATCC	CRL-2554	cancer cell line	-666	-666	fh_PANC0213_PANCREAS-Tumor	rnaseq	5.9	24.04	59	0.3515	0.3802	0.3790	0.3381	0.3267	0.3385	0.3398	0.3786	0.3781	0.3814
HH	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_C05_383644	38	134	-666	-666	M	lymphoma,cutaneous,T cell	HH	haematopoietic,lymphoid,T lymphocyte	ATCC	CRL-2105	cancer cell line	-666	-666	fh_HH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.4	21.84	56	0.3607	0.3568	0.3923	0.3468	0.2630	0.3370	0.3370	0.3785	0.3780	0.3813
KD	-666	20.6	78	KD	-666	-666	fibroblast,lip	KD	oral	JCRB	JCRB9103	cancer cell line	-666	-666	fh_KD-Tumor	rnaseq	15.7	24.05	58	0.3644	0.3722	0.3859	0.3621	0.3127	0.3162	0.3498	0.3720	0.3788	0.3779
MDAMB134VI	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_D08_523486	42.9	193	MDA-MB-134-VI	-666	F	carcinoma,ductal	MDAMB134VI	breast	ATCC	HTB-23	cancer cell line	Y	pleural_effusion	fh_MDAMB134VI_BREAST-Tumor	rnaseq	6	29	55	0.3506	0.3657	0.3891	0.3283	0.3276	0.3375	0.3422	0.3650	0.3797	0.3920
HUT78	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_A06_436588	42.8	160	HUT 78	-666	M	mycosis fungoides-Sezary syndrome	HUT78	haematopoietic,lymphoid,cutaneous,T lymphocyte	ATCC	TIB-161	cancer cell line	-666	-666	fh_HUT78_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.2	20.3	55	0.3560	0.3496	0.3916	0.3487	0.2627	0.3500	0.3441	0.3757	0.3753	0.3814
NCIH2171	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_D03_240926	42.6	130	NCI-H2171|H2171|H-2171	-666	M	carcinoma,small cell	NCIH2171	lung	ATCC	CRL-5929	cancer cell line	Y	pleural_effusion	fh_NCIH2171_LUNG-Tumor	rnaseq	5.4	21.53	55	0.3479	0.3740	0.3886	0.3526	0.2722	0.3176	0.3468	0.3819	0.3763	0.3912
HS616T	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_F04_454684	26.3	77	HS 616.T	-666	M	lymphoma,Hodgkins	HS616T	haematopoietic,lymphoid	ATCC	CRL-7378	cancer cell line	-666	-666	fh_HS616T_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	28.32	59	0.3500	0.3771	0.3887	0.3500	0.3508	0.3192	0.3463	0.3616	0.3757	0.3826
ECC12	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_G10_698876	27.5	90	ECC12	-666	-666	carcinoma,small cell	ECC12	stomach	RIKEN	-666	cancer cell line	-666	-666	fh_ECC12_STOMACH-Tumor	rnaseq	15.7	18	57	0.3526	0.3778	0.3888	0.3609	0.2927	0.3164	0.3316	0.3722	0.3768	0.3920
KIJK	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_E08_419780	33.9	127	KI-JK	-666	M	lymphoma,anaplastic large cell	KIJK	haematopoietic,lymphoid	HSRRB	-666	cancer cell line	N	-666	fh_KIJK_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	14.22	56	0.3614	0.3775	0.3923	0.3413	0.2685	0.3244	0.3358	0.3684	0.3767	0.3820
OUMS23	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_C09_436520	26.2	94	OUMS-23	-666	-666	carcinoma	OUMS23	large intestine,colon	HSRRB	-666	cancer cell line	N	-666	fh_OUMS23_LARGE_INTESTINE-Tumor	rnaseq	7.2	22.64	57	0.3449	0.3751	0.3839	0.3569	0.3250	0.3244	0.3411	0.3651	0.3690	0.3953
BHY	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_A08_698824	18.4	51	BHY	-666	M	carcinoma,squamous cell	BHY	upper aerodigestive tract	DSMZ	-666	cancer cell line	-666	-666	fh_BHY_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	6.4	34.92	61	0.3530	0.3762	0.3810	0.3409	0.3170	0.3420	0.3372	0.3740	0.3774	0.3721
KNS81	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_B10_419862	38.3	118	KNS-81	-666	M	glioma,astrocytoma,grade IV	KNS81	CNS	HSRRB	-666	cancer cell line	N	-666	fh_KNS81_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.6	31.44	57	0.3531	0.3703	0.3973	0.3481	0.3227	0.3143	0.3457	0.3661	0.3692	0.3841
SU8686	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_B08_698806	23.3	67	SU.86.86	-666	F	carcinoma,ductal	SU8686	pancreas	ATCC	CRL-1837	cancer cell line	Y	liver	fh_SU8686_PANCREAS-Tumor	rnaseq	6.9	22.21	58	0.3650	0.3662	0.3861	0.3504	0.3526	0.3262	0.3325	0.3731	0.3647	0.3666
CORL88	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_E11_569432	22.7	89	COR-L88	-666	M	carcinoma,small cell	CORL88	lung	ECACC	-666	cancer cell line	-666	-666	fh_CORL88_LUNG-Tumor	rnaseq	5.7	22.12	59	0.3469	0.3573	0.3915	0.3501	0.2968	0.3141	0.3383	0.3737	0.3851	0.3956
HS706T	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_H08_436438	25.4	78	HS 706.T	-666	F	sarcoma,giant cell	HS706T	bone	ATCC	CRL-7447	cancer cell line	-666	-666	fh_HS706T_BONE-Tumor	rnaseq	15.7	22.05	59	0.3585	0.3636	0.3882	0.3430	0.3252	0.3196	0.3513	0.3644	0.3778	0.3804
HCC1187	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_G09_383594	32.3	105	-666	-666	F	carcinoma,ductal,primary	HCC1187	breast	ATCC	CRL-2322	cancer cell line	-666	-666	fh_HCC1187_BREAST-Tumor	rnaseq	6.9	23.03	57	0.3491	0.3860	0.3827	0.3346	0.3113	0.3351	0.3370	0.3712	0.3844	0.3788
TE159T	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_F06_454696	20.3	63	TE 159.T	-666	M	rhabdomyosarcoma	TE159T	-666	ATCC	CRL-7752	cancer cell line	-666	-666	fh_TE159T_SOFT_TISSUE-Tumor	rnaseq	7.2	26.96	60	0.3447	0.3749	0.3928	0.3472	0.3471	0.3207	0.3465	0.3619	0.3739	0.3788
ECGI10	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_D12_698846	22.4	65	EC-GI-10	-666	-666	carcinoma	ECGI10	oesophagus	RIKEN	-666	cancer cell line	-666	-666	fh_ECGI10_OESOPHAGUS-Tumor	rnaseq	6.4	16.95	58	0.3502	0.3682	0.3785	0.3473	0.3437	0.3111	0.3436	0.3717	0.3828	0.3632
HS739T	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_E11_436480	25.3	68	HS 739.T	-666	F	carcinoma	HS739T	breast	ATCC	CRL-7477	cancer cell line	-666	-666	fh_HS739T_BREAST-Tumor	rnaseq	7.2	29.45	60	0.3579	0.3836	0.3885	0.3393	0.3514	0.3181	0.3457	0.3651	0.3735	0.3797
CORL311	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_C12_569462	27.6	98	COR-L311	-666	M	carcinoma,small cell	CORL311	lung	ECACC	-666	cancer cell line	N	-666	fh_CORL311_LUNG-Tumor	rnaseq	4.8	24.13	58	0.3528	0.3629	0.3880	0.3463	0.2902	0.3033	0.3395	0.3704	0.3719	0.3857
SNU349	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_A01_779644	33.9	98	SNU-349|NCI-SNU-349	-666	M	clear cell renal cell carcinoma	SNU349	kidney	KCLB	-666	cancer cell line	N	-666	fh_SNU349_KIDNEY-Tumor	rnaseq	6.7	35.75	58	0.3675	0.3835	0.3884	0.3436	0.3368	0.3228	0.3348	0.3660	0.3709	0.3782
NCIH889	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_C05_240906	31.4	98	NCI-H889|H889	-666	F	carcinoma,small cell	NCIH889	lung	ATCC	CRL-5817	cancer cell line	Y	lymph_node	fh_NCIH889_LUNG-Tumor	rnaseq	6.4	13.19	56	0.3491	0.3633	0.3896	0.3478	0.2853	0.3040	0.3425	0.3713	0.3705	0.3889
CADOES1	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_D08_474656	40.4	171	CADO-ES1	-666	F	sarcoma,Ewings,PNET	CADOES1	bone	DSMZ	-666	cancer cell line	Y	pleura	fh_CADOES1_BONE-Tumor	rnaseq	5.5	30.87	56	0.3515	0.3716	0.3837	0.3427	0.3032	0.3148	0.3533	0.3904	0.3671	0.3806
K562	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_B12_257644	45.8	175	K-562	-666	F	CML,blast phase	K562	haematopoietic,lymphoid,undifferentiated granulocyte	ATCC	CCL-243	cancer cell line	Y	pleural_effusion	fh_K562_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.7	17.25	54	0.3327	0.3737	0.3825	0.3501	0.2804	0.3108	0.3481	0.3603	0.3775	0.3807
HS698T	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_E10_523570	19.1	57	HS 698.T	-666	M	carcinoma	HS698T	large intestine,colon	ATCC	CRL-7435	cancer cell line	Y	connective_tissue,trunk	fh_HS698T_LARGE_INTESTINE-Tumor	rnaseq	15.7	27.89	60	0.3451	0.3697	0.3862	0.3447	0.3287	0.3178	0.3459	0.3613	0.3681	0.3828
TM87	-666	20.1	80	-666	-666	-666	-666	TM87	-666	-666	-666	cancer cell line	-666	-666	fh_TM-87-Tumor	rnaseq	15.7	18.54	58	0.3511	0.3768	0.3880	0.3562	0.3235	0.3158	0.3327	0.3626	0.3738	0.3782
WM115	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_B12_241088	28.6	99	WM-115	Metastatic pair: WM-115 and WM-266-4 are from the same patient	F	melanoma	WM115	skin	ATCC	CRL-1675	cancer cell line	-666	-666	fh_WM115_SKIN-Tumor	rnaseq	6	29.95	58	0.3619	0.3684	0.3886	0.3461	0.3193	0.3202	0.3302	0.3580	0.3677	0.3625
HS578T	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_C01_383628	23.6	60	HS 578T	-666	F	carcinoma,ductal	HS578T	breast	ATCC	HTB-126	cancer cell line	-666	-666	fh_HS578T_BREAST-Tumor	rnaseq	6.7	27.18	60	0.3475	0.3756	0.3959	0.3409	0.3241	0.3243	0.3466	0.3619	0.3667	0.3702
SKNFI	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_G02_383638	28.8	120	SK-N-FI|SK-N-F1	-666	M	neuroblastoma,embryonal	SKNFI	autonomic ganglia	ATCC	CRL-2142	cancer cell line	Y	bone_marrow	fh_SKNFI_AUTONOMIC_GANGLIA-Tumor	rnaseq	5.4	23.64	57	0.3471	0.3678	0.3978	0.3428	0.3010	0.3089	0.3423	0.3695	0.3713	0.3768
NCIH1618	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_B03_454592	26.9	95	NCI-H1618|H1618	-666	F	carcinoma,small cell	NCIH1618	lung	ATCC	CRL-5879	cancer cell line	Y	bone_marrow	fh_NCIH1618_LUNG-Tumor	rnaseq	4.6	18.01	57	0.3523	0.3510	0.3858	0.3437	0.2904	0.3104	0.3415	0.3681	0.3687	0.3768
RL	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_A07_296002	58.3	226	-666	-666	M	lymphoma,B cell	RL	haematopoietic,B lymphoblast	ATCC	CRL-2261	cancer cell line	Y	ascites	fh_RL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.6	18.14	53	0.3530	0.3469	0.3806	0.3416	0.2483	0.3376	0.3275	0.3694	0.3797	0.3872
SKMM2	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_E08_523520	35.1	128	SK-MM-2	-666	M	myeloma,plasma cell	SKMM2	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.6	19.32	56	0.3592	0.3512	0.3764	0.3422	0.2893	0.3320	0.3323	0.3665	0.3852	0.3804
CORL279	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_B07_779750	20.1	75	COR-L279	-666	M	carcinoma,small cell lung	CORL279	lung	ECACC	-666	cancer cell line	-666	-666	fh_CORL279_LUNG-Tumor	rnaseq	4.8	29.94	59	0.3437	0.3670	0.3917	0.3449	0.2888	0.3126	0.3527	0.3810	0.3635	0.3738
KASUMI1	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_G04_569524	55.5	176	KASUMI-1	-666	M	leukemia,AML	KASUMI1	haematopoietic,lymphoid	ATCC	CRL-2724	cancer cell line	-666	-666	fh_KASUMI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.1	21.97	55	0.3513	0.3596	0.3844	0.3445	0.2836	0.3208	0.3245	0.3619	0.3745	0.3741
SKNO12	-666	51.1	182	-666	-666	-666	-666	SKNO12	-666	-666	-666	cancer cell line	-666	-666	fh_SKNO-1-2-Tumor	rnaseq	6.6	18.77	55	0.3513	0.3543	0.3868	0.3429	0.2684	0.3225	0.3358	0.3622	0.3778	0.3919
STM9101	-666	30.2	94	-666	-666	-666	-666	STM9101	-666	-666	-666	cancer cell line	-666	-666	fh_STM9101-Tumor	rnaseq	5.5	25.39	58	0.3526	0.3650	0.3824	0.3536	0.2909	0.3173	0.3394	0.3678	0.3665	0.3639
TTC642	-666	25.8	104	-666	-666	-666	-666	TTC642	-666	-666	-666	cancer cell line	-666	-666	fh_TTC642-Tumor	rnaseq	6.7	24.02	57	0.3420	0.3661	0.3812	0.3463	0.3240	0.2977	0.3457	0.3619	0.3739	0.3670
SLR21	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_D02_767966	36.2	99	-666	-666	-666	carcinoma	SLR21	kidney	-666	-666	cancer cell line	-666	-666	fh_SLR21_KIDNEY-Tumor	rnaseq	15.7	22.59	57	0.3550	0.3715	0.3753	0.3305	0.3324	0.3092	0.3409	0.3587	0.3762	0.3678
NCIH1092	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_D11_569548	32.3	118	NCI-H1092|H1092	-666	M	carcinoma,small cell	NCIH1092	lung	ATCC	CRL-5855	cancer cell line	Y	bone_marrow	fh_NCIH1092_LUNG-Tumor	rnaseq	5.5	16.47	56	0.3412	0.3574	0.3854	0.3455	0.2813	0.3087	0.3387	0.3689	0.3664	0.3909
SNU1066	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_A07_569568	28.1	90	NCI-SNU-1066	-666	M	carcinoma,squamous cell	SNU1066	upper aerodigestive tract	KCLB	-666	cancer cell line	-666	-666	fh_SNU1066_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	6.9	27.42	58	0.3507	0.3615	0.3774	0.3461	0.3285	0.3306	0.3197	0.3625	0.3788	0.3673
HS821T	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_B10_474642	20.2	63	HS 821.T	-666	F	sarcoma,giant cell	HS821T	bone	ATCC	CRL-7554	cancer cell line	-666	-666	fh_HS821T_BONE-Tumor	rnaseq	7.2	29.21	61	0.3519	0.3689	0.3816	0.3403	0.3343	0.3090	0.3431	0.3552	0.3688	0.3749
NCIH1184	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_A12_436618	30.2	105	NCI-H1184|H1184|H-1184	-666	M	carcinoma,small cell	NCIH1184	lung	ATCC	CRL-5858	cancer cell line	Y	lymph_node	fh_NCIH1184_LUNG-Tumor	rnaseq	6	18.31	57	0.3431	0.3557	0.3885	0.3501	0.2883	0.3040	0.3431	0.3660	0.3678	0.3881
HL60	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_F07_240982	52.5	164	HL-60	-666	F	leukemia,acute promyelocytic	HL60	haematopoietic,lymphoid	ATCC	CCL-240	cancer cell line	-666	-666	fh_HL60_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	14.92	54	0.3522	0.3390	0.3679	0.3363	0.2725	0.3206	0.3362	0.3645	0.3689	0.3907
RPMI8226	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_F11_296130	54.6	161	RPMI 8226	Identical lines: RPMI 8226, COLO 775 and COLO-677 share high SNP identity and are likely to be RPMI 8226	M	myeloma,plasma cell	RPMI8226	haematopoietic,B lymphocyte	ATCC	CCL-155	cancer cell line	-666	-666	fh_RPMI8226_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	13.08	53	0.3650	0.3571	0.3656	0.3395	0.2775	0.3326	0.3294	0.3725	0.3744	0.3779
KMS20	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_A07_587612	29.9	111	KMS-20	-666	F	myeloma,plasma cell	KMS20	haematopoietic,lymphoid	HSRRB	-666	cancer cell line	N	-666	fh_KMS20_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	14.52	57	0.3593	0.3650	0.3760	0.3383	0.2895	0.3371	0.3322	0.3711	0.3796	0.3642
SNU201	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_A06_587710	50.1	159	SNU-201|NCI-SNU-201	-666	M	glioma,astrocytoma,grade IV	SNU201	CNS	KCLB	-666	cancer cell line	N	-666	fh_SNU201_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	5.5	32.56	56	0.3550	0.3591	0.3819	0.3457	0.3283	0.3128	0.3391	0.3635	0.3637	0.3727
SALE	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_A11_767946	27.6	77	-666	-666	-666	immortalized_epithelial	SALE	lung	-666	-666	immortalized_epithelial	-666	-666	fh_SALE_LUNG-Tumor	rnaseq	5.5	23.76	58	0.3452	0.3687	0.3926	0.3393	0.3114	0.3185	0.3352	0.3591	0.3685	0.3557
CORL47	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_C08_569538	29.4	93	COR-L47	-666	M	carcinoma,small cell	CORL47	lung	ECACC	-666	cancer cell line	N	-666	fh_CORL47_LUNG-Tumor	rnaseq	5.9	13.09	56	0.3491	0.3464	0.3809	0.3430	0.2686	0.3105	0.3199	0.3766	0.3733	0.3831
MJ	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_H01_383610	41.5	162	-666	-666	M	mycosis fungoides-Sezary syndrome	MJ	haematopoietic,lymphoid,T lymphocyte	ATCC	CRL-8294	cancer cell line	-666	-666	fh_MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.4	23.34	55	0.3432	0.3505	0.3778	0.3325	0.2386	0.3374	0.3408	0.3756	0.3708	0.3738
NB4	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_E09_474724	38.4	148	-666	-666	F	leukemia,AML	NB4	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_NB4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	14.89	55	0.3508	0.3526	0.3707	0.3355	0.2504	0.3151	0.3370	0.3647	0.3702	0.3795
C8166	-666	38.6	143	-666	-666	-666	leukemia	C8166	haematopoietic,lymphoid	ECACC	-666	cancer cell line	-666	-666	fh_C8166-Tumor	rnaseq	6.7	17.85	56	0.3449	0.3574	0.3833	0.3410	0.2550	0.3163	0.3402	0.3711	0.3823	0.3583
COLO678	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_F03_523616	26.5	97	COLO-678	-666	M	carcinoma	COLO678	large intestine	DSMZ	-666	cancer cell line	-666	-666	fh_COLO678_LARGE_INTESTINE-Tumor	rnaseq	4.8	26.58	59	0.3499	0.3685	0.3765	0.3326	0.3242	0.3329	0.3374	0.3491	0.3635	0.3631
AML193	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_A10_436614	41.2	155	AML-193	-666	F	leukemia,acute monocytic	AML193	haematopoietic,lymphoid,monocyte	ATCC	CRL-9589	cancer cell line	-666	-666	fh_AML193_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.7	20.11	55	0.3472	0.3479	0.3648	0.3408	0.2725	0.3259	0.3386	0.3646	0.3624	0.3870
GOS3	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_F07_241174	36.6	140	GOS-3	-666	M	glioma,astrocytoma	GOS3	CNS	DSMZ	-666	cancer cell line	N	-666	fh_GOS3_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.1	28.12	57	0.3459	0.3564	0.3781	0.3421	0.3258	0.3144	0.3328	0.3573	0.3598	0.3688
HS606T	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_H08_296172	22.9	72	HS 606.T	-666	F	carcinoma	HS606T	breast	ATCC	-666	cancer cell line	N	-666	fh_HS606T_BREAST-Tumor	rnaseq	7.2	29.98	60	0.3449	0.3759	0.3777	0.3280	0.3460	0.3146	0.3437	0.3603	0.3688	0.3655
NPC	-666	30.8	125	NPC	-666	-666	terminally differentiated neuron	NPC	CNS	-666	-666	primary	N	-666	CMAP_NPC_1	rnaseq	6.4	21.69	57	0.3273	0.3631	0.3847	0.3418	0.2752	0.2985	0.3355	0.3446	0.3580	0.3798
HDLM2	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_H10_523618	43.4	139	HDLM-2	-666	M	lymphoma,Hodgkins	HDLM2	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_HDLM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	23.5	55	0.3576	0.3601	0.3718	0.3280	0.2730	0.3406	0.3375	0.3742	0.3597	0.3532
DMS153	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_A11_454762	22.9	104	DMS 153	-666	M	carcinoma,small cell	DMS153	lung	ATCC	CRL-2064	cancer cell line	Y	liver	fh_DMS153_LUNG-Tumor	rnaseq	4.5	31.97	58	0.3369	0.3540	0.3821	0.3481	0.2818	0.2989	0.3345	0.3516	0.3666	0.3697
KMS34	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_C01_419710	41.4	145	KMS-34	-666	F	myeloma,plasma cell	KMS34	haematopoietic,lymphoid	HSRRB	-666	cancer cell line	N	-666	fh_KMS34_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.9	18.06	55	0.3479	0.3476	0.3751	0.3420	0.2745	0.3306	0.3252	0.3621	0.3846	0.3641
BICR22	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_C12_698888	28.7	72	BICR 22	-666	M	carcinoma,squamous cell	BICR22	upper aerodigestive tract,mouth	ECACC	-666	cancer cell line	N	-666	fh_BICR22_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	19.23	58	0.3422	0.3644	0.3717	0.3384	0.3497	0.3143	0.3179	0.3624	0.3671	0.3601
TE441T	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_B03_474710	28.5	119	TE 441.T	-666	F	rhabdomyosarcoma	TE441T	sofT tissue	ATCC	CRL-7767	cancer cell line	-666	-666	fh_TE441T_SOFT_TISSUE-Tumor	rnaseq	5.3	23.39	58	0.3442	0.3770	0.3700	0.3324	0.2891	0.3100	0.3312	0.3615	0.3463	0.3715
IMR32	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_G02_587654	31.5	112	IMR-32	-666	M	neuroblastoma	IMR32	autonomic ganglia	ATCC	CCL-127	cancer cell line	-666	-666	fh_IMR32_AUTONOMIC_GANGLIA-Tumor	rnaseq	6.4	20.95	58	0.3333	0.3591	0.3843	0.3365	0.2674	0.2961	0.3316	0.3529	0.3649	0.3725
KE97	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_G11_419824	57.1	229	-666	Identical lines: KMS-18 and KE-97 share high SNP identity.	M	myeloma,plasma cell	KE97	haematopoietic,lymphoid,stomach	RIKEN	-666	cancer cell line	-666	-666	fh_KE97_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.7	20.14	53	0.3413	0.3502	0.3753	0.3388	0.2469	0.3327	0.3247	0.3606	0.3683	0.3713
SUPT11	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_D06_523620	37.2	158	SUP-T11	-666	M	lymphoma,peripheral T cell	SUPT11	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_SUPT11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5	22.39	56	0.3439	0.3357	0.3765	0.3426	0.2556	0.3217	0.3298	0.3622	0.3642	0.3620
MKN74	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_C03_419714	29.7	104	-666	-666	M	adenocarcinoma,tubular	MKN74	stomach	HSRRB	-666	cancer cell line	Y	liver	fh_MKN74_STOMACH-Tumor	rnaseq	7.2	17.28	57	0.3373	0.3706	0.3864	0.3434	0.3304	0.3094	0.3130	0.3428	0.3601	0.3717
NCIH929	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_A07_454770	62.9	201	NCI-H929|H929	-666	F	myeloma,plasma cell	NCIH929	haematopoietic,lymphoid,B lymphocyte	ATCC	CRL-9068	cancer cell line	-666	-666	fh_NCIH929_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.3	21.14	54	0.3431	0.3455	0.3708	0.3389	0.2881	0.3174	0.3194	0.3574	0.3738	0.3739
NCIH69	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_C02_454610	48.1	152	NCI-H69|H69	-666	M	carcinoma,small cell	NCIH69	lung	ATCC	HTB-119	cancer cell line	Y	pleural_effusion	fh_NCIH69_LUNG-Tumor	rnaseq	5.6	24.1	55	0.3363	0.3559	0.3827	0.3403	0.2727	0.3090	0.3263	0.3656	0.3625	0.3729
MINO	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_E12_523552	41.6	161	-666	-666	M	lymphoma,mantle cell	MINO	haematopoietic,lymphoid	ATCC	-666	cancer cell line	N	-666	fh_MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.8	19.35	56	0.3498	0.3401	0.3742	0.3357	0.2450	0.3268	0.3154	0.3632	0.3706	0.3656
NCIH2227	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_B03_436620	37.5	122	NCI-H2227|H2227	-666	M	carcinoma,small cell	NCIH2227	lung	ATCC	CRL-5934	cancer cell line	-666	-666	fh_NCIH2227_LUNG-Tumor	rnaseq	5.6	23.5	56	0.3316	0.3495	0.3819	0.3266	0.2979	0.2980	0.3355	0.3601	0.3636	0.3739
BL41	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_C02_698770	42.1	142	BL-41	-666	M	lymphoma,Burkitts	BL41	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	13.84	55	0.3528	0.3338	0.3725	0.3321	0.2269	0.3256	0.3160	0.3628	0.3648	0.3684
SUDHL1	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_C05_474628	39.4	162	SU-DHL-1	-666	M	lymphoma,anaplastic large cell	SUDHL1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_SUDHL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	4.9	17.35	56	0.3380	0.3581	0.3878	0.3447	0.2546	0.3004	0.3267	0.3548	0.3739	0.3676
CORL95	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_E12_569470	18.4	71	COR-L95	-666	M	carcinoma,small cell	CORL95	lung	ECACC	-666	cancer cell line	N	-666	fh_CORL95_LUNG-Tumor	rnaseq	5.3	14.79	59	0.3529	0.3499	0.3708	0.3329	0.2728	0.3138	0.3282	0.3661	0.3623	0.3679
SCLC21H	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_A01_474586	46.1	154	SCLC-21H	-666	M	carcinoma,small cell	SCLC21H	lung	DSMZ	-666	cancer cell line	-666	-666	fh_SCLC21H_LUNG-Tumor	rnaseq	6.7	19.76	55	0.3305	0.3617	0.3726	0.3352	0.2768	0.3114	0.3276	0.3724	0.3522	0.3754
NCIH1836	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_E05_454672	28.5	99	NCI-H1836|H1836	-666	M	carcinoma,small cell	NCIH1836	lung	ATCC	CRL-5898	cancer cell line	-666	-666	fh_NCIH1836_LUNG-Tumor	rnaseq	4.1	29.41	58	0.3482	0.3528	0.3721	0.3323	0.2860	0.3059	0.3240	0.3635	0.3625	0.3723
HS172T	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_B09_523490	39.6	129	HS 172.T	-666	M	carcinoma	HS172T	urinary tract,bladder	ATCC	CRL-7833	cancer cell line	-666	-666	fh_HS172T_URINARY_TRACT-Tumor	rnaseq	5	27.74	57	0.3198	0.3550	0.4010	0.3453	0.3335	0.3085	0.3189	0.3387	0.3629	0.3663
MONOMAC6	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_A07_523562	52	161	MONO-MAC-6	MONO-MAC-1 and MONO-MAC-6 were derived from the same patient	M	leukemia,AML	MONOMAC6	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_MONOMAC6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	16.27	53	0.3478	0.3505	0.3690	0.3305	0.2718	0.3126	0.3364	0.3603	0.3560	0.3680
U937	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_G07_454742	48.8	177	U-937	-666	M	lymphoma,diffuse large B cell	U937	haematopoietic,lymphoid,macrophage	ATCC	CRL-1593.2	cancer cell line	-666	-666	fh_U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	18.5	54	0.3380	0.3370	0.3589	0.3344	0.2718	0.3121	0.3302	0.3660	0.3625	0.3728
RCHACV	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_G12_474660	42.6	148	RCH-ACV	-666	F	leukaemia,acute lymphoblastic B cell	RCHACV	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_RCHACV_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	15.29	55	0.3521	0.3250	0.3577	0.3256	0.2438	0.3244	0.3272	0.3636	0.3619	0.3668
HS688AT	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_E06_454670	22	61	HS 688(A).T	-666	M	melanoma	HS688AT	skin	ATCC	CRL-7425	cancer cell line	-666	-666	fh_HS688AT_SKIN-Tumor	rnaseq	15.7	24.4	60	0.3405	0.3621	0.3762	0.3237	0.3415	0.3049	0.3305	0.3550	0.3627	0.3636
SIMA	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_F05_474682	39.6	146	-666	-666	M	neuroblastoma	SIMA	autonomic ganglia	DSMZ	-666	cancer cell line	-666	-666	fh_SIMA_AUTONOMIC_GANGLIA-Tumor	rnaseq	6.5	22.46	56	0.3363	0.3543	0.3730	0.3212	0.2817	0.2985	0.3295	0.3519	0.3599	0.3695
HEC108	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_E11_419774	22.8	73	HEC-108	-666	F	carcinoma	HEC108	endometrium	HSRRB	-666	cancer cell line	N	-666	fh_HEC108_ENDOMETRIUM-Tumor	rnaseq	7.2	23.5	59	0.3483	0.3571	0.3692	0.3324	0.3153	0.3001	0.3320	0.3523	0.3481	0.3554
REC1	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_F10_474668	54.1	185	REC-1	-666	M	lymphoma,mantle cell	REC1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_REC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.3	25.33	54	0.3459	0.3486	0.3611	0.3280	0.2494	0.3164	0.3265	0.3701	0.3654	0.3439
RS411	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_A07_241054	60	165	RS4;11	-666	F	leukemia,ALL,t(4;11) translocation	RS411	haematopoietic,lymphoid,bone marrow	ATCC	CRL-1873	cancer cell line	-666	-666	fh_RS411_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	16.06	53	0.3614	0.3225	0.3460	0.3118	0.2529	0.3445	0.3254	0.3634	0.3643	0.3649
KMM1	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_H11_419842	23.5	105	KMM-1	-666	M	myeloma,plasma cell	KMM1	haematopoietic,lymphoid	HSRRB	-666	cancer cell line	N	-666	fh_KMM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	11.47	57	0.3399	0.3615	0.3705	0.3390	0.2676	0.3208	0.3189	0.3553	0.3680	0.3566
RS5	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_B01_523464	34.9	79	RS-5	-666	M	mesothelioma	RS5	pleura	DSMZ	-666	cancer cell line	Y	pleural_effusion	fh_RS5_PLEURA-Tumor	rnaseq	7.2	27.97	58	0.3409	0.3634	0.3738	0.3309	0.3431	0.3042	0.3273	0.3459	0.3597	0.3625
SIGM5	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_G01_474646	47.3	171	SIG-M5	-666	M	leukemia,AML	SIGM5	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	16.75	54	0.3435	0.3348	0.3616	0.3366	0.2547	0.3056	0.3270	0.3571	0.3600	0.3660
MOLP8	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_H12_474618	34.5	98	MOLP-8	-666	M	myeloma,plasma cell	MOLP8	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	16.58	55	0.3369	0.3374	0.3621	0.3298	0.3021	0.3257	0.3260	0.3461	0.3679	0.3682
SNU466	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_B05_587708	31	91	SNU-466|NCI-SNU-466	-666	M	glioma,astrocytoma,grade IV	SNU466	CNS	KCLB	-666	cancer cell line	N	-666	fh_SNU466_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	6.3	23.24	58	0.3417	0.3545	0.3676	0.3274	0.3145	0.3134	0.3256	0.3485	0.3560	0.3557
KELLY	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_D09_296078	32.5	136	-666	-666	-666	neuroblastoma	KELLY	autonomic ganglia	DSMZ	-666	cancer cell line	N	-666	fh_KELLY_AUTONOMIC_GANGLIA-Tumor	rnaseq	6.6	17.34	57	0.3333	0.3508	0.3751	0.3326	0.2667	0.2896	0.3301	0.3512	0.3550	0.3697
ECC10	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_D08_698918	23.7	91	ECC10	-666	-666	carcinoma,small cell	ECC10	stomach	RIKEN	-666	cancer cell line	-666	-666	fh_ECC10_STOMACH-Tumor	rnaseq	4.3	30.66	60	0.3365	0.3604	0.3610	0.3304	0.2858	0.3053	0.3304	0.3598	0.3522	0.3614
KMS28BM	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_B08_419858	37.7	142	KMS-28BM	-666	F	myeloma,plasma cell	KMS28BM	haematopoietic,lymphoid	HSRRB	-666	cancer cell line	N	-666	fh_KMS28BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.3	23.27	57	0.3516	0.3438	0.3687	0.3385	0.2680	0.3276	0.3207	0.3536	0.3644	0.3568
SUPM2	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_G05_569418	41.6	155	SUP-M2	-666	F	lymphoma,anaplastic large cell	SUPM2	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	20.19	55	0.3378	0.3503	0.3791	0.3274	0.2683	0.3170	0.3174	0.3573	0.3569	0.3608
NAMALWA	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_A03_779760	46.2	172	NAMALWA	-666	F	lymphoma,Burkitts	NAMALWA	haematopoietic,B lymphocyte	ATCC	CRL-1432	cancer cell line	-666	-666	fh_NAMALWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	15.67	54	0.3365	0.3324	0.3675	0.3262	0.2337	0.3167	0.3137	0.3583	0.3633	0.3640
HEL9217	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_E12_419772	60.8	208	HEL 92.1.7	Identical lines: HEL 92.1.7 is a subclone of HEL	M	AML,erytholeukemia	HEL9217	haematopoietic,lymphoid,erythroblast	ATCC	TIB-180	cancer cell line	-666	-666	fh_HEL9217_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.3	20.09	53	0.3289	0.3445	0.3771	0.3414	0.2534	0.3046	0.3259	0.3467	0.3699	0.3607
PEER	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_B05_454596	38.5	135	-666	-666	F	leukaemia,acute lymphoblastic B cell	PEER	haematopoietic,lymphoid	HSRRB	-666	cancer cell line	N	-666	fh_PEER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.7	15.14	55	0.3322	0.3262	0.3625	0.3246	0.2348	0.3228	0.3292	0.3559	0.3591	0.3827
697	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_E04_474704	49.5	160	-666	-666	M	leukaemia,acute lymphoblastic B cell	697	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_697_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	17.16	54	0.3448	0.3311	0.3600	0.3259	0.2427	0.3170	0.3221	0.3542	0.3530	0.3673
SKNDZ	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_H04_454728	45.4	198	SK-N-DZ	-666	F	neuroblastoma,embryonal	SKNDZ	autonomic ganglia	ATCC	CRL-2149	cancer cell line	Y	bone_marrow	fh_SKNDZ_AUTONOMIC_GANGLIA-Tumor	rnaseq	6	16.22	55	0.3223	0.3428	0.3804	0.3403	0.2668	0.2956	0.3209	0.3508	0.3615	0.3785
KYSE30	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_E06_257704	40.9	122	KYSE-30	-666	M	carcinoma,squamous cell	KYSE30	oesophagus	DSMZ	-666	cancer cell line	N	-666	fh_KYSE30_OESOPHAGUS-Tumor	rnaseq	7.2	27.21	56	0.3344	0.3517	0.3645	0.3300	0.3582	0.3144	0.3099	0.3446	0.3575	0.3488
NCIH2106	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_H12_302140	29.9	108	NCI-H2106|H2106	-666	M	carcinoma,non-small cell	NCIH2106	lung	ATCC	CRL-5923	cancer cell line	Y	lymph_node	fh_NCIH2106_LUNG-Tumor	rnaseq	4.7	24.19	57	0.3293	0.3435	0.3677	0.3278	0.2734	0.2930	0.3255	0.3512	0.3572	0.3585
NCIH1694	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_A03_436582	41.2	179	NCI-H1694|H1694	-666	M	carcinoma,small cell	NCIH1694	lung	ATCC	CRL-5888	cancer cell line	Y	ascites	fh_NCIH1694_LUNG-Tumor	rnaseq	4.9	30.58	56	0.3252	0.3561	0.3756	0.3465	0.2603	0.2924	0.3163	0.3551	0.3541	0.3698
NCIH1385	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_B04_523612	30.9	94	NCI-H1385	-666	F	carcinoma,neuroendocrine,squamous cell	NCIH1385	lung	ATCC	CRL-5867	cancer cell line	Y	lymph_node	fh_NCIH1385_LUNG-Tumor	rnaseq	5.6	12.76	57	0.3494	0.3529	0.3584	0.3316	0.3025	0.2876	0.3208	0.3499	0.3355	0.3479
DMS79	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_H10_296176	24.5	95	DMS 79	-666	-666	carcinoma,small cell	DMS79	lung	ATCC	CRL-2049	cancer cell line	-666	-666	fh_DMS79_LUNG-Tumor	rnaseq	4.1	23.91	58	0.3196	0.3393	0.3732	0.3181	0.2662	0.2916	0.3329	0.3515	0.3619	0.3687
NCIH1963	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_D08_241128	32.3	135	NCI-H1963|H-1963|H1963	-666	M	carcinoma,small cell	NCIH1963	lung	ATCC	CRL-5982	cancer cell line	-666	-666	fh_NCIH1963_LUNG-Tumor	rnaseq	5.3	23.68	57	0.3251	0.3366	0.3684	0.3258	0.2723	0.2865	0.3193	0.3552	0.3499	0.3736
JURLMK1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_G09_523582	51.1	172	JURL-MK1	blast phase	M	CML,blast phase	JURLMK1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_JURLMK1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.8	21.29	55	0.3318	0.3362	0.3622	0.3228	0.2746	0.2994	0.3333	0.3443	0.3685	0.3628
THP1	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_F05_419794	42.7	128	THP-1	-666	M	leukemia,acute monocytic	THP1	haematopoietic,lymphoid,monocyte	ATCC	TIB-202	cancer cell line	-666	-666	fh_THP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	18.85	55	0.3303	0.3270	0.3558	0.3295	0.2671	0.2972	0.3214	0.3491	0.3569	0.3656
RAJI	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_F03_436472	42.8	174	-666	-666	M	lymphoma,Burkitts	RAJI	haematopoietic,B lymphocyte	ATCC	CCL-86	cancer cell line	-666	-666	fh_RAJI_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.6	19.38	55	0.3284	0.3296	0.3605	0.3245	0.2277	0.3167	0.3016	0.3535	0.3599	0.3594
KNS42	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_F05_383662	22.9	92	KNS-42	-666	M	glioma	KNS42	CNS	HSRRB	-666	cancer cell line	-666	-666	fh_KNS42_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	15.7	20.43	58	0.3314	0.3396	0.3614	0.3339	0.2927	0.2883	0.3293	0.3411	0.3492	0.3553
HSC4	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_G04_419802	19.1	60	HSC-4	-666	M	carcinoma,squamous cell	HSC4	upper aerodigestive tract,tongue	HSRRB	-666	cancer cell line	-666	-666	fh_HSC4_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	15.7	27.35	59	0.3297	0.3471	0.3585	0.3119	0.3032	0.3060	0.3071	0.3455	0.3564	0.3590
BL70	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_E11_454676	44.2	158	BL-70	-666	M	lymphoid neoplasm	BL70	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.9	13.27	55	0.3334	0.3220	0.3594	0.3218	0.2205	0.3119	0.3019	0.3506	0.3561	0.3536
MV411	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_C10_257664	56.6	175	MV-4-11	-666	M	leukemia,biphenotypic B myelomonocytic	MV411	haematopoietic,lymphoid	ATCC	CRL-9591	cancer cell line	-666	-666	fh_MV411_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	19.32	54	0.3432	0.3212	0.3427	0.3121	0.2578	0.3082	0.3184	0.3578	0.3541	0.3598
F36P	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_H05_474752	62.1	206	F-36P	-666	M	leukemia,AML	F36P	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_F36P_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.1	20.39	53	0.3392	0.3360	0.3583	0.3259	0.2713	0.3049	0.3175	0.3372	0.3391	0.3445
REH	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_G12_454736	40.8	163	-666	-666	-666	leukaemia,acute lymphoblastic B cell leukaemia,non-T,non-B	REH	haematopoietic,lymphoid	ATCC	CRL-8286	cancer cell line	-666	-666	fh_REH_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.6	16.2	55	0.3398	0.3194	0.3585	0.3228	0.2261	0.3124	0.3019	0.3454	0.3534	0.3626
DND41	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_C04_523598	40.9	142	DND-41	-666	M	leukaemia,acute lymphoblastic B cell	DND41	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_DND41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.8	16.19	56	0.3343	0.3161	0.3503	0.3156	0.2350	0.3195	0.3195	0.3587	0.3488	0.3650
DB	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_C11_383604	50.1	198	-666	-666	M	lymphoma,diffuse large B cell	DB	haematopoietic,B lymphoblast	ATCC	CRL-2289	cancer cell line	-666	-666	fh_DB_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	3.7	31.87	55	0.3263	0.3310	0.3667	0.3267	0.2469	0.3059	0.3063	0.3441	0.3566	0.3557
MOLM13	BSM_PARES_P_NCLE_RNA_REDO_HG-U133_PLUS_2_E03_257698	88.8	302	MOLM-13	-666	M	leukemia,AML	MOLM13	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_MOLM13_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.2	24.16	52	0.3352	0.3264	0.3539	0.3179	0.2641	0.2966	0.3184	0.3480	0.3491	0.3588
KMS27	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_B06_419854	30	100	KMS-27	-666	M	myeloma,plasma cell	KMS27	haematopoietic,lymphoid	HSRRB	-666	cancer cell line	N	-666	fh_KMS27_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.6	18.09	58	0.3317	0.3420	0.3531	0.3140	0.2609	0.3059	0.3116	0.3434	0.3595	0.3568
HS742T	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_A01_698800	25.5	51	Hs 742.T	-666	F	adenocarcinoma,scirrhous	HS742T	breast	ATCC	CRL-7482	cancer cell line	-666	-666	fh_HS742T_BREAST-Tumor	rnaseq	7.2	24.72	60	0.3328	0.3519	0.3591	0.3080	0.3336	0.3005	0.3153	0.3324	0.3509	0.3420
SKM1	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_B06_454594	32.5	140	SKM-1	-666	M	leukemia,AML	SKM1	haematopoietic,lymphoid	HSRRB	-666	cancer cell line	-666	-666	fh_SKM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.7	23.49	57	0.3328	0.3270	0.3492	0.3209	0.2602	0.2976	0.3125	0.3459	0.3494	0.3584
CI1	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_E12_454674	31.5	127	CI-1	-666	F	lymphoma,B cell	CI1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	17.26	55	0.3323	0.3242	0.3567	0.3184	0.2367	0.3169	0.2987	0.3491	0.3584	0.3466
SET2	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_D07_587724	41.2	148	SET-2	established from the peripheral blood of a 71-year-old woman with essential thrombocythemia at megakaryoblastic leukemic transformation in 1995; cells were described to carry the JAK2 V617F mutation	F	haematopoietic neoplasm,Thrombocythemia	SET2	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_SET2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5	27.49	57	0.3467	0.3419	0.3515	0.3230	0.2595	0.2940	0.3289	0.3445	0.3441	0.3379
MC116	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_A07_383728	65.1	241	-666	B_cell_lymphoma_unspecified, undifferentiated, non-Hodgkin"s	M	lymphoma,B cell	MC116	haematopoietic,B lymphoblast	ATCC	CRL-1649	cancer cell line	Y	ascites	fh_MC116_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.3	19.09	53	0.3348	0.3290	0.3534	0.3191	0.2273	0.3204	0.3025	0.3514	0.3536	0.3492
HS819T	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_C01_454612	22.4	59	HS 819.T	-666	M	chondrosarcoma	HS819T	bone	ATCC	CRL-7891	cancer cell line	-666	-666	fh_HS819T_BONE-Tumor	rnaseq	7.2	32.56	60	0.3264	0.3531	0.3598	0.3196	0.3366	0.2951	0.3210	0.3387	0.3459	0.3489
BICR56	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_A02_698820	32.3	70	BICR 56	-666	F	carcinoma,squamous cell	BICR56	upper aerodigestive tract,mouth	ECACC	-666	cancer cell line	N	-666	fh_BICR56_UPPER_AERODIGESTIVE_TRACT-Tumor	rnaseq	7.2	18.31	57	0.3257	0.3461	0.3593	0.3210	0.3526	0.3055	0.3044	0.3360	0.3441	0.3447
PFEIFFER	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_B06_474580	43.2	164	-666	-666	M	lymphoma,diffuse large B cell	PFEIFFER	haematopoietic,B lymphocyte	ATCC	CRL-2632	cancer cell line	Y	pleural_effusion	fh_PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	23.35	54	0.3266	0.3306	0.3588	0.3254	0.2412	0.3109	0.3033	0.3551	0.3468	0.3469
RI1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_H01_523574	54.8	175	RI-1	established from the peripheral blood of a 57-year-old woman with B-cell Non-Hodgkin lymphoma (B-NHL, lymphocytic, small cell type progressing to large non-convoluted cell type) in the refractory terminal stage in 1977	F	lymphoma,B cell	RI1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_RI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.7	15.46	53	0.3433	0.3276	0.3501	0.3159	0.2406	0.3242	0.3085	0.3601	0.3584	0.3492
MM1S	BSM_METIS_P_NCLE_RNA1_HUMAN_U133_PLUS_2.0_G08_241008	48.7	153	-666	-666	-666	myeloma,plasma cell	MM1S	haematopoietic,lymphoid	-666	-666	cancer cell line	-666	-666	fh_MM1S_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	17.5	54	0.3343	0.3289	0.3499	0.3171	0.2525	0.3118	0.3055	0.3420	0.3533	0.3297
AMO1	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_H11_474690	26.5	94	AMO-1	-666	F	myeloma,plasma cell	AMO1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	14.38	56	0.3398	0.3231	0.3486	0.3209	0.2427	0.3049	0.3107	0.3422	0.3578	0.3391
GA10	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_G04_383646	37.5	135	GA-10	-666	M	lymphoma,Burkitts	GA10	haematopoietic,B lymphocyte	ATCC	CRL-2392	cancer cell line	-666	-666	fh_GA10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.7	14.92	56	0.3212	0.3111	0.3534	0.3164	0.2178	0.3036	0.2919	0.3415	0.3474	0.3530
KARPAS299	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_H04_569434	36.1	110	KARPAS-299	-666	M	lymphoma,anaplastic large cell	KARPAS299	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_KARPAS299_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	13.59	55	0.3272	0.3306	0.3540	0.3113	0.2678	0.3069	0.3080	0.3374	0.3419	0.3496
KMH2	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_F04_474748	24.7	98	KM-H2	-666	M	lymphoma,Hodgkins	KMH2	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_KMH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.1	17.49	57	0.3278	0.3451	0.3529	0.3148	0.2418	0.3099	0.3125	0.3552	0.3426	0.3471
ST486	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_H08_454720	31.2	136	-666	-666	F	lymphoma,Burkitts	ST486	haematopoietic,B lymphoblast	ATCC	CRL-1647	cancer cell line	Y	ascites	fh_ST486_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	14.67	56	0.3261	0.3180	0.3558	0.3112	0.2207	0.3122	0.3005	0.3457	0.3545	0.3529
TTTHYROID	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_B07_523626	23.9	91	TT	-666	F	carcinoma,medulla	TTTHYROID	thyroid	ATCC	CRL-1803	cancer cell line	-666	-666	fh_TT_THYROID-Tumor	rnaseq	5.9	45.01	60	0.3414	0.3482	0.3530	0.3151	0.3010	0.2963	0.3187	0.3395	0.3372	0.3440
KMRC3	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_A08_454772	29.2	79	KMRC-3	-666	-666	clear cell renal cell carcinoma	KMRC3	kidney	HSRRB	-666	cancer cell line	N	-666	fh_KMRC3_KIDNEY-Tumor	rnaseq	6.6	32.33	59	0.3322	0.3517	0.3501	0.3078	0.3156	0.2991	0.3132	0.3396	0.3433	0.3270
MOLM6	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_E07_523534	53.5	162	MOLM-6	blast phase	M	CML,blast phase	MOLM6	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_MOLM6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.9	23.16	55	0.3345	0.3305	0.3411	0.3033	0.2709	0.3011	0.3235	0.3383	0.3430	0.3356
KG1	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_C05_454618	43	157	KG-1	-666	M	leukemia,AML	KG1	haematopoietic,B lymphoblast	ATCC	CCL-246;CRL-8031	cancer cell line	-666	-666	fh_KG1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.1	25.8	56	0.3335	0.3240	0.3499	0.3125	0.2467	0.3073	0.3192	0.3361	0.3468	0.3500
P3HR1	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_A05_436586	47.4	184	P3HR-1	-666	M	lymphoma,Burkitts	P3HR1	haematopoietic,B lymphoblast	ATCC	HTB-62	cancer cell line	Y	ascites	fh_P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.4	19.37	55	0.3228	0.3098	0.3488	0.3170	0.2265	0.3088	0.2980	0.3443	0.3478	0.3503
KMS21BM	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_B04_419850	49.3	141	KMS-21BM	-666	M	myeloma,plasma cell	KMS21BM	haematopoietic,lymphoid	HSRRB	-666	cancer cell line	N	-666	fh_KMS21BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.9	22.39	55	0.3385	0.3309	0.3480	0.3097	0.2725	0.3032	0.3125	0.3318	0.3429	0.3311
KARPAS620	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_F09_474650	42.2	131	KARPAS-620	-666	F	myeloma,plasma cell	KARPAS620	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_KARPAS620_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	15.41	55	0.3347	0.3176	0.3511	0.3167	0.2464	0.3149	0.3055	0.3383	0.3490	0.3384
TOLEDO	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_D06_436564	48.8	170	-666	-666	F	lymphoma,diffuse large B cell	TOLEDO	haematopoietic,lymphoid,T lymphocyte	ATCC	CRL-2631	cancer cell line	-666	-666	fh_TOLEDO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.5	19.97	55	0.3212	0.3204	0.3605	0.3127	0.2233	0.3029	0.3023	0.3384	0.3594	0.3527
SKNBE2	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_C06_454620	28.1	128	SK-N-BE(2)	-666	M	neuroblastoma	SKNBE2	autonomic ganglia	ATCC	CRL-2271	cancer cell line	Y	bone_marrow	fh_SKNBE2_AUTONOMIC_GANGLIA-Tumor	rnaseq	5.6	28.56	58	0.3058	0.3358	0.3574	0.3090	0.2571	0.2773	0.3148	0.3358	0.3392	0.3523
BDCM	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_H04_296164	38.2	130	-666	-666	M	leukaemia,acute lymphoblastic B cell	BDCM	haematopoietic,lymphoid	ATCC	CRL-2740	cancer cell line	-666	-666	fh_BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	18.63	55	0.3236	0.3256	0.3437	0.3075	0.2444	0.3064	0.3070	0.3393	0.3465	0.3417
MONOMAC1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_G03_523458	58.9	176	MONO-MAC-1	MONO-MAC-1 and MONO-MAC-6 were derived from the same patient	M	leukemia,AML	MONOMAC1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_MONOMAC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.7	21.52	54	0.3338	0.3161	0.3425	0.3122	0.2614	0.2922	0.3038	0.3372	0.3323	0.3438
L363	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_F03_474754	42.3	153	L-363	-666	F	myeloma,plasma cell	L363	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	12.42	55	0.3130	0.3264	0.3577	0.3154	0.2678	0.2832	0.3065	0.3170	0.3390	0.3370
L1236	BSM_BRAKE_P_NCLE_RNA2_HG-U133_PLUS_2_H01_241210	32.2	122	L-1236	-666	M	lymphoma,Hodgkins	L1236	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_L1236_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	19.65	56	0.3293	0.3337	0.3400	0.3101	0.2471	0.3120	0.3027	0.3551	0.3417	0.3359
INA62	-666	50.5	185	-666	-666	-666	-666	INA62	-666	-666	-666	cancer cell line	-666	-666	fh_INA-6-2-Tumor	rnaseq	5.3	20.26	55	0.3154	0.3179	0.3487	0.3140	0.2548	0.2877	0.3038	0.3270	0.3450	0.3416
SUDHL5	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_G02_474760	59.8	211	SU-DHL-5	-666	F	lymphoma,diffuse large B cell	SUDHL5	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_SUDHL5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.3	22.62	54	0.3179	0.3065	0.3483	0.3125	0.2231	0.3053	0.2977	0.3393	0.3402	0.3514
HEL	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_B04_698780	61.6	191	HEL	Identical lines: HEL 92.1.7 is a subclone of HEL	M	leukaemia,AML	HEL	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_HEL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.4	19.51	53	0.3174	0.3253	0.3446	0.3158	0.2568	0.2919	0.3186	0.3377	0.3386	0.3405
HS737T	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_F03_454682	22.9	63	HS 737.T	-666	F	sarcoma,giant cell	HS737T	bone	ATCC	CRL-7473	cancer cell line	-666	-666	fh_HS737T_BONE-Tumor	rnaseq	7.2	29.31	60	0.3218	0.3418	0.3485	0.3099	0.3287	0.2826	0.3055	0.3269	0.3382	0.3382
EM2	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_D10_474678	46	157	EM-2	-666	F	CML,blast phase	EM2	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.2	20.24	56	0.3172	0.3217	0.3429	0.3144	0.2592	0.2927	0.3144	0.3357	0.3387	0.3486
A3KAW	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_F06_419792	23.1	85	A3-KAW	-666	F	lymphoma,diffuse large B cell	A3KAW	haematopoietic,lymphoid,stomach	HSRRB	-666	cancer cell line	-666	-666	fh_A3KAW_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	16.82	58	0.3184	0.3239	0.3338	0.3076	0.2820	0.2945	0.3116	0.3274	0.3435	0.3414
M07E	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_E06_474722	40.7	151	M-07E|MO7e	-666	F	leukemia,AML	M07E	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_M07E_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	17.13	55	0.3215	0.3200	0.3441	0.3077	0.2663	0.2937	0.3117	0.3280	0.3403	0.3487
NCIH1105	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_E03_569422	28	116	NCI-H1105|H1105	-666	M	carcinoma,small cell	NCIH1105	lung	ATCC	CRL-5856	cancer cell line	Y	lymph_node	fh_NCIH1105_LUNG-Tumor	rnaseq	4	29.51	58	0.3041	0.3147	0.3467	0.3088	0.2518	0.2731	0.3098	0.3300	0.3422	0.3466
CORL24	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_E06_569536	26.5	94	COR-L24	-666	M	carcinoma,small cell	CORL24	lung	ECACC	-666	cancer cell line	N	-666	fh_CORL24_LUNG-Tumor	rnaseq	4.8	27.81	59	0.3000	0.3242	0.3515	0.3062	0.2459	0.2741	0.2970	0.3361	0.3400	0.3440
L540	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_H03_523604	35.4	123	L-540	-666	F	lymphoma,Hodgkins	L540	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_L540_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.7	19.61	56	0.3207	0.3145	0.3381	0.3083	0.2426	0.3009	0.3223	0.3397	0.3369	0.3389
HT	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_G12_383614	41.1	181	-666	B_cell_lymphoma_unspecified,diffuse mixed	M	lymphoma,B cell	HT	haematopoietic,B lymphoblast	ATCC	CRL-2260	cancer cell line	Y	ascites	fh_HT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.8	20.53	55	0.3183	0.3108	0.3452	0.3093	0.2262	0.2946	0.2963	0.3280	0.3436	0.3485
NOMO1	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_C11_474588	48.3	163	NOMO-1	-666	F	leukemia,AML	NOMO1	haematopoietic,lymphoid	HSRRB	-666	cancer cell line	-666	-666	fh_NOMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.9	25.94	55	0.3233	0.3063	0.3279	0.3052	0.2552	0.2968	0.3026	0.3396	0.3320	0.3348
HCC33	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_B10_698916	37	133	HCC-33	-666	M	carcinoma,small cell	HCC33	lung	DSMZ	-666	cancer cell line	N	-666	fh_HCC33_LUNG-Tumor	rnaseq	5.3	23.93	57	0.2988	0.3221	0.3606	0.3068	0.2435	0.2704	0.2981	0.3185	0.3423	0.3568
P31FUJ	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_C03_436532	28.6	111	P31-FUJ	-666	M	leukemia,AML	P31FUJ	haematopoietic,lymphoid	HSRRB	-666	cancer cell line	-666	-666	fh_P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	19.97	56	0.3209	0.3105	0.3279	0.3026	0.2562	0.2862	0.3035	0.3328	0.3308	0.3433
CD34	-666	36.6	121	CD34	-666	-666	CD34+ cells	CD34	bone marrow	-666	-666	primary	N	-666	CMAP_CD34POS	rnaseq	6.7	22.21	57	0.3213	0.3151	0.3374	0.3081	0.2546	0.2820	0.3064	0.3285	0.3344	0.3335
SUDHL10	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_E03_523566	62.1	186	SU-DHL-10	-666	M	lymphoma,diffuse large B cell	SUDHL10	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	Y	pleura	fh_SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.1	16.04	54	0.3179	0.3045	0.3406	0.3038	0.2243	0.3046	0.2902	0.3286	0.3366	0.3408
NCIH1876	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_E05_569520	27.4	114	NCI-H1876|H1876	-666	M	carcinoma,small cell	NCIH1876	lung	ATCC	CRL-5902	cancer cell line	Y	lymph_node	fh_NCIH1876_LUNG-Tumor	rnaseq	4.9	22.89	58	0.3023	0.3195	0.3462	0.3109	0.2623	0.2656	0.2919	0.3246	0.3293	0.3460
SEM	BSM_NIECE_P_NCLE_RNA3_HG-U133_PLUS_2_A12_296012	32.8	128	-666	-666	F	leukaemia,acute lymphoblastic B cell	SEM	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_SEM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.9	17.23	56	0.3187	0.3143	0.3392	0.3025	0.2336	0.2939	0.2879	0.3294	0.3447	0.3341
EJM	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_H06_474692	28.7	94	-666	-666	F	myeloma,plasma cell	EJM	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_EJM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	17.32	57	0.3188	0.3177	0.3389	0.2983	0.2498	0.2911	0.2938	0.3253	0.3343	0.3277
CHP126	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_F01_523554	36.6	130	CHP-126	-666	F	neuroblastoma	CHP126	autonomic ganglia	DSMZ	-666	cancer cell line	-666	-666	fh_CHP126_AUTONOMIC_GANGLIA-Tumor	rnaseq	5.9	27.65	57	0.3025	0.3297	0.3457	0.3014	0.2564	0.2711	0.3089	0.3200	0.3307	0.3362
HNT342	-666	39	155	-666	-666	-666	-666	HNT342	-666	-666	-666	cancer cell line	-666	-666	fh_HNT-34-2-Tumor	rnaseq	5.2	24.43	56	0.3257	0.3206	0.3333	0.2922	0.2759	0.2950	0.3024	0.3186	0.3279	0.3272
HS822T	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_E08_454666	22.2	59	HS 822.T	-666	F	sarcoma,Ewings,PNET	HS822T	bone	ATCC	CRL-7556	cancer cell line	-666	-666	fh_HS822T_BONE-Tumor	rnaseq	6.6	29.94	61	0.3160	0.3323	0.3416	0.3034	0.3293	0.2773	0.3032	0.3189	0.3333	0.3311
KO52	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_B07_419852	47.3	161	K052	-666	M	leukemia,AML	KO52	haematopoietic,lymphoid	HSRRB	-666	cancer cell line	N	-666	fh_KO52_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.7	23.63	56	0.3201	0.3105	0.3347	0.3007	0.2454	0.2891	0.3048	0.3279	0.3296	0.3390
OCIM1	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_F11_474766	46.9	183	OCI-M1	-666	-666	leukemia,AML	OCIM1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_OCIM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.3	20.77	54	0.3145	0.3158	0.3404	0.3090	0.2582	0.2796	0.2944	0.3187	0.3283	0.3340
SUDHL4	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_E04_523644	53	186	SU-DHL-4	-666	M	lymphoma,diffuse large B cell	SUDHL4	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	Y	pleura	fh_SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6	21.63	55	0.3167	0.3098	0.3336	0.3020	0.2281	0.2919	0.2851	0.3308	0.3359	0.3354
NUDUL1	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_F06_474744	40.2	127	NU-DUL-1	-666	M	lymphoma,B cell	NUDUL1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_NUDUL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	16.03	55	0.3156	0.2993	0.3372	0.2992	0.2210	0.2979	0.2815	0.3302	0.3338	0.3332
SUDHL6	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_F08_474592	55.4	189	SU-DHL-6	-666	M	lymphoma,diffuse large B cell	SUDHL6	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.2	19.3	55	0.3173	0.3029	0.3357	0.3049	0.2171	0.3025	0.2930	0.3297	0.3334	0.3273
JJN3	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_C08_523538	55.7	187	JJN-3	-666	F	myeloma,plasma cell	JJN3	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_JJN3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.9	20.36	55	0.3104	0.3092	0.3416	0.3095	0.2411	0.2897	0.2967	0.3185	0.3389	0.3298
KHM1B	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_C08_419728	30.6	106	KHM-1B	-666	M	myeloma,plasma cell	KHM1B	haematopoietic,lymphoid	HSRRB	-666	cancer cell line	N	-666	fh_KHM1B_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	13.76	57	0.3227	0.2992	0.3307	0.2986	0.2446	0.2942	0.2887	0.3258	0.3396	0.3328
JM1	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_H02_383622	32.3	130	-666	-666	-666	lymphoma,B cell	JM1	haematopoietic,lymphoid	ATCC	CRL-10423	cancer cell line	-666	-666	fh_JM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6	14.1	56	0.3096	0.2967	0.3425	0.3035	0.1978	0.2850	0.2875	0.3284	0.3449	0.3409
PLB9852	-666	56.9	187	-666	-666	-666	-666	PLB9852	-666	-666	-666	cancer cell line	-666	-666	fh_PLB-985-2-Tumor	rnaseq	6.3	22.11	54	0.3113	0.3112	0.3301	0.3008	0.2557	0.2834	0.3024	0.3248	0.3259	0.3372
OCIAML5	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_G10_523540	63	206	OCI-AML5	-666	M	leukemia,AML	OCIAML5	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.9	21.7	54	0.3226	0.3001	0.3276	0.2958	0.2544	0.2739	0.3011	0.3265	0.3305	0.3307
KMS11	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_G05_419804	45.2	148	KMS-11	-666	F	myeloma,plasma cell	KMS11	haematopoietic,lymphoid	HSRRB	-666	cancer cell line	N	-666	fh_KMS11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6	18.87	55	0.3021	0.3088	0.3412	0.3097	0.2332	0.2828	0.2948	0.3202	0.3360	0.3309
CMK	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_F12_587556	42.9	127	-666	Identical lines: CMK, CMK-86 and CMK-11-5 share high SNP identity	-666	leukemia,AML	CMK	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_CMK_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.9	19.19	55	0.3116	0.3164	0.3337	0.3055	0.2340	0.2817	0.2993	0.3240	0.3294	0.3243
JEKO1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_C07_523466	39.1	124	JEKO-1	-666	F	lymphoma,mantle cell	JEKO1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_JEKO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	16.05	56	0.3315	0.2955	0.3257	0.2955	0.2187	0.3003	0.2935	0.3398	0.3442	0.3294
SUPT1	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_F05_436460	37.5	163	SUP-T1	-666	M	leukaemia,T-ALL	SUPT1	haematopoietic,lymphoid,T lymphoblast	ATCC	CRL-1942	cancer cell line	-666	-666	fh_SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.4	18.01	55	0.2964	0.3071	0.3461	0.3049	0.2123	0.2861	0.3005	0.3239	0.3276	0.3496
RPMI8402	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_C04_474596	41.8	126	RPMI-8402	-666	F	leukaemia,T-ALL	RPMI8402	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.2	13.72	55	0.3046	0.3012	0.3285	0.2969	0.2243	0.2917	0.2941	0.3301	0.3300	0.3451
SUPB15	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_G04_436500	40.6	154	SUP-B15	-666	M	leukaemia,acute lymphoblastic B cell	SUPB15	haematopoietic,lymphoid,spleen	ATCC	CRL-1929	cancer cell line	-666	-666	fh_SUPB15_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.3	23.99	56	0.3119	0.3019	0.3371	0.2973	0.2203	0.3010	0.2856	0.3230	0.3293	0.3360
MEC1	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_F12_474616	34	114	MEC-1	MEC-1 and MEC-2 were derived from the same patient	M	chronic lymphocytic leukaemia-small lymphocytic Lymphoma	MEC1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_MEC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	16.07	56	0.3092	0.3059	0.3340	0.2946	0.2223	0.2952	0.2931	0.3203	0.3317	0.3174
U266B1	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_H05_419830	45.6	161	U-266	-666	M	myeloma,plasma cell	U266B1	haematopoietic,B lymphoblast	ATCC	TIB-196	cancer cell line	-666	-666	fh_U266B1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.5	19.14	55	0.3021	0.3111	0.3350	0.2953	0.2382	0.2864	0.2859	0.3124	0.3329	0.3200
LAMA84	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_F04_523560	51.8	161	LAMA-84	-666	F	CML,blast phase	LAMA84	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_LAMA84_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	17.06	55	0.2992	0.3176	0.3293	0.3054	0.2675	0.2750	0.3020	0.3209	0.3279	0.3274
KARPAS422	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_H02_523610	37.2	160	KARPAS-422	Identical lines: KARPAS-422 and OCI-LY10 share high SNP identity.	-666	lymphoma,diffuse large B cell	KARPAS422	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_KARPAS422_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.5	31.15	56	0.3018	0.3032	0.3208	0.2902	0.2400	0.2882	0.2932	0.3227	0.3123	0.3292
HUNS1	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_A09_436608	29	113	-666	-666	M	myeloma,plasma cell	HUNS1	haematopoietic,lymphoid	ATCC	-666	cancer cell line	-666	-666	fh_HUNS1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	15.65	56	0.3031	0.3054	0.3280	0.2940	0.2106	0.3023	0.2953	0.3247	0.3291	0.3216
ME1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_C05_523542	64.1	208	ME-1	-666	M	leukemia,AML	ME1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_ME1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.3	22.05	55	0.3273	0.2991	0.3174	0.2802	0.2423	0.2878	0.2887	0.3259	0.3289	0.3269
SUDHL8	BSM_GILDS_P_NCLE_RNA11_REDO_HG-U133_PLUS_2_G04_587730	33.9	124	SU-DHL-8	-666	M	lymphoma,diffuse large B cell	SUDHL8	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	11.23	55	0.3073	0.2877	0.3310	0.2958	0.2186	0.2919	0.2839	0.3196	0.3290	0.3256
HS611T	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_D05_436566	45.2	152	HS 611.T	-666	F	lymphoma,Hodgkins	HS611T	haematopoietic,lymphoid,spleen	ATCC	CRL-7373	cancer cell line	-666	-666	fh_HS611T_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	22.25	55	0.3080	0.2976	0.3300	0.2902	0.2172	0.2958	0.2727	0.3242	0.3326	0.3222
MOLT13	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_A10_523630	42.9	137	MOLT-13	-666	F	leukaemia,T-ALL	MOLT13	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_MOLT13_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.2	19.12	55	0.2929	0.2927	0.3300	0.2899	0.2115	0.2845	0.2919	0.3217	0.3182	0.3287
SR786	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_A11_523508	24.2	90	SR-786|SR	-666	M	lymphoma,anaplastic large cell	SR786	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	Y	pleura	fh_SR786_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	11.4	57	0.3031	0.3096	0.3483	0.2997	0.2499	0.2706	0.2863	0.3198	0.3225	0.3244
NCCSTCK140	BSM_GAZER_P_NCLE_EXPR_P13_HG-U133_PLUS_2_C06_779678	30.7	110	NCC-StC-K140	-666	-666	carcinoma	NCCSTCK140	stomach	RIKEN	JCRB1228	cancer cell line	-666	-666	fh_NCCSTCK140_STOMACH-Tumor	rnaseq	5.9	26.47	58	0.3158	0.3174	0.3281	0.2994	0.2924	0.2814	0.2841	0.3087	0.3167	0.3126
KE37	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_G11_523586	32.3	122	KE-37	-666	M	leukaemia,T-ALL	KE37	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_KE37_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.3	20.98	57	0.2960	0.2934	0.3279	0.2906	0.2073	0.2850	0.2929	0.3260	0.3218	0.3334
OCIAML3	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_E02_523588	66.3	188	OCI-AML3	-666	M	leukemia,AML	OCIAML3	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_OCIAML3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.4	17.31	54	0.3255	0.3062	0.3125	0.2859	0.2596	0.2766	0.3032	0.3312	0.3147	0.3140
WSUDLCL2	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_H07_474624	77	274	WSU-DLCL2	-666	M	lymphoma,diffuse large B cell	WSUDLCL2	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	Y	pleura	fh_WSUDLCL2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.2	24.79	53	0.3068	0.2867	0.3280	0.2888	0.2258	0.2840	0.2729	0.3204	0.3296	0.3238
KASUMI6	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_E09_523592	50.8	168	KASUMI-6	-666	M	leukemia,AML,subtype M2	KASUMI6	haematopoietic,lymphoid	ATCC	CRL-2775	cancer cell line	-666	-666	fh_KASUMI6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.6	30.5	55	0.3063	0.3031	0.3238	0.2932	0.2512	0.2816	0.2954	0.3167	0.3189	0.3200
KMS182	-666	72.6	219	-666	-666	-666	-666	KMS182	-666	-666	-666	cancer cell line	-666	-666	fh_KMS-18-2-Tumor	rnaseq	5.5	25.75	54	0.3044	0.3037	0.3254	0.2894	0.2450	0.2887	0.2805	0.3120	0.3294	0.3210
KPNYN	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_A05_454774	37.3	143	KP-N-YN	-666	-666	neuroblastoma	KPNYN	autonomic ganglia	HSRRB	-666	cancer cell line	-666	-666	fh_KPNYN_AUTONOMIC_GANGLIA-Tumor	rnaseq	5.6	25.31	57	0.2919	0.3160	0.3386	0.2836	0.2332	0.2617	0.2953	0.3105	0.3175	0.3318
OCIMY52	-666	39.4	126	-666	-666	-666	-666	OCIMY52	-666	-666	-666	cancer cell line	-666	-666	fh_OCI-MY5-2-Tumor	rnaseq	7.2	14.94	55	0.3141	0.2925	0.3233	0.2902	0.2439	0.2912	0.2879	0.3142	0.3221	0.3158
OPM2	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_D12_474702	33.5	105	OPM-2	-666	F	myeloma,plasma cell	OPM2	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	12.37	56	0.3039	0.2856	0.3259	0.2871	0.2605	0.2826	0.2787	0.3028	0.3231	0.3232
JK1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_G12_523456	42	141	JK-1	blast phase	M	CML,blast phase	JK1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_JK1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.7	20.15	56	0.2917	0.3109	0.3264	0.2980	0.2660	0.2733	0.2972	0.3126	0.3198	0.3100
MHHCALL2	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_E05_474712	45.7	189	MHH-CALL-2	-666	F	leukaemia,acute lymphoblastic B cell	MHHCALL2	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_MHHCALL2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	4.9	25.93	55	0.3077	0.2923	0.3210	0.2839	0.2270	0.2938	0.2739	0.3174	0.3296	0.3227
KASUMI2	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_C03_523468	28.6	114	KASUMI-2	-666	M	leukaemia,acute lymphoblastic B cell	KASUMI2	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_KASUMI2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.5	21.51	57	0.3111	0.2976	0.3241	0.2955	0.2250	0.2901	0.2850	0.3257	0.3208	0.3175
OCIMY72	-666	59.3	205	-666	-666	-666	-666	OCIMY72	-666	-666	-666	cancer cell line	-666	-666	fh_OCI-MY7-2-Tumor	rnaseq	4.7	25.76	55	0.3036	0.3042	0.3257	0.2866	0.2633	0.2711	0.2827	0.3031	0.3280	0.3033
JURKAT	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_E03_474654	43	144	-666	-666	M	leukaemia,acute lymphoblastic B cell	JURKAT	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_JURKAT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	4.8	23.73	56	0.3008	0.2917	0.3196	0.2863	0.2116	0.2833	0.2895	0.3242	0.3212	0.3268
OCIAML2	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_G07_523548	58.2	198	OCI-AML2	-666	M	leukemia,AML	OCIAML2	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.2	25.72	55	0.3068	0.2885	0.3175	0.2894	0.2443	0.2658	0.2972	0.3191	0.3183	0.3079
BV173	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_F08_523462	69	203	BV-173	-666	M	CML,blast phase	BV173	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_BV173_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.4	16.9	54	0.3021	0.3008	0.3226	0.2954	0.2274	0.2784	0.2775	0.3111	0.3167	0.3165
NUDHL1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_C09_523624	48.1	149	NU-DHL-1	-666	M	lymphoma,diffuse large B cell	NUDHL1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_NUDHL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	20.87	55	0.3240	0.2943	0.3077	0.2777	0.2377	0.2915	0.2877	0.3218	0.3160	0.2982
EHEB	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_F06_523632	39	114	-666	-666	F	CLL,small lymphocytic lymphoma	EHEB	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_EHEB_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	21.32	56	0.2995	0.2977	0.3166	0.2805	0.2314	0.2916	0.2784	0.3170	0.3194	0.2935
NCO2	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_C05_419702	37.6	156	-666	-666	F	CML	NCO2	haematopoietic,lymphoid	HSRRB	-666	cancer cell line	-666	-666	fh_NCO2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5	27.97	57	0.3000	0.3079	0.3217	0.2886	0.2410	0.2690	0.2890	0.3003	0.3090	0.3138
PRECLH	BSM_RILLS_P_ACHILLESEXP_MAR2011_1_HG-U133_PLUS_2_B05_767792	17	40	-666	-666	-666	immortalized_epithelial	PRECLH	prostate	-666	-666	immortalized_epithelial	-666	-666	fh_PRECLH_PROSTATE-Tumor	rnaseq	4.3	48.78	64	0.2915	0.3266	0.3358	0.2936	0.2598	0.2522	0.2872	0.3072	0.3133	0.2959
DOHH2	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_F09_523480	54	172	DOHH-2	-666	M	lymphoma,diffuse large B cell	DOHH2	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_DOHH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.6	22.96	55	0.3098	0.2908	0.3207	0.2861	0.2168	0.2780	0.2703	0.3116	0.3234	0.3151
MHHNB11	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_A04_523474	63.7	198	MHH-NB-11	-666	M	neuroblastoma	MHHNB11	autonomic ganglia	DSMZ	-666	cancer cell line	-666	-666	fh_MHHNB11_AUTONOMIC_GANGLIA-Tumor	rnaseq	4.3	27.92	55	0.2852	0.3044	0.3192	0.2782	0.2648	0.2574	0.2969	0.3145	0.3068	0.3195
HPBALL	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_D05_523614	32.1	118	HPB-ALL	-666	M	leukaemia,acute lymphoblastic B cell	HPBALL	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_HPBALL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.8	18.19	57	0.2982	0.2840	0.3189	0.2820	0.2126	0.2899	0.2777	0.3194	0.3242	0.3249
NEU	-666	36.3	159	NEU	-666	-666	IPS derived neural progenitor	NEU	CNS	-666	-666	primary	N	-666	CMAP_NEU_1	rnaseq	6.4	20.41	56	0.2798	0.3085	0.3297	0.2798	0.2614	0.2500	0.2830	0.2888	0.3013	0.3220
EOL1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_F10_523454	50	152	EOL-1	-666	M	leukemia,AML	EOL1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_EOL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	4.8	26.44	56	0.3053	0.2940	0.3032	0.2810	0.2319	0.2753	0.2880	0.3066	0.3084	0.3057
GDM1	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_E01_383664	35.4	140	GDM-1	-666	F	leukemia,myelomonoblastic	GDM1	haematopoietic,lymphoid,monoblast	ATCC	CRL-2627	cancer cell line	-666	-666	fh_GDM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.7	27.93	57	0.3033	0.2956	0.3142	0.2793	0.2375	0.2826	0.2745	0.3029	0.3103	0.3001
NALM19	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_D03_523506	38.9	121	NALM-19	-666	M	leukaemia,acute lymphoblastic B cell	NALM19	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_NALM19_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.4	18.65	56	0.2962	0.2887	0.3081	0.2760	0.2181	0.2892	0.2680	0.3088	0.3136	0.3129
ALLSIL	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_C02_523526	42.3	136	ALL-SIL	-666	M	leukaemia,acute lymphoblastic B cell	ALLSIL	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.3	19.38	56	0.2886	0.2807	0.3083	0.2744	0.1985	0.2837	0.2802	0.3075	0.3038	0.3276
MOLT3	-666	56.7	174	MOLT-3	-666	-666	leukemia,ALL	MOLT3	haematopoietic,lymphoid,T lymphoblast	ATCC	CRL-1552	cancer cell line	-666	-666	fh_MOLT3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	4.5	17.27	54	0.2829	0.2761	0.3140	0.2719	0.1981	0.2731	0.2811	0.3093	0.3027	0.3251
NALM1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_G06_523602	37.2	145	NALM-1	-666	F	CML,blast phase	NALM1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_NALM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	4.9	24.83	57	0.2913	0.2796	0.3000	0.2694	0.2157	0.2762	0.2617	0.3073	0.3098	0.3078
P12ICHIKAWA	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_C06_474620	47.1	141	P12-ICHIKAWA	-666	M	leukaemia,T-ALL	P12ICHIKAWA	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	13.28	55	0.2866	0.2725	0.3080	0.2733	0.1894	0.2734	0.2818	0.3133	0.3062	0.3271
HS255T	BSM_CRAZY_P_NCLE_RNA10_HG-U133_PLUS_2_D10_569526	30.4	75	Hs 255.T	-666	F	adenocarcinoma	HS255T	large intestine,colon	ATCC	CRL-7213	cancer cell line	-666	-666	fh_HS255T_LARGE_INTESTINE-Tumor	rnaseq	6.6	36.26	59	0.2836	0.3058	0.3123	0.2771	0.3091	0.2523	0.2802	0.2947	0.3035	0.2998
OCILY19	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_E06_523460	42	135	OCI-LY-19	-666	F	lymphoma,diffuse large B cell	OCILY19	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_OCILY19_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.5	16.74	56	0.3092	0.2824	0.3054	0.2746	0.2073	0.2701	0.2726	0.3065	0.3178	0.2996
GCIY	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_A12_419874	10.8	39	-666	-666	F	carcinoma	GCIY	stomach	RIKEN	-666	cancer cell line	-666	-666	fh_GCIY_STOMACH-Tumor	rnaseq	2.7	47.65	63	0.2832	0.3012	0.3112	0.2824	0.2562	0.2302	0.2783	0.2754	0.2902	0.2746
TALL1	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_G04_698924	55.2	191	TALL-1	-666	M	leukaemia,T-ALL	TALL1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_TALL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	4.8	26.66	55	0.2844	0.2771	0.3198	0.2767	0.1986	0.2708	0.2754	0.2996	0.3041	0.3267
PL21	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_G04_523576	61.8	203	PL-21	-666	M	leukemia,AML	PL21	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_PL21_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.3	24.93	55	0.2859	0.2808	0.3013	0.2732	0.2268	0.2560	0.2880	0.3032	0.2994	0.3142
JVM2	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_F01_474730	32.1	103	JVM-2	-666	F	CLL,small lymphocytic lymphoma	JVM2	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_JVM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.7	19.28	56	0.2826	0.2816	0.2978	0.2666	0.2182	0.2794	0.2709	0.3032	0.3066	0.2910
HUT102	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_F07_436464	38.9	111	HUT 102	-666	M	mycosis fungoides-Sezary syndrome	HUT102	haematopoietic,lymphoid,cutaneous,T lymphocyte	ATCC	TIB-162	cancer cell line	-666	-666	fh_HUT102_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.6	21.09	56	0.2710	0.2853	0.3067	0.2664	0.2196	0.2758	0.2611	0.2955	0.3087	0.2859
KOPN8	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_H12_523484	34.6	126	KOPN-8	-666	F	leukaemia,acute lymphoblastic B cell	KOPN8	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_KOPN8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6	17.66	57	0.2973	0.2733	0.2949	0.2609	0.2053	0.2751	0.2581	0.3068	0.3061	0.3032
MOLT16	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_E08_474644	44.4	131	MOLT-16	-666	F	leukaemia,T-ALL	MOLT16	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_MOLT16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.6	22.42	56	0.2795	0.2627	0.2989	0.2625	0.2004	0.2691	0.2790	0.3039	0.3055	0.3066
D341MED	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_B01_454588	48.9	150	D341 MED	-666	M	PNET,medulloblastoma	D341MED	CNS,cerebellum	ATCC	HTB-187	cancer cell line	-666	-666	fh_D341MED_CENTRAL_NERVOUS_SYSTEM-Tumor	rnaseq	5.5	21.94	55	0.2699	0.2992	0.3045	0.2749	0.2374	0.2270	0.2693	0.2903	0.2940	0.3025
KPNRTBM1	BSM_BITTS_P_NCLE_RNA12_HG-U133_PLUS_2_D04_698920	27.4	103	KP-N-RT-BM-1	-666	-666	neuroblastoma	KPNRTBM1	autonomic ganglia	HSRRB	-666	cancer cell line	-666	-666	fh_KPNRTBM1_AUTONOMIC_GANGLIA-Tumor	rnaseq	5	28.42	59	0.2740	0.2945	0.3088	0.2660	0.2242	0.2439	0.2816	0.2939	0.2865	0.3005
NALM6	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_F11_523638	35.3	137	NALM-6	-666	M	leukaemia,acute lymphoblastic B cell	NALM6	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_NALM6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	4.7	28.09	57	0.2857	0.2703	0.3010	0.2677	0.1842	0.2647	0.2612	0.2979	0.3085	0.3039
LOUCY	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_C10_454628	30.1	122	-666	-666	F	leukemia,ALL t(16;20) translocation	LOUCY	haematopoietic,lymphoid,T lymphoblast	ATCC	CRL-2629	cancer cell line	-666	-666	fh_LOUCY_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.6	23.79	57	0.2742	0.2770	0.3051	0.2656	0.1991	0.2668	0.2571	0.2977	0.3047	0.3094
MHHCALL3	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_G08_523528	34.6	119	MHH-CALL-3	-666	F	leukaemia,acute lymphoblastic B cell	MHHCALL3	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_MHHCALL3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.4	23.27	57	0.2869	0.2744	0.3040	0.2676	0.2013	0.2685	0.2581	0.2981	0.3044	0.2952
OCILY3	BSM_MAKER_P_NCLE_RNA7_HG-U133_PLUS_2_B12_454606	32.9	111	OCI-LY3	-666	-666	lymphoma,diffuse large B cell	OCILY3	haematopoietic,lymphoid	-666	-666	cancer cell line	N	-666	fh_OCILY3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.1	23.12	57	0.2861	0.2755	0.2907	0.2599	0.1878	0.2674	0.2665	0.3013	0.3008	0.2872
CMLT1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_F05_523482	41.1	125	CML-T1	-666	F	CML,blast phase	CMLT1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_CMLT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.4	16.9	55	0.2778	0.2734	0.2977	0.2592	0.2202	0.2633	0.2774	0.2971	0.2956	0.2996
KMS26	BSM_BUNDS_P_NCLE_RNA5_HG-U133_PLUS_2_B05_419848	44.6	139	KMS-26	-666	M	myeloma,plasma cell	KMS26	haematopoietic,lymphoid	HSRRB	-666	cancer cell line	N	-666	fh_KMS26_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	15.7	11.99	54	0.2773	0.2736	0.3065	0.2733	0.2226	0.2597	0.2559	0.2769	0.3104	0.2956
CA46	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_A10_383756	25.4	99	-666	-666	M	lymphoma,Burkitts	CA46	haematopoietic,B lymphocyte	ATCC	CRL-1648	cancer cell line	-666	-666	fh_CA46_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.6	18.94	58	0.2739	0.2727	0.3008	0.2739	0.2100	0.2561	0.2553	0.2929	0.2974	0.2953
OPM12	-666	29.1	89	-666	-666	-666	-666	OPM12	-666	-666	-666	cancer cell line	-666	-666	fh_OPM-1-2-Tumor	rnaseq	6.9	14.6	57	0.2756	0.2633	0.3097	0.2650	0.2311	0.2538	0.2627	0.2784	0.3007	0.2905
DAUDI	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_G11_383602	45.1	148	-666	-666	M	lymphoma,Burkitts	DAUDI	haematopoietic,B lymphoblast	ATCC	CCL-213	cancer cell line	-666	-666	fh_DAUDI_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.3	19.32	55	0.2732	0.2690	0.2981	0.2710	0.1956	0.2633	0.2476	0.2981	0.2965	0.2980
GRANTA519	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_A06_523556	44.9	137	GRANTA-519	-666	F	lymphoma,mantle cell	GRANTA519	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_GRANTA519_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.3	20.1	55	0.2834	0.2781	0.2956	0.2622	0.1984	0.2632	0.2534	0.2899	0.2985	0.2825
EB1	BSM_CASED_P_NCLE_RNA4_HG-U133_PLUS_2_G08_383598	49.9	169	-666	Identical lines: EB1 and EB2 share high SNP identity	F	lymphoma,Burkitts	EB1	haematopoietic,lymphoid	ATCC	HTB-60	cancer cell line	-666	-666	fh_EB1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.8	21.46	55	0.2721	0.2693	0.2979	0.2622	0.2123	0.2545	0.2477	0.2914	0.2929	0.2855
NH6	BSM_AGENT_P_NCLE_RNA6_HG-U133_PLUS_2_C06_436538	24	83	NH-6	-666	-666	neuroblastoma	NH6	autonomic ganglia	HSRRB	-666	cancer cell line	-666	-666	fh_NH6_AUTONOMIC_GANGLIA-Tumor	rnaseq	5.1	34.78	60	0.2643	0.2898	0.3094	0.2607	0.2253	0.2303	0.2796	0.2781	0.2836	0.2866
JVM3	BSM_WATCH_P_NCLE_RNA8_HG-U133_PLUS_2_C10_474758	37.3	114	JVM-3	-666	M	CLL,small lymphocytic lymphoma	JVM3	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_JVM3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	7.2	20.55	56	0.2736	0.2723	0.2803	0.2501	0.2167	0.2601	0.2515	0.2846	0.2901	0.2738
LP1	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_G01_523518	37.7	126	LP-1	-666	F	myeloma,plasma cell	LP1	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_LP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	6.7	17.15	56	0.2766	0.2675	0.2855	0.2640	0.2432	0.2490	0.2471	0.2611	0.2940	0.2787
MHHCALL4	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_H06_523622	33.4	125	MHH-CALL-4	-666	M	leukaemia,acute lymphoblastic B cell	MHHCALL4	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_MHHCALL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	4.8	25.07	58	0.2816	0.2659	0.2822	0.2549	0.1966	0.2617	0.2487	0.2866	0.2922	0.2898
MOLP2	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_A01_523596	40.3	106	MOLP-2	-666	M	myeloma,plasma cell	MOLP2	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_MOLP2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.6	23.62	56	0.2709	0.2645	0.2662	0.2377	0.2286	0.2412	0.2442	0.2723	0.2842	0.2526
MUTZ5	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_H07_523536	30.6	104	MUTZ-5	-666	M	leukaemia,acute lymphoblastic B cell	MUTZ5	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_MUTZ5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	5.5	19.6	58	0.2610	0.2518	0.2663	0.2425	0.1755	0.2481	0.2269	0.2681	0.2737	0.2691
PF382	BSM_SILOS_P_NCLE_RNA9_HG-U133_PLUS_2_G05_523494	45.5	144	PF-382	-666	F	leukaemia,T-ALL	PF382	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	-666	-666	fh_PF382_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	4.7	20.91	56	0.2423	0.2376	0.2728	0.2425	0.1616	0.2302	0.2387	0.2760	0.2679	0.2828
MUTZ3	-666	23.6	105	MUTZ-3	-666	M	leukemia,AML	MUTZ3	haematopoietic,lymphoid	DSMZ	-666	cancer cell line	N	-666	fh_MUTZ3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE-Tumor	rnaseq	4.8	29.25	59	0.2089	0.2101	0.2173	0.1907	0.1989	0.1841	0.1896	0.2068	0.2109	0.2152
